This organization is also tied to Ukraine and its biolabs.

LATEST: OH NOES! #BillGatesBioTerrorist is trending!

NTI Co-Chairman and CEO Ernest J. Moniz and Munich Security Conference (MSC) Chairman Ambassador Wolfgang Ischinger convened 19 current and former global leaders and experts for a March 17, 2021 senior leaders tabletop exercise focused on reducing high-consequence biological threats with potentially catastrophic consequences.

This third annual tabletop exercise organized by NTI’s Global Biological Policy and Programs team (NTI | bio) in conjunction with the MSC is part of the MSC’s “Beyond Westlessness: The Road to Munich 2021” campaign. This effort includes several virtual high-level events and initiatives aimed at advancing the security policy dialogue on priorities for a new transatlantic agenda and laying the groundwork for in-person debates in Munich later in the year. This year’s exercise was conducted on a virtual platform due to the COVID-19 pandemic.

The impact of COVID-19 provided a pressing backdrop for this exercise, as the ongoing pandemic has highlighted weaknesses in the international architecture for preventing, detecting, and responding to pandemic threats. This is an urgent concern because future pandemics could match or exceed COVID-19’s devastating impact in lost lives and shattered economies. Even more concerning is that there are critical gaps in biotechnology oversight that create opportunities for accidental or deliberate misuse with potentially catastrophic global consequences. This was illustrated in the exercise scenario: a localized bioweapons attack with a genetically engineered monkeypox virus begins in the fictional country of Brinia. Over 18 months, the scenario evolves into a globally catastrophic pandemic, leaving 40% of the world’s population infected and over a quarter billion people dead.

The fictional exercise scenario unfolded gradually through a series of short videos that participants reacted to during a facilitated discussion. Key themes emerged regarding the need to strengthen international pandemic risk assessment and early warning systems; to establish clear triggers for national-level anticipatory response and aggressive early action to slow disease transmission and save lives; to reduce biotechnology risks and enhance oversight of life sciences research; and to promote new and stronger international health security preparedness financing mechanisms.

A full report will be published later in 2021. More information about previous exercises can be found in final reports from 2019 and 2020.

Enter the Nuclear Threat Initiative (NTI).

NTI was founded in 2001 by former U.S. Senator Sam Nunn and philanthropist Ted Turner. It serves as the Secretariat for the “Nuclear Security Project”, in cooperation with the Hoover Institution at Stanford. Former Secretary of State George P. Shultz, former Secretary of Defense William J. Perry, former Secretary of State Henry A. Kissinger and Nunn (the “four horsemen of the nuclear apocalypse”) guide the project—an effort to encourage global action to reduce urgent nuclear dangers and build support for reducing reliance on nuclear weapons, ultimately ending them as a threat to the world

Wikipedia

The only connection between nuclear threats and monkey-pox?
Bill Gates and The Rockefeller Foundation, see below:

In early 2018, NTI received a $6 million grant from the Open Philanthropy Project. The grant will be used to “help strengthen its efforts to mitigate global biological threats that have increased as the world has become more interconnected.”

Why?

 In January 2018 NTI announced that it had received $250,000 in support from the Bill and Melinda Gates Foundation. That money will help advance NTI’s efforts in developing a “Global Health Security Index”. The index would analyze a country’s biological programs and policies.

Why?

#BillGatesBioTerrorist: “Ok, What if a bio-terrorist brought smallpox to 10 airports.?”

NTI has received international recognition for work to improve biosecurity, primarily through creating disease surveillance networks. Whether a biological threat is natural or intentional, disease surveillance is a key step in rapid detection and response. Because the response of a health system in one country could have a direct and immediate impact on a neighboring country, or even continent, NTI developed projects that foster cooperation among public health officials across political and geographic boundaries.

In 2003, NTI created the Middle East Consortium for Infectious Disease Surveillance (MECIDS) with participation from Israel, Jordan, and the Palestinian Authority. MECIDS continues to share official health data and conduct infectious disease prevention training.

NTI also created the Connecting Organizations for Disease Surveillance (CORDS), which in 2013 launched as an independent NGO that links international disease surveillance networks, supported by the World Health Organization, and the Food and Agriculture Organization of the United Nations.

This is just the top line of a large and spectacular Board of Directors:

Co-chaired by Moniz, Nunn and Ted Turner, NTI is governed by a Board of Directors with both current and emeritus members from the United States, Japan, India, Pakistan, China, Jordan, Sweden, France and the United Kingdom. They include:

AND BOOM!
The famous Nunn-Lugar duo re-united for yet another mission.
You know them from their previous hit piece, the world famous Nunn–Lugar Act and Pentagon’s activities in the former USSR, including Ukraine’s biolabs.
See: US RAN GRUESOME BIOWEAPON RESEARCH IN OVER 25 COUNTRIES. WUHAN, TIP OF AN ICEBERG

Advisors to the Board of Directors include leading figures in science, business and international security. Advisors to the Board include:

NTI’s staff includes experts in international affairs, nonproliferation, security and military issues, public health, medicine and communications, who have operational experience in their areas of specialty

Former U.S. Secretary of Energy Ernest J. Moniz was named co-chair and chief executive officer by the Board of Directors of the Nuclear Threat Initiative (NTI) in March 2017.  He began serving in June 2017.

An American nuclear physicist who was named as the 13th United States Secretary of Energy by President Barack Obama in May 2013. He is one of the founders of The Cyprus Institute and he was the Associate Director for Science in the Office of Science and Technology Policy in the Clinton administration.

Before his appointment as Secretary of Energy, he served in a variety of advisory capacities, including at BP, General Electric and the King Abdullah Petroleum Studies and Research Center in Riyadh, Saudi Arabia.

WIKIPEDIA

In November 2020, Moniz was named a candidate for Secretary of Energy in the Biden Administration.] However, former Governor of Michigan Jennifer Granholm was chosen instead.[ Most likely because Moniz has been criticized by environmentalists for his ties to the oil and gas industries. During his career, Moniz has served on the advisory boards for BP, one of the largest oil and gas companies, and General Electric. Prior to his appointment as Secretary of Energy, Moniz served as a trustee of the King Abdullah Petroleum Studies and Research Center in Saudi Arabia, according to Wikipedia.

Meanwhile, he turned 200% woke-green.

Al Gore would be pleased to hear that “An Inconvenient Truth,” his documentary on global climate change, passed the MIT test. Ernest J. Moniz, director of the MIT Energy Initiative, and Peter H. Stone, professor of climate dynamics at the MIT Center for Global Change Science, declared that Gore did “a fine job framing the problem.”

MIT

Ah, well…

 His parents were both immigrants from Portugal. Ernest Moniz father’s name is under review and mother unknown at this time. We will continue to update details on Ernest Moniz’s family.

Ted Turner is founder and co-chair of NTI, a global security organization working to reduce threats from nuclear, biological and chemical weapons; chairman of the Turner Foundation, Inc., which supports efforts to grow and diversify the movement, conserve land to protect and restore wildlife and biodiversity, catalyze the transition to a clean energy future, and protect and restore water resources; chairman of the United Nations Foundation, which promotes a more peaceful, prosperous and just world; and chairman and co-founder of the Ted’s Montana Grill restaurant chain, which operates 47 locations nationwide.
Turner is also chairman of Turner Enterprises, Inc., a private company, which manages his business interests, land holdings and investments, including the oversight of two million acres in 11 states and in Argentina, and more than 50,000 bison head.

NIT

Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats

REPORT Nov 23, 2021

In March 2021, NTI partnered with the Munich Security Conference to conduct a tabletop exercise on reducing high-consequence biological threats. The exercise examined gaps in national and international biosecurity and pandemic preparedness architectures—exploring opportunities to improve prevention and response capabilities for high-consequence biological events. Participants included 19 senior leaders and experts from across Africa, the Americas, Asia, and Europe with decades of combined experience in public health, biotechnology industry, international security, and philanthropy.

This report, Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats: Results from the 2021 Tabletop Exercise Conducted in Partnership with the Munich Security Conferencewritten by Jaime M. Yassif, Ph.D., Kevin P. O’Prey, Ph.D., and Christopher R. Isaac, M.Sc., summarizes key findings from the exercise and offers actionable recommendations for the international community.

Exercise Summary

Developed in consultation with technical and policy experts, the fictional exercise scenario portrayed a deadly, global pandemic involving an unusual strain of monkeypox virus that first emerged in the fictional nation of Brinia and spread globally over 18 months. Ultimately, the exercise scenario revealed that the initial outbreak was caused by a terrorist attack using a pathogen engineered in a laboratory with inadequate biosafety and biosecurity provisions and weak oversight. By the end of the exercise, the fictional pandemic resulted in more than three billion cases and 270 million fatalities worldwide.

Discussions throughout the tabletop exercise generated a range of valuable insights and key findings. Most significantly, exercise participants agreed that, notwithstanding improvements following the global response to COVID-19, the international system of pandemic prevention, detection, analysis, warning, and response is woefully inadequate to address current and anticipated future challenges. Gaps in the international biosecurity and pandemic preparedness architecture are extensive and fundamental, undermining the ability of the international community to prevent and mount effective responses to future biological events—including those that could match the impacts of COVID-19 or cause damage that is significantly more severe.

Report Findings and Recommendations

Discussion among exercise participants led to the following key findings:

(The full findings are available on page 14 of the report.)

  • Weak global detection, assessment, and warning of pandemic risks. The international community needs a more robust, transparent detection, evaluation, and early warning system that can rapidly communicate actionable information about pandemic risks.
  • Gaps in national-level preparedness. National governments should improve preparedness by developing national-level pandemic response plans built upon a coherent system of “triggers” that prompt anticipatory action, despite uncertainty and near-term costs—in other words, on a “no-regrets” basis.
  • Gaps in biological research governance. The international system for governing dual-use biological research is neither prepared to meet today’s security requirements, nor is it ready for significantly expanded challenges in the future. There are risk reduction needs throughout the bioscience research and development life cycle.
  • Insufficient financing of international preparedness for pandemics. Many countries around the world lack financing to make the essential national investments in pandemic preparedness.

To address these findings, the report authors developed the following recommendations:

(The full recommendations are available on page 22 of the report.)

  1. Bolster international systems for pandemic risk assessment, warning, and investigating outbreak origins
    • The WHO should establish a graded, transparent, international public health alert system.
    • The United Nations (UN) system should establish a new mechanism for investigating high-consequence biological events of unknown origin, which we refer to as a “Joint Assessment Mechanism.”
  2. Develop and institute national-level triggers for early, proactive pandemic response
    • National governments must adopt a “no-regrets” approach to pandemic response, taking anticipatory action—as opposed to reacting to mounting case counts and fatalities, which are lagging indicators.
    • To facilitate anticipatory action on a no-regrets basis, national governments should develop national-level plans that define and incorporate “triggers” for responding to high-consequence biological events.
  3. Establish an international entity dedicated to reducing emerging biological risks associated with rapid technology advances
    • The international community should establish an entity dedicated to reducing the risk of catastrophic events due to accidental misuse or deliberate abuse of bioscience and biotechnology.
    • To meaningfully reduce risk, the entity should support interventions throughout the bioscience and biotechnology research and development life cycle—from funding, through execution, and on to publication or commercialization.
  4. Develop a catalytic global health security fund to accelerate pandemic preparedness capacity building in countries around the world
    • National leaders, development banks, philanthropic donors, and the private sector should establish and resource a new financing mechanism to bolster global health security and pandemic preparedness.
    • The design and operations of the fund should be catalytic—incentivizing national governments to invest in their own preparedness over the long term.
  5. Establish a robust international process to tackle the challenge of supply chain resilience
    • The UN Secretary General should convene a high-level panel to develop recommendations for critical measures to bolster global supply chain resilience for medical and public health supplies.

EXPERIMENT CONCLUSIONS

To learn more about NTI’s previous tabletop exercises at the Munich Security Conference, see our 2019 report, “A Spreading Plague,” and our 2020 report,  “Preventing Global Catastrophic Biological Risks.”

In 2021, I showed that MICROSOFT CREATED BY IBM TO AVOID ANTI-TRUST LAWS. GATES LIKELY JUST A FRONTMAN.
Just as likely, he left a fading enterprise only to front this bigger and more promising business of ‘plandemics’ and great resets. He’s now the face of GAVI and vaccines, which fronts for, the World Bank, the real plandemic writers and directors, as I’ve shown as far as 2020: FINAL EVIDENCE COVID-19 IS A ‘SIMEX’ – PLANNED SIMULATION EXERCISE BY WHO AND WORLD BANK

It was my mistake to put WB and WHO on the same level in that headline, WHO does not exists as an entity with own will and personality, it’s just a drawer of sock-puppets.

As for the World Bank / IMF, they’re ran by our old (anything but) friends… scroll a bit the PDF below and take a look who authors this internal report I snitched from the WB website!

Simpletons cried it’s impossible to set up a global event like a pandemic because no one can align all these countries.
In fact, about 190 countries and governments owe money to WB / IMF and need to borrow more all the time because they run on debt like Twitter. 190 out of less than 200. There is less agreement over how many countries are there than there is about Covid. Because many countries are not recognized by all players, but Bill Gates is recognized as an Overlords spokesperson.
Running human farms on debt is actually how they ended up in a global economic collapse long before Covid, and this is one of the main reasons behind their desperate need for a Great Reset.


Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review

SOURCE

Abstract

Background: Cases of severe autoimmune blistering diseases (AIBDs) have recently been reported in association with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination.

Aims: To describe a report of oropharyngeal Pemphigus Vulgaris (OPV) triggered by the mRNABNT162b2 vaccine (Comirnaty®/ Pfizer/ BioNTech) and to analyze the clinical and immunological characteristics of the AIBDs cases reported following the SARS-CoV-2 vaccination.

Methods: The clinical and immunological features of our case of OPV were documented. A review of the literature was conducted and only cases of AIBDs arising after the SARS-CoV-2 vaccination were included.

Case report: A 60-year old female patients developed oropharyngeal and nasal bullous lesions seven days after the administration of a second dose of the mRNABNT162b2 vaccine (Comirnaty®/ Pfizer/BioNtech). According to the histology and direct immunofluorescence findings showing the presence of supra-basal blister and intercellular staining of IgG antibodies and the presence of a high level of anti-Dsg-3 antibodies (80 U/ml; normal < 7 U/ml) in the serum of the patients, a diagnosis of oropharyngeal Pemphigus Vulgaris was made.

Review: A total of 35 AIBDs cases triggered by the SARS-CoV-2 vaccination were found (including our report). 26 (74.3%) were diagnosed as Bullous Pemphigoid, 2 (5.7%) as Linear IgA Bullous Dermatosis, 6 (17.1%) as Pemphigus Vulgaris and 1 (2.9%) as Pemphigus Foliaceus. The mean age of the sample was 72.8 years and there was a predominance of males over females (F:M=1:1.7). In 22 (62.9%) cases, the disease developed after Pfizer vaccine administration, 6 (17.1%) after Moderna, 3 (8.6%) after AstraZeneca, 3 (8.6%) after CoronaVac (one was not specified). All patients were treated with topical and/or systemic corticosteroids, with or without the addition of immunosuppressive drugs, with a good clinical response in every case.

Conclusion: Clinicians should be aware of the potential, though rare, occurrence of AIBDs as a possible adverse event after the SARS-CoV-2 vaccination. However, notwithstanding, they should encourage their patients to obtain the vaccination in order to assist the public health systems to overcome the COVID-19 pandemic.

IN CONCLUSION:

When you rob a planet, you need large laundromats for all that doe.

And you also need large numbers of very good Public Relations executives. Which are hard to come by in Disneyland.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Everything you didn’t like about Pentagon’s DARPA, CIA’s In-Q-Tel, and more, but with funds stolen from Queen’s subjects and European peasantry.
The business of high-tech slavery is the future and the future is now! Advanced by slave work of course.

UK to host world-leading Nato Defence Innovation Headquarters

From: UK Ministry of Defence, Published 5 April 2022

The UK will partner with Estonia on the Defence Innovation Accelerator for the North Atlantic (DIANA) programme to maintain NATO’s technological edge.

The United Kingdom, in partnership with Estonia, will host the European HQ of a programme for NATO allies to accelerate, test, evaluate and validate new technologies that address critical defence challenges and contribute to Alliance deterrence.

Announced today by the NATO Secretary General, Jens Stoltenberg, the Defence Innovation Accelerator for the North Atlantic (DIANA) will see transatlantic cooperation on critical technologies and help NATO work more closely with industry and academia.

The UK’s accelerator will be twinned with a new accelerator in Tallinn, Estonia to encourage the sharing of expertise, explore the use of virtual sites to trial vehicles, including autonomous ones, and test cyber innovations.

As hosts, the UK and Estonia will:

  • Support start-up companies with funding, guidance and business expertise through twinned accelerator networks.
  • Offer the use of ‘deep tech’ test centres to assess technological solutions to military problems, utilising the Defence BattleLab.
  • Work with NATO to develop a virtual marketplace to connect start-ups with trusted investors, as well as a rapid acquisition service to connect products to buyers at pace.

UK Defence Secretary, Ben Wallace said:

The UK and Estonia are two of the most innovative countries in NATO and our hosting of DIANA will harness that innovation for the benefit of all Allies tackling future military threats.

The UK has a vibrant tech community, combining the academia, financiers, and high-tech start-ups that make it an ideal place to develop the next generation of military technologies.

Estonia was the natural partner for the UK given its international leadership in cyber, autonomy and AI, and our close partnership forged through the Enhanced Forward Presence.

Ranked in the world’s top ten innovative universities, Imperial College London will bring together academia, industry and government by hosting the headquarters of DIANA and a DIANA Accelerator at the Innovation Hub (IHUB) in the White City Innovation District, in a space shared with the UK’s Defence and Security Accelerator (DASA), Major Defence Contractors and The US Department of Defence’s Tri-Service Office.

Supported by DASA, the UK and Estonia DIANA HQ is expected to be operational from July 2022. DIANA is essential to delivering the NATO 2030 vision and ensuring that the Alliance develops the military capabilities needed to deter and defend against existing and future threats.

Estonian Defence Minister, Kalle Laanet.

The goal of DIANA is to support deep technologies companies that contribute to defence. It will bring together talented innovators with new technologies end-users in the area of defence. We are very glad to see that the good cooperation we have with the UK will expand even further and also encompass our universities and private sector more,

Cooperation between the UK and Estonia is working well on every level because we have a common understanding of defence policy. Good relations with Allies is a cornerstone of Estonian defence policy, and a successful start to this programme for us is a sign that this cornerstone is strong.

Co- Director, Institute for Security Science and Technology, Imperial College London, Professor Deeph Chana, said:

As one of the top STEM-B universities in the world, in one of the most diverse cities, Imperial College London is uniquely placed to power a progressive, responsible and holistic dual-use security and defence technology innovation program by hosting DIANA. Coordinated through our Institute for Security Science and Technology and Business School we’re committed to working on disruptive research and innovation to reduce insecurity and to deal with global threats and challenges.

DIANA will support all seven of the key emerging and disruptive technologies that NATO has identified as priorities: artificial intelligence, big-data processing, quantum-enabled technologies, autonomy, biotechnology, hypersonics and space.

She is Estonia’s Prime Minister

What the Estonian Ministry of Defense has to say on this:

Estonia chosen as one of the initiators of the NATO DIANA future technologies programme

5. April 2022 – 19:13

At the NATO summit last June in Brussels, NATO leaders decided to create an innovation accelerator – the DIANA (Defence Innovation Accelerator for the North Atlantic) programme will allow Allies to join their strengths in developing and adopting new and breakthrough technologies in the area of security and defence.

In cooperation between the Estonian ministries of defence, foreign affairs, and economic affairs and communication, Estonia and the United Kingdom submitted a bid for the programme, which was approved in full at the proposal of the NATO Secretary General. Together with the UK, Estonia is set to create the DIANA European headquarters, a NATO start-up accelerator will be founded in Estonia, and several existing testing sites for new technologies will be added to the DIANA accelerator network.

“The goal of DIANA is to support deep technologies companies that contribute to defence. It will bring together talented innovators with new technologies end-users in the area of defence. We are very glad to see that the good cooperation we have with the UK will expand even further and also encompass our universities and private sector more,” commented Minister of Defence Kalle Laanet. “Cooperation between the UK and Estonia is working well on every level because we have a common understanding of defence policy. Good relations with Allies is a cornerstone of Estonian defence policy, and a successful start to this programme for us is a sign that this cornerstone is strong.”

“Estonia and the UK are two of the most innovative nations in the Alliance, hosting respectively the most unicorn firms per capita, and the most unicorns in total. With Estonia’s impressive leadership in cyber, autonomy and AI, and the close partnership forged through our enhanced Forward Presence (eFP), they were a natural partner for the UK on this important initiative,” said UK Defence Secretary Ben Wallace.

“Trust in this Estonian initiative is a sign of our good reputation in creating favourable ecosystems for start-up innovation and developing new technologies. The fact that DIANA will be launched both in Estonia and the UK is an example of cooperation at work – both domestically between ministries, universities and the private sector, as well as across borders,” added Minister of Foreign Affairs Eva-Maria Liimets.

DIANA is a highly ambitious cooperation format that will bring together civil and military experts to develop and implement dual-use technologies in member states as well as across the transatlantic Alliance.

In addition, Estonia will participate at the negotiations for the founding of a NATO innovation fund. The objective of the fund is to support dual-use deep technology start-ups with investments, by offering trusted capital and creating additional opportunities for growth. States that have decided to join the fund will formalise the agreement at the NATO summit set to take place at the end of June.

Going forward, Estonia will continue preparations for the launch of the DIANA programme in 2023.

Additional information: press@mod.gov.ee

“Dual use” as in vaccines / bioweapons, I shall add.

Here’s a clue on how much DIANA’s future victims will be paying for it. This will be just launch money:

Defence sector innovation: NATO to invest €1B in startups

 THE RECURSIVE, 24 JUNE 2021  3 MINS READ

us-army-soldiers-army-men-54098

NATO, the intergovernmental defence alliance between 30 European and North American countries, launches a €1B fund and an accelerator targeting deeptech startups in the defence sector. The goal is to leverage the innovation capabilities of startups to develop the next generation of war machines. Part of NATO 2030, the move follows a period of concern for Alliance leaders regarding China’s increased reliance on tech for its military strategy.

At the end of two virtual meetings in early June, Foreign and Defence ministers agreed on the need to reinforce the transatlantic defence partnership between Europe and North America amid intensifying global competition. We need to sharpen our technological edge (…) We see that new and disruptive technologies, such as autonomous systems, artificial intelligence, and big data are really changing the way our militaries are going to operate in the future,” NATO Secretary-General Jens Stoltenberg said.

The Defence Innovation Accelerator for the North Atlantic (DIANA) is to become the center point for countries in the alliance to coordinate and cooperate on developing new technologies. DIANA will add offices and test centers throughout Alliance countries. 

“The goal is to have DIANA reach initial operating capability (IOC) by 2023,” David van Weel, assistant secretary-general for emerging security challenges, added in a virtual roundtable with reporters, following the 31st annual summit on June 14 in Brussels.

Planning to stay ahead of the curve is particularly important, as China has been investing heavily in new technologies to strengthen its military power and fuel its ambition to become a leader in the use of AI. The defence accelerator is also a recognition from European and North American leaders of the prevalence of disruptive technologies – and a decision to harness their unique potential to strengthen common defence strategies. 

How startups benefit from NATO’s initiative

For startups, this will be an opportunity to work together with the government sector and academia towards accelerating the achievement of national security and transatlantic collaboration goals. “Sometimes a technology company may not realize that their product could be viable for the defence community,” David van Weel said. Startups will also benefit from entering a network of stakeholders that can help them develop and get funded.

DIANA will be supporting startups working on either of the seven key emerging and disruptive technologies (EDTs) that NATO deems critical for the future: AI, big-data processing, quantum-enabled tech, autonomy, biotechnology, hypersonics, and space.

The accelerator includes a trusted capital marketplace that will enable funding opportunities for companies by connecting them to pre-qualified investors. Additionally, startups will receive support through a venture capital fund. The NATO Innovation Fund has been set up to support companies developing dual-use and key tech that could serve the Alliance. The fund will be an opt-in for member countries and would be underwritten by about €70M per year. Van Weel added that NATO would be looking for a partner from the private sector to help run the daily business operations of the fund.

DIANA is unique to NATO’s innovation efforts in that it has been built with the needs of the startup community in mind. It specifically targets early-stage startups rather than larger companies and traditional defence firms, in order to harness their unique ability for innovation.

IF YOU’RE NAIVE ENOUGH TO THINK THIS IS ABOUT DEFENSE, AND NOT THE INSANE DAVOS TRANSHUMANIST AGENDA…

… I will bring to your attention the fact that NATO has already adopted its own “Agenda 2030”, titled “NATO 2030”, and both of these are just “The Great Reset for Different Niches of Dummies” in their specific lingo. That’s all they are.
Proportionally, “NATO 2030” talks about climate change about as much as “The Great Reset”.

Also note how NATO presents itself more and more as a business accelerator.
Transhumanist businesses with a multinational army funded by half a billion unsuspecting dupes and NPCs in NATO countries and beyond. What could go wrong, right?

NATO hopes to launch new defense tech accelerator by 2023

DEFENSE NEWS,  Jun 22, 2021

Secretary-General Jens Stoltenberg gives press conference at the NATO summit in Brussels on June 14, 2021. (Photo by FREDERIC SIERAKOWSKI/BELGA MAG/AFP via Getty Images)

STUTTGART, Germany — In less than two years, NATO hopes to have its own, modified version of the U.S. Defense Advanced Research Projects Agency (DARPA) up and running.

Alliance members agreed at the 31st annual summit, held June 14 in Brussels, to launch a new initiative dubbed the Defence Innovation Accelerator of the North Atlantic, or DIANA, meant to speed up trans-Atlantic cooperation on critical technologies, and help NATO work more closely with private-sector entities, academia and other non-governmental entities.

The goal is to have DIANA reach initial operating capability (IOC) by 2023, David van Weel, assistant secretary-general for emerging security challenges, said at a Tuesday virtual roundtable with reporters. By next year, the hope is to have “the initial parts … starting to come up into fruition,” he added.

In the long term, DIANA will have headquarters both in North America and in Europe, and link to existing test centers throughout NATO member countries that will be used for “validating, testing, and co-designing applications in the field of emerging and disruptive technologies,” van Weel said. DIANA will also be responsible for building and managing a network meant to help relevant startups grow and support NATO’s technology needs via grant programs.

The focus will be on national security and defense purposes, and DIANA will not ask for or solicit companies’ intellectual property, van Weel noted.

While he singled out artificial intelligence, big-data processing, and quantum-enabled technologies, DIANA is meant to support all seven of the key emerging and disruptive technologies — or EDTs — that NATO has identified as critical for the future. The other four include: autonomy, biotechnology, hypersonics and space.

Sometimes a technology company may not realize that their product could be viable for the defense community, he added.

One key component of DIANA will be a trusted capital marketplace, where smaller companies can connect with pre-qualified investors who are interested in supporting NATO’s technology efforts. Ensuring that investors are vetted ahead of time will allow NATO to ensure “that the technology will be protected from illicit transfers,” van Weel said.

The fund is modeled after a The U.S. Defense Department set up its own trusted capital marketplace in 2019 as a tool that then-DoD acquisition czar Ellen Lord said could help encourage domestically based venture capitalists to fund national security and defense projects. That marketplace served as inspiration for the announced NATO trusted capital marketplace, per the alliance.

Members also agreed for the first time to build up a venture capital fund to support companies developing dual-use and key technologies that could be useful to NATO, and which will be optional for member-nations to participate in. The NATO Innovation Fund, as it’s called, would have a running time of about 15 years to start, and would be underwritten by about 70 million euro (about $83 million) per year, per van Weel.

The goal is not for NATO headquarters or for its member-nations to run the innovation fund, he noted. “The actual running of a venture capital fund, we believe, should be done by companies that have a broad range of experience in the field.” He cited the U.S.-based capital venture firm In-Q-Tel as an example of the type of partner NATO would seek to run the “day-to-day” business of the fund.

“I read somewhere that NATO is not a bank—we’re not,” van Weel said. “But it will be the nations providing the funds, and giving the general direction.”

These two initiatives of a technology accelerator and innovation fund are “hopefully going to … bring the alliance forward into the 21st century,” van Weel said.

NATO has previously invested in information technology (IT) and software through the NATO Communications and Information Agency (NCIA), but the difference with the innovation fund, and DIANA, is that the alliance wants to better connect with early-stage startups, rather than larger software companies or traditional defense firms, van Weel said.

“DIANA is not about taking over innovation for the NATO enterprise,” he said. “It’s a different community, and requires different funding mechanisms and different types of engagement.”

These two initiatives have been long awaited and demanded by NATO observers, and versions of both a “DARPA-like” technology accelerator and an alliance-wide investment bank were included in a 2020 list of recommendations by NATO’s advisory group on emerging and disruptive technologies.

But it is still early days. While the IOC goal is 2023, “step one is we want to know from allies what they want to offer to DIANA,” van Weel said. Once the NATO Innovation Fund has its participating members, for example, a charter will be set up that will lay out the funding models, rapid contracting processes, and leadership guidelines.

“We are trying to do this as fast as we can,” van Weel assured, but then noted, “we do want to get it right, because … with the startup community, you only get one chance.”

If you want to deepen your understanding of the situation and the context here, also read:

EVERYTHING WE PUBLISHED ON DARPA

BOMBSHELL! GERMAN & UK DEFENSE WORK ON MASSIVE “HUMAN AUGUMENTATION” PROJECT FOR CIVILIAN POPULATION! SWEDEN AND FINLAND INVOLVED TOO

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Imagine being a legit theory for years, then being downgraded to “conspiracy theory”, only to bounce back even stronger less than a year later

DESIGNER BUGS: HOW THE NEXT PANDEMIC MIGHT COME FROM A LAB

“Why we need to take the threat of bioengineered superbugs seriously.”

By R. Daniel Bressler and Chris Bakerlee  Dec 6, 2018, Vox

This story is part of a group of stories called

Finding the best ways to do good.

This week, diplomats from around the world are meeting in Geneva, Switzerland, as part of an annual gathering of state parties for the Biological Weapons Convention (BWC). The BWC has an important mandate: It prohibits the 182 countries that have signed on and ratified the convention from developing, producing, and stockpiling biological weapons.

The BWC, and the biosecurity community broadly, has historically been more focused on existing pathogens with clear potential to be used as biological weapons, such as anthrax and the agents causing botulism and Q fever. In addition, health security experts are worried about the “next big one” — the next global pandemic. Pandemic diseases are often zoonotic, meaning they jump from animals to humans. Zoonotic diseases like EbolaZika, SARS, and HIV are created when, say, the wrong pig meets up with the wrong bat — and then meets the wrong human.

The emergence of such diseases depends a great deal on spontaneous genetic mutations and circumstantial factors. So here’s a scary thought: Possible future pandemics may not depend on the chance meeting of different animal species and chance mutations, but may be deliberately designed instead. New tools from the field of synthetic biology could endow scientists with the frightening ability to design and manufacture maximally dangerous pathogens, leapfrogging natural selection.

The threat is very much on the minds of security officials. This past May, the Johns Hopkins Center for Health Security (CHS) led an exercise involving former US senators and executive branch officials on how the country would respond to an international outbreak of an engineered pathogen. In this fictional scenario, a terrorist group constructed a virus that was both deadly and highly contagious. More than a year into the made-up pandemic, the worldwide death toll was soaring past 150 million, the Dow Jones had fallen by 90 percent, and there was a mass exodus from cities amid famine and unrest.

In biotech, the story of the past several decades has been one of exponential progress. Just 75 years ago, we were not even confident that DNA was the primary material governing genetic heredity. Today, we are able to readwrite, and edit genomes with increasing ease.

But biotechnologies are dual-use — they can be used for both good and ill. We fear that with even just current capabilities, an engineered pandemic could join the growing list of seismic changes made possible by biotechnological advances. Sufficiently capable actors could work to resurrect the deadliest pathogens of the past, like smallpox or Spanish flu, or modify existing pathogens such as bird flu to be more contagious and lethal. As genome engineering technologies become more powerful and ubiquitous, the tools necessary for making these modifications will become increasingly accessible.

This leads to the terrifying specter of independent actors intentionally (or unintentionally) engineering pathogens with the potential to inflict worse harm than history’s deadliest pandemics. No obvious physical or biological constraints preclude the construction of such potent biological weapons. According to biosecurity expert Piers Millett, “If you’re deliberately trying to create a pathogen that is deadly, spreads easily, and that we don’t have appropriate public health measures to mitigate, then that thing you create is amongst the most dangerous things on the planet.”

Mitigating this risk is shaping up to be one of the major challenges of the 21st century — not only because the stakes are high, but also because of the myriad obstacles standing between us and a solution.

The technologies that help us might also hurt us

Natural pandemics can be horrific and catch us completely off guard. For example, three years elapsed between the first officially documented US AIDS cases in 1981 and the identification of HIV as its cause. It took another three years to develop and approve the first drug treating HIV. While antiretroviral treatments now allow those living with HIV to manage the disease effectively (that is, if they can afford the treatment), we still lack a promising HIV vaccine.

Yet as ill-equipped as we may be to fight newly emergent natural pathogens, we are even less prepared to cope with engineered pathogens. In the coming decades, it may become possible to create pathogens that fall well outside the range of infectious agents modern medicine has learned to detect, treat, and contain.

Worse yet, malicious actors might build disease-causing microbes with features strategically tailored to thwart existing health security measures. So while advances in the field of synthetic biology will make it easier for us to invent therapeutics and other technologies that can defend us from pandemics, those very same advances may allow state and nonstate actors to design increasingly harmful pathogens.

For example, new gene-synthesis technologies loom large on the horizon, allowing for the automated production of longer DNA sequences from scratch. This will be a boon for basic and applied biomedical research — but it also will simplify the assembly of designer pathogens.

U.S. Army’s Dugway Proving Grounds, Laboratory For Testing Biological And Chemical Weapons
A technician at the Smartman Laboratory facility at the US Army’s Dugway Proving Ground on August 15, 2017, in Dugway, Utah. Workers at this facility handle some of the deadliest biological and chemical agents on earth.

Compared to other weapons of mass destruction, engineered pathogens are less resource-intensive. Although malicious actors would currently need university-grade laboratories and resources to create them, a bigger obstacle tends to be access to information. The limits of our knowledge of biology constrain the potential of any bioengineering effort. Some information, like how to work proficiently with a specific machine or cell type, can be acquired only through months or years of supervised training. Other information, like annotated pathogen genome sequences, may be easy to access through public databases, such as those maintained by the National Center for Biotechnology Information.

If information such as pathogen genome sequences or synthetic biology protocols is available online, this could make it much easier for malicious actors to build their own pathogens. But even if they’re not online, hackers can also steal sensitive information from the databases of biotechnology companies, universities, and government laboratories.

Preventing damage from engineered pathogens is complicated by the fact that it takes only one lapse, one resourceful terrorist group, or one rogue nation-state to wreak large-scale havoc. Even if the majority of scientists and countries follow proper protocols, a single unilateral actor could imperil human civilization.

And some wounds can be self-inflicted. Between 2004 and 2010, there were more than 700 incidents of loss or release of “select agents and toxins” (i.e., scary stuff) from US labs. In 11 instances, lab workers acquired bacterial or fungal infections. In one instance, a shipment of a harmful fungus was lost — and, according to the FBI, destroyed — in transit. In a world in which well-meaning but sometimes careless biologists are creating dangerous organisms in the lab, such accidental release events could prove even more frightening.

A global problem

Like naturally occurring pandemics, engineered pandemics will not respect national borders. A contagious pathogen released in one country will emigrate. Actions that protect against engineered pathogens are an example of a global public good: Since a deadly engineered pathogen would adversely affect countries around the world, doing something to prevent them is a service that benefits the whole world.

A fundamental challenge of global public goods is that they tend to be underprovided. With global public goods, individual countries prefer to free ride over unilaterally providing global public goods if they can get away with it.

This doesn’t mean that countries won’t do anything to provide global public goods; they just won’t do as much as they should. For example, a country such as the United States will consider the potential damage an engineered pathogen could wreak on its 325 million people, and it will take actions to prevent this from happening. However, the actions it takes won’t be as extensive as they would be if it were to consider the toll an engineered pathogen could take on the planet’s 7.6 billion people.

To address this dilemma, world leaders created the Biological Weapons Convention in the 1970s. The BWC has the important goal of constraining bioweapons development; in practice, it has been ineffective at verifying and enforcing compliance.

Unlike the BWC, the major nuclear and chemical weapons treaties have extensive formal verification mechanisms. The Nuclear Non-Proliferation Treaty (NPT), effective since 1970, verifies the compliance of signatories through the International Atomic Energy Agency, which has a staff of about 2,560. The Chemical Weapons Convention (CWC), effective since 1997, verifies compliance through the Organisation for the Prohibition of Chemical Weapons, which won the Nobel Peace Prize in 2013. It has a staff of 500. By contrast, the Implementation Support Unit for the BWC, the convention’s sole administrative body, currently has just four employees.

And bioweapons have specific characteristics that make verification and enforcement difficult compared to chemical and nuclear weapons.

Consider nuclear technology. Nuclear power plants require low levels of uranium enrichment (typically around 5 percent), whereas nuclear weapons require highly enriched uranium (typically above 90 percent). Highly enriched uranium requires large industrial facilities with precise centrifuges. When granted access, it is comparatively easy for inspectors to determine when a facility is being used for the production of highly enriched uranium.

Partly for these reasons, no country has ever developed nuclear weapons while being a party to the NPT. Of the nine nuclear weapons nations, the US, USSR (whose weapons are now exclusively owned by Russia), UK, France, China, and likely Israel had nuclear weapons before the treaty was enforced. India (first test in 1974) and Pakistan (first test in 1998) never signed the NPT. North Korea withdrew from the treaty in 2003, three years before its first nuclear test in 2006.

In contrast, bioengineered organisms require fewer resources and smaller facilities to make, and it is harder to readily distinguish between organisms that are being developed for scientific purposes from those that are being developed with malicious intent.

Historically, the BWC does not have a good track record of preventing the possession of bioweapons. The Soviet Union maintained a large bioweapons program after it signed on to the BWC in 1975. The South African apartheid regime held bioweapons in the 1980s and ’90s while being a party to the BWC.

Fearing that invasive verification by the BWC could compromise sensitive intellectual property and hurt the competitiveness of its cutting-edge biotechnology sector, the US chose to withdraw from negotiations at the BWC’s Fifth Review Conference in 2001. The US later rejoined those negotiations, but serious measures to improve the BWC’s verification and enforcement mechanisms have not been implemented, and the agreement remains largely ineffective.

Despite this concern about the invasiveness of verification, there is a growing consensus that the BWC must become more effective. The 2015 Bipartisan Report of the Blue Ribbon Study Panel on Biodefense, chaired by Joe Lieberman, the 2000 Democratic vice presidential candidate, and Tom Ridge, the first secretary of homeland security under George W. Bush, called for the vice president and the secretary of state to chair a series of meetings with relevant Cabinet members and experts to come to an agreement on verification protocols that would satisfy US concerns while adequately enforcing compliance with the treaty. The study led to the introduction of the National Biodefense Strategy Act of 2016, which is still awaiting a vote.

In September 2018, the Trump administration released a National Biodefense Strategy, though this document contained little specific information on how the US would strengthen the BWC and didn’t mention Cabinet-level meetings chaired by the vice president, as was recommended by the blue ribbon panel.

US Marines And New York Fire Fighters Take Part In Chemical Incident Drill In Penn Station
Emergency personnel walk down the aisle of an Amtrak train during a biological preparedness drill being led by members of the Chemical Biological Incident Response Force (CBIRF), a unit in the United States Marine Corps, at Penn Station during the early morning hours on September 22, 2012, in New York City. 

Some have questioned the seriousness of the threat posed by bioweapons. For example, in his recent book, Harvard University professor Steven Pinker suggests that “Bioterrorism may be [a] phantom menace.” He claims that terrorists wouldn’t weaponize pandemic pathogens, since their goal is typically “not damage but theater.” Others have suggested that even if terrorists wanted to engineer a pathogen as a weapon, they’d lack the requisite biological knowledge and practical know-how to get the job done.

While it is true (and quite fortunate) that these factors reduce at least the present risk of a biological attack, it is cold comfort. In the coming decades, it will only become easier for nonstate actors to acquire and deploy powerful biotechnologies for ill. And beyond terrorists, state actors also pose serious risks.

For example, Japan launched devastating bioattacks against China during World War II. Japanese Unit 731 dropped bombs filled with swarms of plague-infested fleas on Chinese cities, likely killing hundreds of thousands of civilians. The unit’s commander, Shiro Ishii, found plague to be a potent weapon because it could present itself as a natural epidemic and kill large numbers of people through person-to-person transmission.

In addition, the US had a bioweapons program from 1943 to 1969 that, among other things, made propaganda videos bragging about testing biological weapons on human subjects. The Soviet Union’s covert bioweapons program that it maintained after signing on to the BWC had more employees at its peak in the 1980s than Facebook currently has.

We don’t know what we don’t know — but here’s what we can do

Many questions remain unanswered when it comes to the potentially catastrophic risks posed by engineered pathogens. For example, what is the full spectrum of microbes that cause human disease? And which types of microbes would most likely be used as bioweapons? Research centers such as the Center for Health Security at Hopkins, the Future of Humanity Institute, and the Nuclear Threat Initiative are working hard to answer such questions.

But just because we don’t have answers to all the questions — and don’t even know all the questions to begin with — doesn’t mean there aren’t things we can do to mitigate our risks.

Thinking and acting globally

For starters, we should develop a process to address advancements in biotechnology in the BWC. Currently, the BWC lacks a dedicated forum where the treaty implications of new developments in biotechnology can be discussed. Other international agreements like the CWC have dedicated scientific advisory boards to track and respond to new science and technological changes. The BWC has no such board.

There’s some movement on this issue — the Johns Hopkins Center for Health Security hosted an event in Geneva earlier this week to discuss how the BWC can evolve to address rapid advances in biotechnology. Still, it is crucial to establish a permanent institutional capacity within the BWC to address biotechnological change.

This all connects to another priority: give the BWC’s Implementation Support Unit more resources. The four-person implementation support unit, the convention’s sole administrative body, has immense responsibilities that far exceed its current resources. These responsibilities include supporting and assisting nations as they implement the treaty, administering a database of assistance requests, facilitating communication between the parties, and much more.

But the resources remain minuscule, especially compared to other international treaties. The annual cost allocated to BWC meetings and its implementation support unit is less than 4.5 percent of the cost allocated to the CWC. This inadequate budget sends a grim signal about how seriously the world is currently taking the growing risks from bioweapons.

Another global priority should be finding ways to regulate dual-use gene synthesis technologies. To facilitate their research, biologists regularly order short, custom pieces of DNA from companies that specialize in their manufacture. In 2009, the International Gene Synthesis Consortium proposed guidelines for how gene synthesis companies should screen customers’ orders for potentially dangerous chunks of DNA, such as those found in harmful viruses or toxin genes. Most companies voluntarily follow these guidelines, and they represent 80 percent of the global market.

However, even companies currently applying recommended screening procedures only test whether ordered sequences match those of known pathogens. An engineered pathogen with a novel genome could potentially slip past this filter.

Presently, the gene synthesis market is expanding internationally and synthesis costs are falling. It is urgent that governments both independently and multilaterally act to mandate proper screening of sequences and customers. As Kevin Esvelt of MIT writes, “adequately screening all synthesized DNA could eliminate the most serious foreseeable hazards of biotech misuse by nonstate actors.”

Dealing with biorisk on the ground and in the lab

Beyond developing new global standards and practices, we need to adopt more flexible countermeasures to face off the threat of bioengineered pathogens. As noted in a recent CHS report, “One of the biggest challenges in outbreak response, particularly for emerging infectious diseases, is the availability of reliable diagnostic assays that can quickly and accurately determine infection status.”

Diagnostics based on cutting-edge genome sequencing methods could provide detailed information about all the viruses and bacteria present in a blood sample, including even completely novel pathogens. Meanwhile, as genome sequencing technology becomes less expensive, it could be more widely applied in clinics to provide unprecedented real-time insights into genetic diseases and cancer progression.

We also need to invest more in developing antivirals that hit a wider range of targets. Such broad-spectrum drugs may stand a better chance of slowing the proliferation of an engineered bug than treatments specific to single known pathogens.

And we should also develop “platform” technologies that allow rapid vaccine development. Currently, the process of designing, testing, and manufacturing a vaccine to prevent the spread of a new pathogen takes years. Ideally, we could immunize all at-risk individuals within months of identifying the pathogen. Accelerating vaccine development will require us to innovate new and likely unconventional technologies, such as vectored immunoprophylaxis or nucleic acid vaccines.

Even as we pursue and accelerate such research, we should also be mindful of the possibility of self-inflicted wounds. To avert a terrible accident, the international biomedical community should establish firmer cultural guardrails on the research into pathogens.

Currently, career advancement, financial gain, and raw curiosity motivate biologists at all levels to push the envelope, and we all stand to gain from their efforts. However, these same incentives can sometimes lead researchers to take substantial and perhaps unjustified risks, such as evolving dangerous strains of influenza to be more contagious or publishing instructions for cultivating a close cousin of the smallpox virus. It’s important for biologists to do their part to promote a culture in which this adventurous intellectual spirit is tempered by caution and humility.

Encouragingly, synthetic biology luminaries like Esvelt and George Church of Harvard University are doing just that, pioneering technological safeguards to mitigate accidental release risks and advocating policies and norms that would make 21st-century biology a less perilous pursuit. As the tools of synthetic biology spread to other disciplines, their example is one that others should follow.

Underlying the prescriptions above is the need to approach the problem with the sense of urgency it warrants. As our biotechnological capabilities grow, so too will the threat of engineered pathogens. An engineered pandemic won’t announce itself with a towering mushroom cloud, but the suffering of the individuals it touches will be no less real.

R. Daniel Bressler is a PhD candidate in the sustainable development program at Columbia University. His research is at the intersection of dual-use technologies, environmental change, and the capacity for collective action in the international system to deal with these issues. Find him on Twitter @DannyBressler1.

Chris Bakerlee is a PhD candidate in molecules, cells, and orgamisms at Harvard University, where he uses genetic engineering to study how evolution works. Find him on Twitter @cwbakerlee.

BONUS

SOURCE

Below are screenshots of the edits made by Vox.

Below are screenshots from Vox’s 2020 articles.

Vox was founded in April 2014 by Ezra Klein, Matt Yglesias, and Melissa Bell. Prior to founding Vox, Ezra Klein was a former Washington Post columnist where he worked as the head of Wonkblog, a public policy blog. Vox is run by Vox Media, a digital publishing network founded by Jerome Armstrong, Tyler Bleszinski, and Markos Moulitsas.

According to its website, Vox Media’s portfolio includes 13 other brands: Vox, New York Magazine, The Verge, The Cut, Eater, Vulture, The Strategist, Polygon, SB Nation, Intelligencer, Curbed, Grub Street, and Recode.” – Tech StartUps

“Think outside the Vox”

Silview.media

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

The notorious Lock Step Scenario, proposed by The Rockefeller Foundation in 2010, is just one chapter in a larger document titled “Scenarios for the Future of Technology and International Development”.
As the Covid narrative is being buried in the bomb craters in Ukraine, it felt like a matter of common sense to ask myself if we’re entering another chapter of the same book.

This scenario may seem, for now, not as consistent with what’s going on as Lock Step is. It will probably never be, because they learn, change and adapt faster than us.
However, I find it chillingly close to the mainstream narrative. Many of he predictions that are not confirmed yet seem very likely to occur in the near future, in my assessment. After all, we’re just starting transitioning out of Lock Step into something new.
It’s up to everyone’s awareness, experience and wit to identify analogies and decide how relevant this document is, I’m just gong to add one more dare:
My bet is that if you find the good tips about the present and near future developments in this reading, you will be ahead of the curve just like the people who picked up on the Lock Step scenario early 2020.

NOTE: Their narrative starts in 2010, the real world events started 2020. And there’s more reasons you should ignore the years in their timeline, that’s not supposed to be exact science, focus on the succession of events and their mechanisms, rather.

HACK ATTACK SCENARIO


An economically unstable and shock-prone
world in which governments weaken, criminals thrive,
and dangerous innovations emerge
Devastating shocks like September 11, the
Southeast Asian tsunami of 2004, and the
2010 Haiti earthquake had certainly primed
the world for sudden disasters. But no one
was prepared for a world in which large-scale
catastrophes would occur with such breathtaking
frequency. The years 2010 to 2020 were dubbed
the “doom decade” for good reason: the 2012
Olympic bombing, which killed 13,000, was
followed closely by an earthquake in Indonesia
killing 40,000, a tsunami that almost wiped
out Nicaragua, and the onset of the West China
Famine, caused by a once-in-a-millennium
drought linked to climate change.


Not surprisingly, this opening series of deadly
asynchronous catastrophes (there were more) put
enormous pressure on an already overstressed
global economy that had entered the decade
still in recession. Massive humanitarian relief
efforts cost vast sums of money, but the primary
sources—from aid agencies to developed-world
governments—had run out of funds to offer.
Most nation-states could no longer afford their
locked-in costs, let alone respond to increased
citizen demands for more security, more
healthcare coverage, more social programs and
services, and more infrastructure repair. In
2014, when mudslides in Lima buried thousands,
only minimal help trickled in, prompting the
Economist headline: “Is the Planet Finally
Bankrupt?”


These dire circumstances forced tough tradeoffs.
In 2015, the U.S. reallocated a large share of its
defense spending to domestic concerns, pulling
out of Afghanistan—where the resurgent Taliban
seized power once again. In Europe, Asia, South
America, and Africa, more and more nation-
states lost control of their public finances, along
with the capacity to help their citizens and
retain stability and order. Resource scarcities and
trade disputes, together with severe economic
and climate stresses, pushed many alliances
and partnerships to the breaking point; they
also sparked proxy wars and low-level conflict
in resource-rich parts of the developing
world. Nations raised trade barriers in order to
protect their domestic sectors against imports
and—in the face of global food and resource
shortages—to reduce exports of agricultural
produce and other commodities. By 2016, the
global coordination and interconnectedness
that had marked the post-Berlin Wall world was
tenuous at best.


With government power weakened, order rapidly
disintegrating, and safety nets evaporating,
violence and crime grew more rampant.
Countries with ethnic, religious, or class
divisions saw especially sharp spikes in hostility:
Naxalite separatists dramatically expanded
their guerrilla campaign in East India; Israeli-
Palestinian bloodshed escalated; and across Africa,
fights over resources erupted along ethnic or tribal lines.

Meanwhile, overtaxed
militaries and police forces could do little to stop
growing communities of criminals and terrorists
from gaining power. Technology-enabled gangs
and networked criminal enterprises exploited
both the weakness of states and the desperation
of individuals.

With increasing ease, these
“global guerillas” moved illicit products through
underground channels from poor producer
countries to markets in the developed world.
Using retired 727s and other rogue aircraft, they
crisscrossed the Atlantic, from South America
to Africa, transporting cocaine, weapons, and
operatives. Drug and gun money became a
common recruiting tool for the desperately poor.

Criminal networks also grew highly skilled
at counterfeiting licit goods through reverse
engineering. Many of these “rip-offs” and
copycats were of poor quality or downright
dangerous. In the context of weak health
systems, corruption, and inattention to
standards—either within countries or
from global bodies like the World Health
Organization—tainted vaccines entered the
public health systems of several African
countries.

“WE HAVE THIS LOVE AFFAIR
WITH STRONG CENTRAL STATES,
BUT THAT’S NOT THE ONLY
POSSIBILITY. TECHNOLOGY IS
GOING TO MAKE THIS EVEN MORE
REAL FOR AFRICA. THERE IS THE
SAME CELLPHONE PENETRATION
RATE IN SOMALIA AS IN RWANDA.
IN THAT RESPECT, SOMALIA
WORKS.”

– Aidan Eyakuze, Society for International
Development, Tanzania

In 2021, 600 children in Cote d’Ivoire
died from a bogus Hepatitis B vaccine, which
paled in comparison to the scandal sparked by
mass deaths from a tainted anti-malarial drug
years later. The deaths and resulting scandals
sharply affected public confidence in vaccine
delivery; parents not just in Africa but elsewhere
began to avoid vaccinating their children, and
it wasn’t long before infant and child mortality
rates rose to levels not seen since the 1970s.
Technology hackers were also hard at work.
Internet scams and pyramid schemes plagued
inboxes.

Meanwhile, more sophisticated
hackers attempted to take down corporations,
government systems, and banks via phishing
scams and database information heists, and their
many successes generated billions of dollars in
losses. Desperate to protect themselves and their
intellectual property, the few multinationals
still thriving enacted strong, increasingly
complex defensive measures. Patent applications
skyrocketed and patent thickets proliferated,
as companies fought to claim and control even
the tiniest innovations. Security measures and
screenings tightened.


This “wild west” environment had a profound
impact on innovation. The threat of being
hacked and the presence of so many thefts and
fakes lowered the incentives to create “me first”
rather than “me too” technologies. And so many
patent thickets made the cross-pollination of
ideas and research difficult at best. Blockbuster
pharmaceuticals quickly became artifacts of
the past, replaced by increased production
of generics. Breakthrough innovations still
happened in various industries, but they were
focused more on technologies that could not be
easily replicated or re-engineered. And once
created, they were vigorously guarded by their
inventors—or even by their nations. In 2022, a
biofuel breakthrough in Brazil was protected as a
national treasure and used as a bargaining chip
in trade with other countries.


Verifying the authenticity of anything was
increasingly difficult. The heroic efforts
of several companies and NGOs to create
recognized seals of safety and approval proved
ineffective when even those seals were hacked.
The positive effects of the mobile and internet
revolutions were tempered by their increasing
fragility as scamming and viruses proliferated,
preventing these networks from achieving the
reliability required to become the backbone
of developing economies—or a source of
trustworthy information for anybody.


Interestingly, not all of the “hacking” was bad.
Genetically modified crops (GMOs) and do-it
yourself (DIY) biotech became backyard and
garage activities, producing important advances.
In 2017, a network of renegade African scientists
who had returned to their home countries after
working in Western multinationals unveiled
the first of a range of new GMOs that boosted
agricultural productivity on the continent.


But despite such efforts, the global have/have
not gap grew wider than ever. The very rich still
had the financial means to protect themselves;
gated communities sprung up from New York
to Lagos, providing safe havens surrounded by
slums. In 2025, it was de rigueur to build not
a house but a high-walled fortress, guarded by
armed personnel. The wealthy also capitalized on
the loose regulatory environment to experiment
with advanced medical treatments and other
under-the-radar activities.


Those who couldn’t buy their way out of
chaos—which was most people—retreated
to whatever “safety” they could find. With
opportunity frozen and global mobility at a
near standstill—no place wanted more people,
especially more poor people—it was often a
retreat to the familiar: family ties, religious
beliefs, or even national allegiance. Trust
was afforded to those who guaranteed safety
and survival—whether it was a warlord, an
evangelical preacher, or a mother. In some
places, the collapse of state capacity led to a
resurgence of feudalism. In other areas, people
managed to create more resilient communities
operating as isolated micro versions of formerly
large-scale systems. The weakening of national
governments also enabled grassroots movements
to form and grow, creating rays of hope amid
the bleakness.

By 2030, the distinction between
“developed” and “developing” nations no longer
seemed particularly descriptive or relevant. •

ALSO READ:

2ND BATCH OF FAUCI E-MAILS: INVITE TO ROCKEFELLER’S TRILATERAL COMMISSION

ROCKEFELLERS ONCE SAID: READY YOUR TINFOIL HATS FOR MIND CONTROL. AND THEY SHOWED US A DOOR TO THE MAGNETIC JABS

[EXCLUSIVE] FINAL EVIDENCE COVID-19 IS A ‘SIMEX’ – PLANNED SIMULATION EXERCISE BY WHO AND WORLD BANK

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

Dr. Malone was so damn right when he said we’re barely scratching the surface on the biolabs topic.
And so was I when I insisted you should pay special attention to the research on insects that’s been going on not only in the US funded labs in Ukraine and Georgia, but all over the world, including US soil.

UNIVERSITY OF SOUTH CAROLINA WELCOMES YOU TO YOUR WORST NIGHTMARE YOU HAVEN’T EVEN FATHOMED YET

THE CHERNOBYL & FUKUSHIMA RESEARVH INITIATIVE BY DTRA, THE US AGENCY FUNDING THE UKRAINE BIOLABS

SUMMARY OF THE INITIATIVE AND ITS RESEARCH

                                           (for a PDF version of this text click here)

The Chernobyl Research Initiative began formal research activities in Ukraine in 2000, Belarus in 2005, and Fukushima, Japan, in July, 2011. To date, the group has conducted more than 35 research expeditions to Chernobyl and 16 expeditions to Fukushima.

USC’s Chernobyl Research Initiative was the first and currently is the only research group to utilize a multidisciplinary approach to address the health and environmental outcomes of radiation effects in free-living natural populations. This has permitted the investigation of both acute (short term) and chronic (long term and multi-generational) exposures.

The Chernobyl Research Initiative is also currently the only research team studying plants and animals in both Chernobyl and Fukushima.

Key funding sources have included the Samuel Freeman Charitable Trust, the CNRS (France), the National Science Foundation, and the National Geographic Society. Subsequently, additional funding sources have included the Civilian Research Development Foundation (CRDF), the National Institutes of Health (NIH), Qiagen GmbH, the Fulbright Foundation, the University of South Carolina Office of Research and the College of Arts and Sciences, the Academy of Finland, and gifts from private citizens.

To date, more than 90 scientific publications have resulted from this initiative, most in the past 10 years (see link above for publications). This research has been highlighted in many newspaper reports and television programs including the New York Times, The Economist, Harpers, the BBC, CNN, CBS’s 60 Minutes, and Miles O’Brian of PBS News Hour (see links above for media coverage).

The team has pioneered the use of ecological, genetic and dosimetric technologies in order to unravel the health and environmental consequences of chronic low-dose exposure resulting from the Chernobyl and Fukushima disasters. These have included massively replicated ecological censuses of natural populations of birds, mammals and insects to investigate population and demographic effects; DNA sequencing and genotoxicity testing to assess short and long term genetic damage to individuals living in the wild; and the use of miniature dosimeters attached to wild animals and field measurements of whole body burdens of radioisotopes in birds and mammals to obtain accurate estimates of realized external and internal radiation doses to animals living under natural conditions. Recently, the group has expanded to include epidemiological and genetic studies of human populations (especially children) living in Chernobyl-affected regions of Ukraine.

Key results include the discovery of tumors, cataracts and damaged sperm in birds from high radiation areas of Chernobyl, and impacts on biodiversity in Fukushima. Exciting new results include the discovery that some species of birds may have developed resistance to the effects of radiation and effects on neurological development in small mammals in both Chernobyl and Fukushima.

These two disasters differ in the time since the events, and the amount and diversity of radionuclides that were released, although the predominant source of radiation is cesium-137 in both locations.

DTRA in Fukushima – Operation Tomodachi by the agency funding Ukrainian biolabs

We are seeking funding to support the following ongoing and planned future research activities of the Chernobyl + Fukushima Research Initiative:

1)Continued monitoring of Fukushima populations of birds, small mammals, and insects in order to test for changes in population sizes (abundances) and numbers of species (biodiversity) through time.

2)Continued monitoring of barn swallows and rodents (mice and voles) populations for cancers, survival, reproduction, and genetic damage in Fukushima and Chernobyl (in collaboration with the CNRS, France, Rikkyo University, Tokyo, the Wild Bird Society of Japan, the National Institute of Forestry, Japan, and the University of Jyvaskyla, Finland).

3)Initiate a new project to study effects of radiation on tree growth and soil microbial activity in Fukushima (in collaboration with Chubu University, Nagoya, Japan).

4)Initiate a new project to investigate effects of radiation growth, fertility, and genetic damage in cows living in highly radioactive regions of Fukushima (in collaboration with the Fukushima Cattle Ranchers Association).

5)Initiate a new project to examine mutation rates in humans using whole genome DNA sequencing. Initially this project will focus on families living in contaminated regions of Ukraine. The project is in collaboration with the Montreal Neurological Institute and Hospital at McGill University, the Center of Radiological Research at Columbia University, and the Institute for Radiation Medicine in Kiev, Ukraine.

6)Continued development of new methods for measurement of dose and genetic damage in wild populations of animals.

7)Coordination of an international consortium of independent scientists to provide unbiased evidenced-based information concerning the health and environmental risks related to nuclear accidents. This group will compile, evaluate, and interpret the current scientific and medical literature and develop a literature suitable for public distribution via the print and internet media, as well as public presentations in Japan and internationally.

Highlights from research published by the Chernobyl Research Initiative include the following:

•Population sizes and numbers of species (i.e. biodiversity) of birds, mammals, insects, and spiders are significantly lower in areas of high contamination in Chernobyl.

•For many birds and small mammals, life spans are shorter and fertility is depressed, in areas of high contamination.

•In Fukushima, only birds, butterflies, and cicadas showed significant declines during the first summer following the accident. Other groups were not negatively affected.  Now, five years later, effects on birds have increased.

•There is considerable variability among species in their sensitivity to radionuclides. Many species are not affected, and a few species even appear to increase in numbers in areas of high contamination in both Chernobyl and Fukushima, presumably in response to competitive release (i.e. more available food and shelter) and fewer predators.

•Many species show evidence of genetic damage stemming from acute exposures and the differences observed between Fukushima and Chernobyl suggests some species may show the consequences of mutation accumulation over multiple generations.

•Some individuals and species show no evidence of genetic damage in relation to radiation exposure and some even show evidence of evolutionary adaptation to the effects of radiation through increased antioxidant activity, which may provide protection against ionizing radiation.

•The bird species that are most likely to show declines in numbers in response to radiation are those that historically have shown increased mutation rates for other reasons possibly related to DNA repair ability or reduced defenses against oxidative stress.

•Deleterious effects of radiation exposure seen in natural populations in Chernobyl include increased rates of cataracts, tumors, growth abnormalities, deformed sperm, and albinism. 

Maps of Contaminated regions of Fukushima (left), Ukraine, Belarus and Russia (right), and Europe (below). Fukushima map courtesy of Shane Welch; other maps courtesy of the European Union.

•Neurological development is impacted as evidenced by depressed brain size in both birds and rodents and consequent effects on cognitive ability and survival have been demonstrated in birds.

•Tree growth and microbial decomposition in the soil are also depressed in areas of high radiation. 

•In Fukushima, the first signs of developmental abnormalities have been observed in birds in 2013, although significant genetic damage has not yet been documented for birds or rodents.

DTRA Chief: “We provided safe and secure storage for deadly pathogens in former USSR countries” 2009

Do I need to spell it out?
They are using these grounds for experiments.
Did they end up being experiment grounds by accident?
People in Chernobyl have been evacuated, but fauna and flora are hardly impacted by radiation.
Radiation does not discriminate by species.
You know who does that?
Viruses and bacteria.

DTRA 2008: “We design and test weapon systems and pathogens”
Notice anything interesting in this 2018 DTRA presentation?

DARPA IS A PENTAGON AGENCY WOKING FOR AGRICULTURE WITH GENETICALLY MODIFIED INSECTS THAT CAN POTENTIALLY BE WEAPONIZED. THEY SAY.

DARPA Presents Its “Insect Allies” Genetic Modification Program “for Agriculture”
“DARPA’s GMO insects program can be weaponized” – US scientists sounded the alarm years ago

WASHINGTON — DARPA, the Pentagon’s high-tech office, is working with the government of Ukraine to develop capabilities to help Kiev in its hybrid warfare challenge.

DARPA director Steven Walker, who recently took over that job after five years as the agency’s deputy, told reporters that he had personally visited the country in 2016 for talks with Ukrainian military, intel and industry leaders.

“We did have a good visit to the Ukraine,” Walker said Thursday at a breakfast hosted by the Defense Writer’s Group. “Yes, we have followed up with them, and through the U.S. European Command, we have started several projects with the Ukraine, mostly in the information space.”

“Not providing them weapons or anything like that, but looking at how to help them with information,” Walker added, before declining to go into further detail.

Ukraine has become a testing ground for hybrid warfare techniques from Russia and Russian-backed militant groups ever Russia’s invasion of Ukrainian territory in 2014, including disinformation campaigns. While that has allowed Moscow to test out new capabilities and techniques, it also provides an opportunity to develop counter techniques — which may benefit the U.S. and its allies in the long term.

“I think we’ve got to get better, as a country, in information warfare and how we approach info warfare,” Walker said. “I think there are capabilities there that we need to improve upon, and DAPRA is working in some of those areas.”

This is not the first tie between DARPA and Kiev. The Ukrainian government has hired Tony Tether, who led DARPA for the entirety of the George. W. Bush administration, to help lead a reorganization of their science and technology efforts, something Tether in a LinkedIn post said was necessary in part because so much of Ukraine’s S&T facilities were in the territory seized by Russia.

The former DARPA head has also consulted for the Ukroboronprom group, Ukraine’s largest defense contractor, and just a few weeks ago was added to the group’s supervisory board in a move that Ukrainian president Petro Poroshenko called a “symbol of effective cooperation between Ukrainian and American partners.”

Tether is expected to try and recreate some of what make DARPA so successful in Ukraine, but Walker notes that many countries have tried to do that — and failed, in large part due to a cultural fear of giving workers the freedom to fail they need.

“When I talk to others about DARPA and why it works, many other cultures say ‘this couldn’t happen,’” Walker noted.

More broadly, Walker said part of what he wants to see at DARPA during his tenure is looking at increasing counterinsurgency capabilities.

“I think as more populations across the world move to larger and larger cities, we need to understand the three dimensionality of cites and how to operate in those very crowded, very three-dimensional spaces,” Walker said, noting DARPA is working on ways to sense and map underground tunnels and infrastructure.

Updated 3/1/18 at 1:45 PM EST to reflect the fact that after publication, DARPA confirmed that Walker visited Ukraine in 2016.

About Aaron Mehta

Aaron Mehta was deputy editor and senior Pentagon correspondent for Defense News, covering policy, strategy and acquisition at the highest levels of the Defense Department and its international partners.

DARPA Is Making Insects That Can Deliver Bioweapons, Scientists Claim

BY HANNAH OSBORNE ON 10/4/18 AT 2:00 PM EDT

gettyimages-139677923
The U.S. government’s Defense Advanced Research Projects Agency (DARPA) has been accused of trying to create a new class of biological weapons that would be delivered via virus-infected insects. Aphids are one of the insects being used in the DARPA program.ISTOCK

The U.S. government’s Defense Advanced Research Projects Agency (DARPA) has been accused of trying to create a new class of biological weapons that would be delivered via virus-infected insects.

The Insect Allies program was announced by DARPA in 2016. It is a research project that aims to protect the U.S. agricultural food supply by delivering protective genes to plants via insects, which are responsible for the transmission of most plant viruses. Scientists believe loading the bugs up with viruses that would offer plants protective benefits could be one way of ensuring food security in the event of a major threat.

In an editorial published in the journal Science, a group of researchers led by Richard Guy Reeves, from the Max Planck Institute for Evolutionary Biology in Germany, says Insect Allies isn’t exactly what it says it is. Instead, they claim DARPA is potentially developing insects as a means of delivering a “new class of biological weapon.”

How Does Insect Allies Work?

There are many threats that could impact upon food security. This includes environmental disasters, natural pathogens and intentional attacks. Crop failure, for whichever of these reasons, has the potential to have devastating consequences—wheat and maize, for example, are relied upon by hundreds of millions across the globe for their basic nutritional needs.

ConceptArtInsectAlliesOctober32016v4FINAL619-316
Scientists with the Defense Advanced Research Projects Agency (DARPA) are looking at introducing genetically modified viruses that can edit chromosomes directly, like using insects to transmit genetically modified material into plants.DARPA

Genetically altering a species to make it more resilient comes with problems. Introducing alterations directly into a species’ chromosome is slow, as the alteration must be passed down through generations before it takes hold.

Instead, scientists with DARPA are looking at introducing genetically modified viruses that can edit chromosomes directly in fields—these are known as horizontal environmental genetic alteration agents (HEGAAs).

The DARPA program is using the principles of HEGAAs but, unlike traditional methods of dispersal—like spraying fields with them—it wants to spread them through insects. At the moment, maize and tomato plants are being used in experiments and the insects being used for dispersal are leafhoppers, aphids and whiteflies.

“Insect Allies aims to develop scalable, readily deployable, and generalizable countermeasures against potential natural and engineered threats to mature crops,” Blake Bextine, DARPA Program Manager for Insect Allies, told Newsweek. “The program is devising technologies to engineer and deliver these targeted therapies on relevant timescales—that is, within a single growing season. To do so, Insect Allies researchers are building on natural, efficient, and highly specific plant virus and insect vector delivery systems to transfer modified, protective genes to plants.”

Why Biological Weapons?

Reeves and his colleagues offer a number of assertions about why Insect Allies could end up being a means of bioweapon dispersal. Firstly, they question the very nature of the project—the use of insects. Why, they say, are insects so integral? What is the problem with spraying HEGAAs?

The team says Insect Allies “appears very limited in its capacity to enhance U.S. agriculture or respond to national emergencies…. As a result, the program may be widely perceived as an effort to develop biological agents for hostile purposes and their means of delivery.”

Potentially, the viruses being introduced could do harm instead of good. The insects could be used to disperse agents that would prevent seeds from growing. “HEGAA weapons could be extremely transmissible to susceptible crop species, particularly where insects were used as the means of delivery,” they write. “Chromosomal editing would be targetable to particular crop varieties dependent on their genome sequence (presumably those varieties not grown by the deploying parties).”

gettyimages-935444786
Maize, one of the crops being tested by Defense Advanced Research Projects Agency (DARPA), is relied upon by millions of people for basic nutrition. Scientists believe loading the bugs up with viruses that would offer plants protective benefits could be one way of ensuring food security in the event of a major threat.ISTOCK

The development of an insect-based system, according to the authors, points to “an intention to develop a means of delivery of HEGAAs for offensive purposes.” The technology, they say, could quickly be simplified and used to develop a whole new class of biological weapons. “In our view, the program is primarily a bad idea because obvious simplifications of the work plan with already-existing technology can generate predictable and fast-acting weapons, along with their means of delivery, capable of threatening virtually any crop species,” they wrote.

The team calls for more transparency from DARPA as the Insect Allies progresses. However, it also says the potential to weaponize this technology is already out there. They say weapons programs are driven by the perceived activities of competitors—maybe the Insect Allies program is a response to intelligence about another nation’s capabilities.

Furthermore, “the mere announcement of the Insect Allies Program, with its presented justifications, may motivate other countries to develop their own capabilities in this arena—indeed, it may have already done so…. Reversal of funding for this DARPA project…would not in itself close the particular Pandora’s box that HEGAAs or their insect dispersal may represent.”

RELATED STORIES

DARPA Making Weaponized Insects?

DARPA denies the assertions made by Reeves and his colleagues. “DARPA is producing neither biological weapons nor the means for their delivery,” a spokesman told Newsweek. “We do accept and agree with concerns about potential dual use of technology, an issue that comes up with virtually every new powerful technology.” He said these concerns are the reason Insect Allies has been structured in the way it is—supposedly as a transparent and university-led research project that encourages communication. “We also have numerous, layered safeguards in place to maintain biosecurity and ensure the systems we’re developing function only as intended,” the DARPA spokesperson added.

Bextine reiterated this point. Researchers working with DARPA are allowed to publish their results and work with different agencies. The experiments they carry out are done so in biosecure greenhouses. “At no point in the program is DARPA funding open release of Insect Allies systems,” Bextine said.

He said he disagrees with the conclusion of the editorial in Science, saying technology and research that deals with food security and gene editing “have a higher bar than most for transparency”—and Insect Allies, he says, meets these high standards.

Responding to the queries relating to delivery—why spraying technology cannot be used—Bextine said these are just not up to the challenge, especially when it comes to responding at a large scale to the most severe threats.

“Many existing methods for protecting crops are inefficient, expensive, imprecise, or destructive to plants, may require significant infrastructure, and often provide only limited efficacy,” he said. “Sprayed treatments are impractical for introducing genetic modifications on a large scale and potentially infeasible if the spraying technology does not access the necessary tissues with specificity. Meanwhile, traditional selective breeding methods for introducing protective traits into plants require years to propagate, nowhere near the speed required to prevent a fast-moving threat from developing into a crisis.”

He added that DARPA would never receive funding for the next generation of aerial spraying technology. The development of this new technology is dependent on industry and other research funders. “Instead, we reach for fundamentally new ways of delivering more precise, efficacious treatments through systems that can be readily adapted to confront a range of potential threats.

“Emerging biotechnologies—and especially the cutting-edge research being performed on Insect Allies—are pushing science into new territories. DARPA is proud to be taking a proactive role in working with stakeholders to inform a new framework for considering how the benefits of these technologies can be most safely realized.”

US military plan to spread viruses using insects could create ‘new class of biological weapon’, scientists warn

Agency says it is trying to genetically modify crops, but experts think this goal is ‘simply not plausible’

The Independent, 05 October 2018 11:16

US military plan to spread viruses using insects could create ‘new class of biological weapon’, scientists warn

Insects could be turned into “a new class of biological weapon” using new US military plans, experts have warned.

The Insect Allies programme aims to use bugs to disperse genetically modified (GM) viruses to crops.

Such action will have profound consequences and could pose a major threat to global biosecurity, according to a team that includes specialist scientists and lawyers.

However, the Defence Advanced Research Projects Agency (Darpa), which is responsible for developing military technologies in the US, says it is merely trying to alter crops growing in fields by using viruses to transmit genetic changes to plants.

In theory, this rapid engineering would allow farmers to adapt to changing conditions, for example by inserting drought-resistance genes into corn instead of planting pre-engineered seeds.

But this seemingly inoffensive goal has been slammed by the scientists, who say the plan is simply dangerous and that insects loaded with synthetic viruses will be difficult to control.

They also say that despite being in operation since 2016 and distributing $27m in funds to scientists, Darpa has failed to properly justify the existence of such a programme.

Research programme with potential for dual use: scientists fear that the Insect Ally programme by the US could encourage other states to increase their own research activities in the field of biological warfare (MPG/D.Duneka)
Research programme with potential for dual use: scientists fear that the Insect Ally programme by the US could encourage other states to increase their own research activities in the field of biological warfare (MPG/D.Duneka) (MPG/ D. Duneka)

“Given that Darpa is a military agency, we find it surprising that the obvious and concerning dual-use aspects of this research have received so little attention,” Felix Beck, a lawyer at the University of Freiburg, told The Independent.

Dr Guy Reeves, an expert in GM insects at the Max Planck Institute for Evolutionary Biology, said that there has been hardly any debate about the technology and the programme remains largely unknown “even in expert circles”.

He added that despite the stated aims of the programme, it would be far more straightforward using the technology as a biological weapon than for the routine agricultural use suggested by Darpa.

“It is very much easier to kill or sterilise a plant using gene editing than it is to make it herbicide or insect-resistant,” explains Reeves.

Experiments are reportedly already underway using insects such as aphids and whiteflies to treat corn and tomato plants.

Mr Beck said he and fellow experts were not suggesting that the US military wanted to create biological weapons, but that the proposed agricultural uses are “simply not plausible for a number of reasons”.

Firstly, they note that if farmers wanted to use genetically modified viruses to improve their crops, there is no reason not to use conventional spraying equipment.

They also noted that despite Darpa stating that no insects used should survive longer than two weeks, if such safeguards were not in place “the spread could in principle be unlimited”.

Mr Beck added: “The quite obvious question of whether the viruses selected for development should or should not be capable of plant-to-plant transmission – and plant-to-insect-to-plant transmission – was not addressed in the Darpa work plan at all”.

Air Force fails to acknowledge mysterious meteor that crashed to Earth near US military base

Making their case in the journal Science, the team noted that if Insect Allies’ research cannot be justified, it could be perceived as breaching the UN’s Biological Weapons Convention.

“Because of the broad ban of the Biological Weapons Convention, any biological research of concern must be plausibly justified as serving peaceful purposes,” explained Professor Silja Voeneky, a specialist in international law at Freiburg University.

“The Insect Allies Program could be seen to violate the Biological Weapons Convention, if the motivations presented by Darpa are not plausible.

“This is particularly true considering this kind of technology could easily be used for biological warfare.”

To prevent any suspicion and to avoid encouraging other nations to develop their own technologies in this area, the authors of the study have called for more transparency from Darpa if it intends to pursue such programmes.

A spokesperson from Darpa defended the programme, explaining that using insects to apply these gene altering treatments could provide advantages over sprays.

“Most importantly in this context, sprayed treatments are impractical for introducing protective traits on a large scale and potentially infeasible if the spraying technology cannot access the necessary plant tissues with specificity, which is a known problem,” they said.

“If Insect Allies succeeds, it will offer a highly specific, efficient, safe, and readily deployed means of introducing transient protective traits into only the plants intended, with minimal infrastructure required.”

LMFAO

Ukroboronprom Appoints Former DARPA Head as Supervisory Board Member

Ukroboronprom Appoints Former DARPA Head as Supervisory Board Member

Anthony Tether, Former Head of US DARPA was appointed as member of UOP Supervisory Board (Image: Ukroboronprom)

Ukraine’s state run Ukroboronprom has appointed former head of US Defense Advanced Research Projects Agency (DARPA), Anthony Tether as member of UOP Supervisory Board.

Anthony Tether has been in charge of Ukroboronprom long-term development for over a year and a half. He assists in implementing UOP development strategy, implementation of reforms, corporatization, and international audit. The former head of DARPA contributed to strengthening Ukroboronprom’s export potential and investment development. Under his chairmanship, the State General Advanced Research and Development Agency (GARDA, the prototype of the American DARPA) was created, the company said in a statement Thursday.

“As a member of the Supervisory Board, Anthony Tether will help Ukroboronprom to implement the reform strategy and international audit,” said Roman Romanov, Ukroboronprom Director General.

Earlier, Mykhaylo Zhurovs’kyy – the rector of the National Technical University of Ukraine “Kyiv Polytechnic Institute named after I. Sikorsky” – was elected as Chairman of the Supervisory Board. Lieutenant General Yaroslav Skal’ko, former commander-in-chief of the Ukrainian Air Force, was elected as Vice-Chairman.

On January 31, the Ukroboronprom Supervisory Board – after a long-term meeting -took key decisions on the activities of the Concern. During the meeting, UOP management report was heard; strategic directions for UOP development, corporatization process of UOP enterprises-participants, the international audit, the system of effective anti-corruption measures, creation of an advisory body and other issues were discussed.

Ukraine to Create DARPA-like Defence Research Agency

Ukraine to Create DARPA-like Defence Research Agency

Ukriane will soon set up its General Advanced Research & Development Agency (GARDA), modeled along the American Defence Advanced Research Projects Agency (DARPA) at Igor the Sikorsky Kyiv Polytechnic Institute (KPI).

This was stated by UKROBORONPROM Director General Pavlo Bukin during his speech at the Verkhovna Rada of Ukraine, during the parliamentary hearings “National Innovation System: State and Legislative Development”.

“It was decided to create an agency of advanced technologies based on the DARPA model, to implement technologies in the defense industry. Mykhaylo Zhurovs’kyy – the rector of the National Technical University of Ukraine “Kyiv Polytechnic Institute named after I. Sikorsky” – agreed that the agency will be based at this very university. I am sure this decision will contribute to the greatest effect”, stressed Pavlo Bukin.

At the same time, he mentioned that the issue of innovative technologies development is connected with the necessity of legislative changes that would improve the mechanisms of financing such projects.

“The legal framework for innovation in Ukraine is sufficiently developed, but some aspects need to be improved, as they hamper financing. When it comes to research institutes and design bureaus – their resources are limited. It is necessary to legislatively create a mechanism for innovation activity financing and preferential taxation, “- said UKROBORONPROM Director General Pavlo Bukin from the rostrum of the Verkhovna Rada of Ukraine.

He named UGV “Phantom-2” development among UOP innovations. “This platform allows to destroy the enemy’s manpower and to transport the goods, and it has already passed the test abroad, and it can be considered to be a result of the activities of the State Concern and its design engineering bureaus,” said Pavlo Bukin.

Ukroboronprom head: Ukraine’s military industrial complex during hybrid warfare

By Roman Romanov, Dec 11, 2017
Roman Romanov is the director general of Ukrainian defense company Ukroboronprom.

Three years ago, Ukraine was facing an unexpected challenge – Russia’s military aggression. The annexation of Crimea and the first battles in Donbass were a total shock to the Ukrainian armed forces and the domestic defense industry. At that time, defense and law enforcement agencies were uncapable of performing their tasks; weapons and military equipment were not ready for operational use; and the military-industrial complex could not meet the needs of the Army.

Unfortunately, over the past 25 years, Ukrainian defense enterprises received no orders from the state – more than half of the plants were practically closed. The main types of the military equipment manufactured required Russian components.

Outlook 2018: Perspectives from global thought leaders

In 2014, we completely stopped our cooperation with the Russian defense industry, and Ukroboronprom received the task to provide the Army with necessary weapons and military equipment in the shortest possible time.

First of all, we formed a new team of Ukroboronprom managers, who managed to quickly make qualitative changes and introduce the best business and management practices. We replaced about half of the directors of Ukroboronprom enterprises, mainly those who failed to adapt their way of thinking to new realities; we initiated repair and overhaul of the military equipment – Ukroboronprom enterprises organized 55 mobile maintenance crews, restoring military equipment directly in the anti-terrorist operation zone.

Furthermore, we arranged the import of critical components and organized the repair and manufacture of modernized military equipment samples. Ukroboronprom heads for strategic partnership with Western countries and NATO-Ukraine defense-technical cooperation.

In 2015, Ukroboronprom began implementing a new strategic task – the State Defense Order. Ukroboronprom enterprises launched serial production of new military equipment samples. The Army began to receive sniper rifles, mortars, modernized tanks and new armored personnel carriers manufactured in Ukraine.

The next urgent task was set: to overcome the dependence on imported components from the Russian Federation. To solve this problem, we launched a large-scale import substitution program to attract domestic reserves and set up cooperation within the country with enterprises of any form of ownership.

Ukroboronprom representatives visited all regions of Ukraine, held meetings with governors and discussed the issues of attracting the region’s industry to cooperation with Ukroboronprom.

As a result, enterprises from all regions of Ukraine began to join the import-substitution program implementation. As of today, 414 small, medium and large enterprises of Ukraine and 200,000 specialists joined the process. In fact, Ukroboronprom has attracted the whole country to working on strengthening the Ukrainian Army and the development of the country’s economy.

Furthermore, we renewed the workforce, attracted scientific and educational potential of the country: memorandums of cooperation were signed with 48 Ukrainian universities. Today, we train young specialists: 8,000-plus students had their practical training at Ukroboronprom enterprises and almost 600 of them are already working at our plants.

Memorandums of cooperation were signed with 30 institutes of the National Academy of Sciences of Ukraine. Attracting talented Ukrainian scientists and young specialists resulted in 535 promising developments upon the anvil and 80 projects that are already being implemented at Ukroboronprom enterprises.

We set ourselves to the task of expanding partnerships and implementing NATO standards for all stages of armament life cycles. The work on the introduction of the AQAP 2000 series standards at Ukroboronprom enterprises is launched. The ISO 9001 system already operates at 73 percent for Ukroboronprom enterprises.

Ukroboronprom specialists actively participate in multinational projects of the NATO concept Smart Defence, as well as in the meetings of the NATO-Ukraine Joint Working Group on Defence-Technical Cooperation.

In 2016, the development of the Ukroboronprom reform strategy was launched. The state concern Ukroboronprom held a meeting of a specially established tendering committee, involving the specialist of the Independent Defence Anti-Corruption Committee of Transparency International Ukraine, to help select the international consulting company using a “competitive dialogue” procedure. Thus, the concern started the process of conducting an international audit. We launched the next stage of Ukroboronprom’s reform. Implementation of such a large-scale process – as international audit and transformation of Ukroboronprom’s enterprises into joint stock companies – will last for about two years.

As a result of military operations in the anti-terrorist operation area, 900-plus technical solutions were introduced and implemented by Ukroboronprom engineers in the armored vehicles operated by the Army, having significantly improved tactical and operational characteristics of the military equipment and taking into account hybrid war experience.

Today, the latest developments of our specialists are being used and tested in the anti-terrorist operation zone. A good example is the unmanned complex Spectator, developed by the specialists of state concern Ukroboronprom, together with scientists of the National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute.” In May 2015, a contract for production was signed. And in January 2016, the first batch was transferred to Ukraine’s armed forces. This high-tech product has been successfully used in combat conditions for more than a year. The prototype of the new tactical UAV, Horlytsya, developed by the Ukrainian enterprises, successfully performed its first flight.

Hybrid war in the east of Ukraine forced us – taking into account combat experience – to develop unmanned equipment for performing various tasks on the battlefield without putting our soldiers’ lives at risk.

Ukroboronprom withstood the challenge of the war and in three years transferred about 16,000 units of weapons and military equipment to the military. Thanks to the work of the entire defense industry of Ukraine, our armed forces – from combat-ineffective units in 2014 – turned into a well-armed Army.

DARPA wants to alter human skin biomes to fight deadliest enemy: mosquitos

Researchers developing long-lasting topical cream that alters skin’s “microbiome” so troops can ward off disease-carrying insects.

Breaking Defense, March 07, 2022

Mosquitos potentially carry a range of deadly diseases, from malaria to yellow fever. (Photo by James Gathany/CDC. Public Domain.)

WASHINGTON: The Defense Advanced Research Projects Agency may have been created to develop cutting-edge technology to help the US take on the Soviet Union in the Cold War, but now it’s taking on another deadly enemy: mosquitos.

DARPA’s latest idea, now entering its second phase, is to get down to the molecular level to make a topical cream that would actually alter the “microbiome” of human skin to make it less appetizing to the disease-carrying insects.

“The ReVector program aims to precisely, safely, and efficiently reduce mosquito attraction and biting, and, subsequently, to help maintain the health of military personnel operating in disease-endemic regions,” the agency said in a release last month.

While tiny compared to the USSR and totally lacking artillery, the mosquito is the deadliest animal on the planet, responsible for spreading malaria, which kills more than 400,000 people every year, in addition to other deadly diseases. Throughout human history militaries have struggled with mosquito-borne maladies, from the million-plus cases that waylayed soldiers during the Civil War to the over 80,000 cases among US servicemembers in Vietnam.

Even though a vast majority of those survived, the disease disrupted the forces’ ability to fight, at times in critical moments. Army researchers currently estimate malaria infections are responsible for up to 21,000 lost work hours and between $1.2 and $4.4 million per year in evacuation and medical costs.

The treatment for malaria has progressed significantly in recent decades, but the ReVector program aims to stop the disease before it can get into the human body at all. The program’s first phase involved the development of technology to “modify human skin microbes” and the “volatile molecules” it produces, and testing the effect of those modifications on mosquitos.

“In Phase 2, the team plans to advance testing in animal models and move complex microbiome communities,” ReVector program manager Linda Chrisley said in the release.

The release explained that “ultimately, ReVector seeks to develop topical formulations that could be applied shortly before a mission with minimal equipment or training, and last for at least two weeks without reapplication, offering improved, sustained protection against disease vectors.”

DARPA is working with Stanford University researchers on the project, and the agency notes the research is reviewed by the US Food and Drug Administration and “if necessary” the Environmental Protection Agency “to ensure that technologies are effective and do not pose a threat to humans or the environment.”

PENTAGON UNIT A1266 STUDIES INSECTS AS BIOTERRORISM AGENTS ON RUSSIA’S DOORSTEPS:

Pentagon Biolabs – Russia has been long complaining about them – 2018 Investigative Documentary

Entomological Warfare?

DARPA has been working for several years on genetic editing of mosquitoes. Through its “Insect Allies” program, DARPA has been working, using CRISPR gene-editing and gene drive technologies, on manipulating the Aedes Aegypti mosquito. The US Department of Defense has spent at least $100 million in the controversial technology known as “gene drives” making the US military a top funder and developer of the gene-modifying technology. “Gene drives are a powerful and dangerous new technology and potential biological weapons could have disastrous impacts on peace, food security and the environment, especially if misused,” said Jim Thomas, co-director of ETC Group, an environment safety group. “The fact that gene drive development is now being primarily funded and structured by the US military raises alarming questions about this entire field.”

Entomological warfare is a type of biological warfare that uses insects to transmit diseases. The Pentagon, using DARPA research, has allegedly performed such entomological tests secretly in the Republic of Georgia and Russia. Is the DARPA development, together with Gates’ foundation and Oxitec, of the gene edited mosquitoes a covert program in entomological warfare?

The Pentagon presently has top security bio laboratories in 25 countries across the world funded by the Defense Threat Reduction Agency (DTRA) under a $ 2.1 billion military program– Cooperative Biological Engagement Program (CBEP). They are in former Soviet Union countries such as Georgia and Ukraine, the Middle East, South East Asia and Africa. Among their projects, Phlebotomine sand fly species were collected under the heading, “Surveillance Work on Acute Febrile Illness,” in which all (female) sand flies were tested to determine their infectivity rate. A third project, also including sand flies collection, studied the characteristics of their salivary glands. This is weaponization research.

The controversial person picked by the Biden Administration to become the first Cabinet-level science advisor, Eric Lander, came from the MIT-Harvard Broad Institute. Lander is a specialist in gene drive and gene editing technologies and played a major role in the flawed US Human Genome Project. This is not the kind of science we need to be supporting. It is rather part of what is obviously a larger eugenics agenda and Bill Gates is again playing a key role.
SOURCE

BONUS:

US military to develop genetically modified plants to use as spies

New synthetic biology programme makes use of natural capabilities to gather intelligence

The Independent, 23 November 2017 16:55

The highly attuned sensory abilities of plants could be employed to gather intelligence for the military
The highly attuned sensory abilities of plants could be employed to gather intelligence for the military (Getty Images/iStockphoto)

The US military wants to deploy plants as “the next generation of intelligence gatherers”.

Genetically modified plants could be employed as self-sustaining sensors to gather information in settings unsuitable for more traditional technologies.

The Defence Advanced Research Projects Agency (DARPA), which is responsible for the development of emerging technologies in the US military, has called for scientists to submit ideas for how to harness the power of plants.

In the past, DARPA has produced information-gathering technologies such as the satellites and seismographs employed to ensure Soviet compliance with the Nuclear Test Ban Treaty.

But in this new initiative, termed the Advanced Plant Technologies (APT) programme, the agency is looking to the natural world for help.

“Plants are highly attuned to their environments and naturally manifest physiological responses to basic stimuli such as light and temperature, but also in some cases to touch, chemicals, pests and pathogens,” said Dr Blake Bextine, the manager of the ATP programme.

“Emerging molecular and modelling techniques may make it possible to reprogramme these detection and reporting capabilities for a wide range of stimuli, which would not only open up new intelligence streams, but also reduce the personnel risks and costs associated with traditional sensors,” said Dr Bextine.

The idea is that plants’ natural capabilities can be co-opted to detect relevant chemicals, harmful microorganisms, radiation and electromagnetic signals.

Modifying the genomes of plants would enable the military to control the types of sensing they are doing, and also trigger certain responses that can be monitored remotely using existing hardware.

Technology already exists to monitor plants from the ground, air and even from space.

“Advanced Plant Technologies is a synthetic biology programme at heart,” said Dr Bextine.

“As with DARPA’s other work in that space, our goal is to develop an efficient, iterative system for designing, building, and testing models so that we end up with a readily adaptable platform capability that can be applied to a wide range of scenarios.”

Past experiments with plants that have been modified in this manner have resulted in organisms that have difficulty settling in the natural environment, where they would be deployed.

The additional strain placed on the modified plants by their new duties makes it difficult for them to survive and compete with surrounding plants. This will be a key area that the new programme seeks to address.

The “proposers day” is being held on 12 December in Arlington, Virginia. It will lay out the objectives of DARPA’s programme and take submissions for research projects that are relevant to the initiative.

Gene Edited Catastrophe in Brazil

New Eastern Outlook, 02.10.2019 Author: F. William Engdahl

A British-American gene-editing company has released millions of genetically modified mosquitoes containing a dominant lethal gene, each week for 27 months in the Bahia, Brazil region in a test to see if the gene-edited mosquitoes would mate with local mosquitoes carrying Zika, malaria or other mosquito-borne diseases. A new study documents the alarming fact that following an initial reduction of the target population of mosquitoes, after some months the “population which had been greatly suppressed rebounded to nearly pre-release levels.” Scientists to date have no idea what dangers are presented by the new mutations. This once more highlights the dangers of uncontrolled gene-editing of species.

According to a new published study in Nature Reports journal, genetically engineered mosquitoes produced by the biotech company, Oxitec, now part of the US company Intrexon, have escaped human control after trials in Brazil and are now spreading in the environment.

On paper the theory was brilliant. Strains of “yellow fever” male mosquitoes taken from Cuba and Mexico were altered using gene-editing to make it impossible for their offspring to survive. Oxitec then began a systematic release of tens of millions of the manipulated mosquitoes over more than two years in the the city of Jacobina in the region of Bahia in Brazil. The Oxitec theory was the altered mosquitoes would mate with normal females of the same type which carry infectious diseases like dengue fever, and kill them off in the process.

Unanticipated Outcome…’

A team of scientists from Yale University and several scientific institutes in Brazil monitored the progress of the experiment. What they found is alarming in the extreme. After an initial period in which the target mosquito population markedly declined, after about 18 months the mosquito population recovered to pre-release levels. Not only that, the paper notes that some of the mosquitos likely have “hybrid vigor,” in which a hybrid of the natural with the gene-edited has created “a more robust population than the pre-release population” which may be more resistant to insecticides, in short, resistant “super mosquitoes.”

The scientists note that, “Genetic sampling from the target population six, 12, and 27–30 months after releases commenced provides clear evidence that portions of the transgenic strain genome have been incorporated into the target population. Evidently, rare viable hybrid offspring between the release strain and the Jacobina population are sufficiently robust to be able to reproduce in nature…” They continue, “Thus, Jacobina Ae. aegypti are now a mix of three populations. It is unclear how this may affect disease transmission or affect other efforts to control these dangerous vectors.” They estimate that between 10% and 60% of the Bahia natural Ae. Aegypti mosquitoes now had some gene-edited OX513A genome. They conclude that “The three populations forming the tri-hybrid population now in Jacobina (Cuba/Mexico/Brazil) are genetically quite distinct, very likely resulting in a more robust population than the pre-release population due to hybrid vigor.”

This was not supposed to happen. Professor of ecology and evolutionary biology, Jeffrey Powell, senior author of the study, remarked on the findings: “The claim was that genes from the release strain would not get into the general population because offspring would die. That obviously was not what happened.” Powell went on to note, “But it is the unanticipated outcome that is concerning.”

A Gates Foundation Project

The Brazil study deals a major alarm signal on the uncontrolled release of gene-edited species into nature. It calls to mind the horror plot of Michael Crichton’s 1969 science fiction novel, Andromeda Strain. Only it is no novel.

The Oxitec mosquitoes were developed using a highly controversial form of gene-editing known as gene drive. Gene Drive, which is also being heavily funded by the Pentagon’s DARPA, combined with CRISPR gene-editing, aims to force a genetic modification to spread through an entire population, whether of mosquitoes or potentially humans, in just a few generations.

The scientist who first suggested developing gene drives in gene-editing, Harvard biologist Kevin Esvelt, has publicly warned that development of gene editing in conjunction with gene drive technologies has alarming potential to go awry. He notes how often CRISPR messes up and the likelihood of protective mutations arising, making even benign gene drives aggressive. He stresses, “Just a few engineered organisms could irrevocably alter an ecosystem.” Esvelt’s computer gene drive simulations calculated that a resulting edited gene “can spread to 99 percent of a population in as few as 10 generations, and persist for more than 200 generations.” This is very much what has now been demonstrated in the mosquito experiment in Brazil.

Notable is the fact that the Oxitec Brazil mosquito experiment was funded by the Bill & Melinda Gates Foundation. In June, 2018 Oxitec announced a joint venture with the Gates Foundation, “to develop a new strain of Oxitec’s self-limiting Friendly™ Mosquitoes to combat a mosquito species that spreads malaria in the Western Hemisphere.” The Brazil results show the experiment is a catastrophic failure as the new strain is anything but self-limiting.

The Gates Foundation and Bill Gates have been backing development of the radical gene-editing technology and gene drive technology for more than a decade. Gates, a long-time advocate of eugenics, population control and of GMO, is a strong gene-editing promoter. In an article in the May/June 2018 magazine of the New York Council on Foreign Relations, Foreign Affairs, Gates hails gene editing technologies, explicitly CRISPR. In the article Gates argues that CRISPR and other gene-editing techniques should be used globally to meet growing demand for food and to improve disease prevention, particularly for malaria. In his article he adds, “there is reason to be optimistic that creating gene drives in malaria-spreading mosquitoes will not do much, if any, harm to the environment.

Every bit as alarming as the failure of the Brazil gene-editing mosquito experiment is the fact that this technology is being spread with virtually no prior health or safety testing by truly independent government institutions. To date the US Government relies only on industry safety assurances. The EU, while formally responsible to treat gene-edited species similarly to GMO plants, is reportedly trying to loosen the regulations. China, a major research center for gene-editing, has extremely lax controls. Recently a Chinese scientist announced an experiment in human gene-editing allegedly to make newborn twins resistant to HIV. Other experiments are proliferating around the world with gene-edited animals and even salmon. The precautionary principle has been thrown to the winds when it comes to the new gene-editing revolution, not a reassuring situation.

Currently Oxitec, which denies that the Brazil results show failure, is now trying to get regulatory approval from the US Environmental Protection Agency to conduct a similar experiment with the same gene-edited species in Texas and Florida. One of the people involved in the attempt, Texan Roy Bailey, is a Washington lobbyist and close friend of Randal Kirk, the billionaire CEO of Intrexon, owner of Oxitec. Bailey is also a major Trump fundraiser. Let’s hope that regulatory prudence and not politics decide the outcome

F. William Engdahl is strategic risk consultant and lecturer, he holds a degree in politics from Princeton University and is a best-selling author on oil and geopolitics, exclusively for the online magazine “New Eastern Outlook.”

MORE RESOURCES

Genetically modified mosquitoes could be released in Florida and Texas beginning this summer
https://theconversation.com/genetically-modified-mosquitoes-could-be-released-in-florida-and-texas-beginning-this-summer-silver-bullet-or-jumping-the-gun-139710

Gates Foundation Oxitec Grant
https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2018/06/OPP1181812

Gates Foundation and Oxitec Fight Malaria with Genetically-Modified Mosquitoes
https://www.labiotech.eu/industrial/gates-foundation-oxitec-malaria-mosquito/

Gates Foundation Awards $4.1 Million for Mosquito Engineering
https://philanthropynewsdigest.org/news/gates-foundation-awards-4.1-million-for-mosquito-engineering

Mosquitoes are the new syringe? Seattle lab nibbles at malaria vaccine
https://www.seattletimes.com/seattle-news/science/mosquitoes-are-the-new-syringe-seattle-lab-nibbles-at-malaria-vaccine/

Researchers Turn Mosquitoes Into Flying Vaccinators
https://www.sciencemag.org/news/2010/03/researchers-turn-mosquitoes-flying-vaccinators

US Army & Gates Study Immunization Via Mosquito Bite With Radiation-attenuated Sporozoites (IMRAS)
https://clinicaltrials.gov/ct2/show/NCT01994525

Who is the biggest killer on the planet?
http://www.hardydiagnostics.com/wp-content/uploads/2016/05/The-Most-Deadly-Animals.pdf

EPA suspends enforcement of environmental laws amid coronavirus
https://thehill.com/policy/energy-environment/489753-epa-suspends-enforcement-of-environmental-laws-amid-coronavirus

So yeah, nothing to worry here, just “health labs” and SPAs …

Thanks Fukushima Exposed for the great and timely contribution that decisively helped me complete this investigation!

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Only days ago, Luc Montagnier was up in arms on the barricades against Covidiocracy. Suddenly, he is told to have left the battlefield, in peace, not as a fallen general.
Why such a sudden ‘change of heart’?
This is the question.

Got around doing a little video summary, but the devil is in the details below.

“At the age of 89 (August 18, 1932 – February 8, 2022), Professor Luc Montagnier died at the American Hospital in Neuilly-sur-Seine. Doctor Gérard Guillaume, one of his most faithful collaborators, tells us that he left in peace, surrounded by his children.

He was a biologist and virologist, but also and above all a man of remarkable intelligence, who lived for science. In addition to having been named Nobel Prize for Medicine in 2008 for the discovery of the AIDS virus, he worked alongside the greatest scientific institutes in the world during his life. Emeritus research director at the CNRS, professor at the Institut Pasteur, director of the Center for Molecular and Cellular Biology at Queens College of the City University of New York, director of a research institute at the Jiao-tong University of Shanghai. He supported the Academy of Sciences as well as the National Academy of Medicine through his research for many years. For this, he has received countless awards and accolades.

Despite his advanced age and despite all the criticism he suffered in the autumn of his life, notably from part of the scientific community, Luc Montagnier has always fought for free science. We were lucky enough to be able to welcome him several times at FranceSoir, and would like to give him all the honors that are due to him.” – France Soir

He’s just earned his wings

The official announcements say he died in peace, “surrounded by his youngsters”.

Many call this death ‘sudden’, as in “unforeseen”.

Others. such as myself, have been wondering for long why is he still allowed to roam free and blow the whistle, given his deep involvement with the AIDS scam, his out-spoken anti-Pharmafia stance and, more recently, his total dissidence to the Covid / vaccine narrative.

Rare video from World Health Summit, 2010

“His death took place on Tuesday 8 February, on the same day as the funeral of the Italian biologist Franco Trinca struck down by a very violent and suspicious form of Covid-19 despite being in excellent health and used to take care of himself with a thousand precautions. Trinca had often taken up the complaints of the internationally renowned French scientist who, having worked in the field of vaccines, had denounced the dangers of gene serums based on messenger RNA above all for the risk of creating degenerative brain diseases from prions, as highlighted in our latest investigation.” – VT

OMG OMG!
SOURCE

NO CAUSE OF DEATH PROVIDED



Information surrounding his death are inexistent yet, I’m writing this less than 12h after the official announcement. I will add here anything relevant to it, as much as to why he was a major threat to Pharmafia and the WEF cartel.

UPDATE: Associated Press and thus the global mainstream media finally caught up but still no additional info, just more character assassination rituals.

LAST TIMES HE APPEARED IN PUBLIC:

Four weeks before Montagnier’s death:

“On January 9, Montagnier once again appeared on an international media, the Wall Street Journal, in an editorial titled Omicron makes Biden’s vaccination obligations obsolete, co-signed by American constitutionalist Jed Rubenfeld who another disgraced celebrity: married to Amy Chua, fellow law professor at Yale and author of the world bestseller on the mother tiger, Rubenfeld accused of sexual assaults on female students and suspended by Yale for two years. After the article on the Wsj and before the intervention in Milan, Luc Montagnier appeared last Wednesday in the Luxembourg House of Parliament to support a petition against compulsory vaccination, but his commitment against vaccines began well before the Covid era.” – Italy24 News

So, on January 12, 2022, he concluded his career gloriously participating in THIS INVESTIGATION ON CHILDHOOD COVID VACCINATION BY THE LUXEMBOURG PARLIAMENT

And then…

Three weeks before Montagnier’s death:

January 15th, 2022, at a protest in Milan, Italy:

He seems in pretty good shape to me.

“Luc Montagnier, who in 2009 suggested fighting AIDS with better nutrition, he is experiencing an unexpected return these days, accompanied as always by the American assistant and companion Suzanne McDonnell Long, who was next to him in Milan when he added that it was a crime to give this vaccine to children. As in the past, when Montagnier sold expensive papaya preparations in pharmacies, the problem that the professor does not provide any proof of what he claims. His sentences are not based on any research he has done in recent months or years, but respect for the scientific community is not something that would interest him or his followers.” – Italy24 News

So he almost literally died on the barricades…

Last time I checked…

New evidence, including sworn affidavits from leading experts such as Professor Luc A. Montagnier, has been submitted to the International Criminal Court by lawyers in several countries alleging Government’s across the world and their advisors are complicit in genocide, crimes against humanity and breaches of the Nuremberg Code.Daily Expose

“Attorney Melinda C. Mayne, and Kaira S. McCallum submitted a 27-page ‘Request for Investigation’ to the International Criminal Court (ICC) at The Hague back in April 2021 alleging the UK Government and its advisors were complicit in crimes against humanity in the name of Covid-19.

On the 28th of April 2021, the pair received a formal acknowledgement from the ICC and were assigned a case number – ‘141/21’. Since then the pair have been gathering new evidence to use in their ICC claim and have established connections with lawyers and research scientists from around the world.

A new press release released on the 17th August, which can be viewed here, confirms that the pair have received sworn affidavits from leading experts including research scientist and nuclear cardiologist Dr Richard M. Fleming, the Nobel Laureate virologist Professor Luc  A. Montagnier, and Dr Kevin W. McCairn, a neuroscientist and expert on neurological disease.

Professor Luc A Montagnier, who won a Nobel prize for his work on the HIV virus, claimed in April 2020 that he believed the novel coronavirus was created in a laboratory. Then in May 2021 the expert virologist stated that “Mass vaccinations are a scientific error as well as a medical error. It is an unacceptable mistake. The history books will show that, because it is the vaccination that is creating the variants”.

A new claim has also been submitted to the ICC due to the vast amount of new evidence and information that has come to light in the past few months, and the lawyers say they now have compelling evidence that “the SARS-CoV-2 virus and the Covid-19 ‘vaccines’ are deliberately engineered bioweapons that have been released in two phashes on unsuspecting peoples of the world”.

Attorney Melinda C. Mayne, and Kaira S. McCallum have also confirmed that they have now be joined by lawyers who have filed similar Requests for Investigation to the International Criminal Court, in France, the Czech Republic and Slovakia.

Because of this a letter was sent to the ICC on the 12th August 2021 requesting they all be allowed to submit a joint claim, whilst also submitting preliminary evidence for the allegations common to everyone across the world, and requesting the right to have claims specific to individual countries also investigated by the ICC.” – Daily Expose

They called him a “conspirationist” because he was an early adept of the Chinese lab origin of the virus

KARy MULLIS, THE PCR INVENTOR, DIED JUST A FEW MONTHS BEFORE COVID.
DID MONTAIGNER, THE HIV DISCOVERER, DIE JUST MONTHS BEFORE A BIG AIDS RESURGENCE?

Seven weeks before Montagnier’s death:

Four days before Montagnier’s death:

You’ve seen the increasing media coverage about a new HIV strain, I suppose.

Instead of AIDS, I’d call that, and I’m not the only one, “Vaccine-Induced Auto-Immune Syndrome”, but let’s pretend we go along with the official narrative.

Logically, Montaigner should’ve been the first to summon with the Bat Signal.

That never happened. His death happened.

The day Montagnier died:

This was aired in US on the day Montagnier died.

I think we need a recap. we’ll start here and I will gradually build a picture, come back later:

WUHAN-GATES – 3. “COVID-19 Created in Lab with HIV”. Medicine Nobel confirms Indian Research disclosed by Gospa News

(My excerpts, full story HERE)

Professor Luc Montagnier, Nobel Prize for Medicine 2008, to the microphones of the French podcast, specialized in medicine and health, “Pourquoi Docteur” has torn the veil of silence, has broken the sepulcher of taboos, accrediting the research of the Kusuma School of Biology of New Delhi, withdrawn by the authors but republished worldwide by me on Gospa News and Veterans Today a few days ago and immediately targeted by the skepticism of improvised scientists.

Indian research sensationally withdrawn but recovered by Gospa News

«With my colleague, the biomathematician Jean-Claude Perez, we have carefully analyzed the description of the genome of this Rna virus. We weren’t the first, a group of Indian researchers tried to publish a study showing that the complete genome of this virus that has within the sequences of another virus: that of AIDS. The Indian team retracted after publication. But scientific truth always emerges. The AIDS sequence was inserted into the coronavirus genome to attempt to make the vaccine» said Montagnier.

Luc Montagnier, the French virologist Nobel Prize winner for Medicine in 2008 for his AIDS research

In 7 lines, one of the world’s leading experts in medicine makes “tabula rasa” of somewhat sibylline hypotheses so far promoted by virologists, perhaps even induced by some housekeeper worried about national security in the face of the confirmation of a pandemic capable of causing 120 thousand deaths.

His words carry enormous weight: because in 2008 Montagnier discovered the human immunodeficiency virus HIV as the cause of the AIDS epidemic so much that he won the Nobel Prize for Medicine together with Françoise Barré-Sinoussi and Harald zur Hausen.

«Coronavirus would be a manipulated virus, accidentally released from a Chinese laboratory in Wuhan where the AIDS vaccine was being studied. Professor Luc Montagnier said so» writes the Italian Journalism Agency (AGI), one of the few big media to report the news with prominence.

However, it publishes it with less evidence compared to another article on the statements of the American immunologist Anthony Fauci, director of the American National Institute of Allergy and Infectious Diseases, who persistenly supported the natural origin of the virus.

As we have shown in 12 detailed reports on bio-weapon theory, the United States of America are among the prime suspects, together with China, for this pandemic catastrophe.

It is therefore understandable that the American doctor tries to divert attention from the hypothesis of a pathogen manipulated by bioengineering since the most disturbing experiment was conducted by the biosafety 3 of the Burnett Womack Biohazard center at the Chapell Hill site of the University of North Carolina together with the biosafety laboratory 4 of the Wuhan Institute of Virology.

Not only. The research had been supported by the institute where Fauci works through «grants from the National Institute of Allergy & Infectious Disease and the National Institute of Aging of the United States National Institutes of Health (NIH), the National Natural Science Foundation of China and the USAID-EPT-PREDICT funding from EcoHealth Alliance» as stated in the Abstract published by Nature Medicine published in report no. 9.

The trial led to «building a chimeric CoV with a bat CoV S gene (SHC014) in the backbone of a SARS CoV that has adapted to infect mice (MA15) and is capable of infecting human cells».

Researchers Shan-Lu Liu, Linda J. Saif, Susan R. Weiss and Lishan Su wrote that in a study of February 28, in which, however, they showed some fundamental divergences, equal to 96% for about 5 thousand nucleotides, between that “chimeric” CoronaVirus, that is, created in the laboratory and not existing in nature, and the current real pathogen of the SARS-Cov-2 pandemic, so called from the English acronym of Acute Respiratory Severe Syndrome.

But in the supervirus study conducted primarily in the Chapel Hill laboratories of the University of North Carolina, mention that was also made experiments «similar to those using an HIV-based pseudovirus, prepared as previously described and tested on HeLa cells (Wuhan Institute of Virology) which the ACE2 orthologists expressed».

Despite the difference between Covid-19 and the chimeric supervirus, nothing prevents us from thinking that this “prototype” it was then further modified in one of the US Pentagon’s 25 military laboratories, where highly top-secret projects are also managed directly by the Central Intelligence Agency or in one of the 11 existing in the US territory only (on which we will write shortly), including the National Biodefense Analysis and Countermeasures Center – NBACC of the USAMRIID (US Army Medical Institute of Infectious Diseases) in Fort Detrick, Maryland, closed last July for a mysterious biosecurity loss ever better detailed.

http://www.gospanews.net/en/2020/03/24/coronavirus-bioweapon-7-top-secret-military-missions-in-ukraine-fort-detrick-sigonella-wuhan-and-modena/embed/#?secret=YswmTKBpeG

Or that that highly lethal “chimeric supervirus”, such as Covid-19’s “L” genotype, may have been further processed in the Wuhan Virology Institute itself, around which there have been numerous suspicious deaths (of which we will write shortly), concealed by the proverbial Chinese military secrecy imposed by the risk of a capital punishment for espionage or terrorism.

The BSL 4 biosafety labs of the Wuhan Institute of Virology in China

Montagnier is a famous virologist, he was an illustrious professor and researcher of the Pasteur Institute in Paris (one of the first to elaborate a research on the first CoronaVirus strain of SARS in 2003) but for some years he has been working in the most important research center in Shanghai, the Jiao Tong University.

Therefore he is by no means extraneous to matters connected with China and certainly knows Wuhan’s laboratory strongly desired by the entourage of former president Jiang Zemin, historic leader of the Chinese Communist Party who has become popular in the world for international trials for human rights violations in Tibet and for the nickname “executioner of Tiananmen”.

Now Montagnier not only confirms the validity of the Indian study on the traces of HIV inside Covid-19, reported by me in the essential passages from Gospa News and Veterans Today, but supports the “less serious” hypothesis, namely that of an accidental release of the genetically manipulated virus.

Porquoi Docteur’s scoop with the interview with Montagnier

«The hypothesis is that this virus leaves the Wuhan laboratory. It is a high security laboratory but despite all the virus has escaped from the control of the promoters. The history of the fish market is a beautiful legend but it is not possible that it is only a virus transmitted by a bat, it is probably from this that they started, then they modified it. Maybe they wanted to make an AIDS vaccine using a coronavirus as an antigen carrier. A work of sorcerer’s apprentices can be said. Because we must not forget that we are in the world of nature, there are balances to be respected» said Montagnier peremptorily.

According to the scientist, the altered elements of this virus will however be eliminated as it spreads: «Nature does not accept any molecular manipulation, it will eliminate these unnatural changes and even if nothing is done, things will improve, but unfortunately after many deaths».

Also read: AIDS AND COVID ARE TWO COMMERCIAL BRANDS AND ONE BUSINESS MODEL BY FAUCI

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

I dug out for you a big gold nugget from a Johns Hopkins specialist who also inspected Iraq on behalf of UN searching for bioweapons. If you pay close attention, this talk delivers powerful details on GoF beyond the scope of Russia.

Raymond Zilinskas, Monterey Institute of International Studies Speech at the Herrenhausen Symposium “Dual Use Research on Microbes: Biosafety, Biosecurity, Responsibility”, 11.12.2014

A few key-points:

  • You can’t differentiate between bioweapons and vaccine research except by intention, which you can’t really know
  • Bioweapons often target crops and livestock. As in ‘swine-flu’.
  • They experimented with Nipah and Marburg
  • Military oversight as per the Western Military BioTech Complex.
  • They are irresponsibly power-tripping

Raymond A. Zilinskas speaks about the first (1928-1971) and second (called FERMENT, 1972-1992) generation biological warfare programs, relevant elements of the Biological and Toxin Weapons Convention, and Russian weapons based on “genetics”. He provides statistics about the USSR Ministry of Defense biological warfare facilities, the biopreparat biological warfare facilities, and anti-plague institutes. The scientist names examples of FERMENT program’s projects and discusses the program’s legacy in today’s Russia.

The speech has only been recorded in audio:

Zilinskas has worked for the U.S. Office of Technology Assessment, the U.N. Industrial Development Organization, the University of Maryland Biotechnology Institute, the School of Hygiene and Public Health, and the Johns Hopkins University. In 1994, he twice served as UNSCOM biological inspector in Iraq. Currently he directs the Chemical and Biological Weapons Nonproliferation Program at James Martin Center for Nonproliferation Studies, Monterey Institute of International Studies, California.

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

For my mother, who has just buried my father, passed away from a very suspicious heart event involving some clots. She had to bury him in my absence, because the Military BioTech Complex holds us prisoners on two different continents. I had to bury myself in work to keep it together.

Work in progress, I will keep adding pieces to the Tetris until it goes away.
Please return regularly for updates, this is a very long and fascinating story that should change the worldview for most people.

This is to request that the current retention allowance [(b)(6) redaction] for Dr. Anthony S. Fauci be converted to a permanent pay adjustment in the amount [(b)(6) redaction] over his base pay of [(b)(6) redaction] in order to appropriately compensate him for the level of responsibility in his current position of Director, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), especially as it relates to his work on biodefense research activities.”

GW BUSH

Key points

First, in the US, Military and an emerging petrochemical industry with strong roots in agriculture but expanding into health, among others. The Rockefellers were the main force driving this expansion in the US and bridging over the ocean to Germany, the most advanced country in terms of chemical industrialization.
But it was mostly Crown-controlled and Rothschild-controlled from the City of London, through their many henchmen.

After a few good collaborative experiences, the Military and Pharmafia decided they have a future together, and they bought up the Academia to help with the labs and the brains, as both industries already had a foot in the door there.

Two world wars demonstrated there’s hardly any limit to what they can achieve together.

The Cold War is then used as an excuse to develop more surveillance and population control tools. From these efforts spring1 out Silicon Valley and the Internet.

Before the end of 20th century, Big Pharma and Big Tech are fused by all means: capital, gear, agenda.

The Great Military BioTech Complex is born to be the main Operating System of the system.

9/11 is the launch of the new control grid.

Many of the following events were just test runs.

Covid is a forced upgrade of this operating system.

Weapons trade is disguised as “defense”, bioweapons trade as “biodefense”. And the latter is booming.

Transhumanism Airlines depart from Humanism and are set to land in lifeless soulless material existence.

The Military Biotech Complex Origins

After 1865, American inventiveness turned away from war and toward commerce and industry. Development of the lands of the West did promote some agencies to investigate natural resources. The Department of Agriculture, the Department of Commerce and Labor, and the National Park Service appeared during this period. While government research tended toward the applied end of the research spectrum, newly-created private foundations, such as the Rockefeller Foundation and the Carnegie Institute of Washington, supported much of the nation's basic scientific research.- Daniel Else, "Origins of the Military-Industrial Complex", 2017 
This is the official history, not whistleblowing. It’s redacted by a system critter to make crimes palatable to the normies. Still a good starting point

Summary

Daniel Else explored the results of his year-long inquiry into the organizational underpinnings of that military technological revolution of the 1940s and 1950s. By mining the Library’s resources, Else traced the evolving relationship between science and the federal government leading to the creation of the Office of Scientific Research and Development (OSRD) in 1941. A temporary wartime agency, OSRD mobilized the nation’s academic and industrial technological resources in support of the war effort, and in so doing profoundly altered the linkages between science and engineering, industry, and government. Else explored those wartime changes and outline their impact, still seen and felt today more than seven decades after V-J Day.

Event Date September 21, 2017

Notes-  Daniel Else was a specialist in national defense in the Congressional Research Service in the Library of Congress and the 2016 Kluge Staff Fellow at the Library’s John W. Kluge Center.

Finally in 1950, the Air Force created a larger organization, the Air Research and Development Command. The House finally passed the Senate bill that had been passed the year before, and the president signed the bill, establishing the National Science Foundation. So in that five-year gap, what we saw was the creation of a number of military, Department of Defense organizations for science and scientific research, and the final NSF bill contained no mandate for military research for the National Science Foundation. 

So, what are its legacy organizations? A number of federal agencies can trace their origins back to the OSRD. National Science Foundation, of course, the Office of Naval Research, the Army Research Development and Engineering, or, and Evaluation Command, Air Force Office of Scientific Research, DTRA, the Defense Threat Reduction Agency, DARPA, of course, and in the Department of Energy, the National Nuclear Security Administration, which is the custodian of atomic stockpile. - Daniel Else, "Origins of the Military-Industrial Complex", 2017 
Some of Vannevar Bush’s greatest official honors

One of Vannevar Bush’s PhD students at MIT was Frederick Terman, who was later instrumental in the development of “Silicon Valley”.

Wikipedia
CIA’s Senate Hearing on the Heart Attack Gun and the Bioweapons Developed in Fort Derrick (1975)

MEANWHILE, IN EUROPE

AND FROM THERE TO ALL THE QUEEN’S TERRITORIES

MIT is basically MBTC’s main civilian lab
Rockefeller Medicine – James Corbett
One of the most essential videos on Internet. Source

From Dark Winter to the coming winter – how biodefense drills have altered society

DR. HEIKO SCHÖNING: THE STAGE FOR THE DARK WINTER HAS BEEN SET WITH THE ANTHRAX ATTACKS FROM 2001. There was even an Event201 for the Anthrax attacks. It was called “The Dark Winter”

The Dark Winter exercise was the collaborative effort of 4 organizations. John Hamre of the Center for Strategic and International Studies (CSIS) initiated and conceived of an exercise wherein senior former officials would respond to a bioterrorist induced national security crisis. Tara O’Toole and Tom Inglesby of the Johns Hopkins Center for Civilian Biodefense Studies and Randy Larsen and Mark DeMier of Analytic Services, Inc., (ANSER) were the principal designers, authors, and controllers of Dark Winter. Sue Reingold of CSIS managed administrative and logistical arrangements. General Dennis Reimer of the Memorial Institute for the Prevention of Terrorism (MIPT) provided funding for Dark Winter.

DARK WINTER Official page

Deleted article, now ARCHIVED HERE

Simulations and Tabletop Exercises

Part of the: Homeland Security Archived Projects

Preparing homeland security professionals through scenario-based simulations and exercises on key issues.

Steadfast Resolve

The Steadfast Resolve exercise was planned to address the concern that poorly designed government response to the next terrorist attack could disrupt America’s economy and society as much or more than the attack itself. This concern is particularly relevant in the context of an attack that may be harmful, but not catastrophic.

In the event of a next attack, government officials will be under enormous pressure to respond swiftly, more than likely with limited information about the status of the attack or what to expect next. In today’s news cycle, the public – and the situation – will demand a swift and decisive response perhaps before exactly what is happening becomes clear. Confusion, indecision, or false starts at government’s highest levels will be magnified and may have long-lasting ramifications. Getting it wrong will be easier than getting it right. As the Hurricane Katrina experience has demonstrated, a lack of situational awareness, understanding of current plans, and an absence of effective decisionmaking tools can lead to disaster. 

Dark Winter: Bioterrorism Simulation Exercise

In the summer of 2001, a group of senior-level officials, including Gov. Frank Keating of Oklahoma, David Gergen, and James Woolsey, participated in an executive level simulation. Dark Winter simulated a U.S. National Security Council meeting at which senior officials were confronted with a smallpox attack on the United States. The exercise illustrated the issues to be addressed in the event of a bioterrorism crisis, including the challenges facing state and local governments, the role and responsiveness of the federal government, and the likely friction spots between federal- and state-level responders and responses.

Coming as it did before the September 11 terrorist attacks and the subsequent anthrax attacks, Dark Winter generated an enormous amount of interest in both the public policy community and the media. CSIS briefed Vice President Dick Cheney, then National Security Advisor Condoleeza Rice, then FEMA Director Joe Allbaugh, over 80 members of Congress, senior government officials and leaders, including approximately 20 ambassadors to the United States, and senior government officials from Asia, Latin America, and Europe. Besides raising public awareness of the bioterrorism threat, these briefings contributed to the Bush administration’s decision to manufacture 300 million doses of the smallpox vaccine.

Silent Vector: A Critical Energy Infrastructure Simulation Exercise

The events of September 11 and additional intelligence on al Qaeda demonstrate the potential for an attack against the infrastructure of the United States. To face this challenge, CSIS developed an executive-level simulation focusing on U.S. critical energy infrastructure. The exercise took place in October 2002 and employed a simulated National Security Council of senior policymakers with former senator Sam Nunn, now chairman of CSIS’s Board of Trustees, serving as scenario president.

Silent Vector was designed to simulate possible U.S. reaction to a credible threat of terrorist attack when there is not sufficient information for effective protection. The overall purpose of the exercise was to assist the administration and Congress in their attempts to improve the effectiveness of response during the pre-attack phase of a major terrorist incident. Silent Vector challenged current and former senior government leaders to respond to increasingly credible and specific intelligence indicating the possibility of a large-scale attack against critical energy and energy-related infrastructure on the East Coast of the United States.
 

Black Dawn: A Scenario-Based Exercise on Catastrophic Terrorism

Organized under the auspices of the Strengthening the Global Partnership project by CSIS and the Nuclear Threat Initiative, Black Dawn gathered approximately 55 current and former senior officials and experts from the European Council, the European Commission, NATO, 15 member states, and various international organizations to grapple with the challenges associated with preventing the use of weapons of mass destruction (WMD) by terrorists.

The exercise aimed to develop a set of actionable recommendations for the EU, NATO and individual European governments to prevent terrorists from acquiring and using WMD. The exercise was designed to energize discussion and debate as various European countries and institutions entered into their policy and budget deliberations. The central question animating the exercise was this: In hindsight, what could we have done to prevent terrorists from acquiring WMD and conducting such an attack? And what more can and should we do now?

The exercise concluded with several lessons learned: the threat of WMD terrorism is real; it could happen in Europe; prevention is the best option; we can take concrete steps to significantly reduce the risk of terrorists acquiring nuclear, biological, and chemical weapons; Europe has a leadership role to play; and we need to act now.

  • Simon Chair BlogCommentaries on U.S. relations with countries in the Western Hemisphere – focusing on international political economy, trade, investment, energy, and other current events.

A “Dark Winter” for Public Health: Meet Homeland Security’s New Bioterror Czarina

by Tom Burghardt / August 24th, 2009

In the wake of the 2001 anthrax attacks, successive U.S. administrations have pumped some $57 billion across 11 federal agencies and departments into what is euphemistically called “biodefense.” Speaking at the World Economic Forum in Davos, Switzerland in January 2005, former U.S. Senate Majority Leader William Frist, a Bushist acolyte, baldly stated that “The greatest existential threat we have in the world today is biological” and predicted that “an inevitable bioterror attack” would come “at some time in the next 10 years.”

Later that year, Frist and former House Speaker Dennis Hastert (R-IL) covertly inserted language into the 2006 Defense Appropriations bill (H.R. 2863) that granted legal immunity to vaccine manufacturers, even in cases of willful misconduct. It was signed into law by President Bush.

According to Public Citizen and The New York Times, Frist and Hastert benefited financially from their actions; the pair, as well as 41 other congressmen and senators owned as much as $16 million in pharmaceutical stock. revealed that “the Biotechnology Industry Organization (BIO) is purported to be the key author of the language additions. This trade association represents virtually all major vaccine manufacturers.”

The Senate Majority Leader’s alarmist jeremiad at Davos was seconded by Dr. Tara O’Toole who added, “This [bioterrorism] is one of the most pressing problems we have on the planet today.”

Really? Not grinding poverty, global warming or the lack of access by hundreds of millions of impoverished workers and farmers to clean water, an adequate diet, health care or relief from epidemic levels of preventable diseases such as malaria, tuberculosis or diarrhea, but “bioterrorism” as narrowly defined by securocrats and their academic accomplices.

But Dr. Victor W. Sidel, a founder of Physicians for Social Responsibility (PSR) and an outspoken critic of the Bioweapons-Industrial-Complex challenged O’Toole’s hysterical paradigm.

Sidel made the point that there is a fundamental conflict between the state’s national security goals and health care providers’ professional responsibilities to patients. He wrote in 2003 that “military, intelligence, and law enforcement agencies and personnel have long histories of secrecy and deception that are contrary to the fundamental health principles of transparency and truthfulness. They may therefore be unsuitable partners for public health agencies that need to justify receiving the public’s trust.”

In this context, the choice of O’Toole as the Department of Homeland Security’s (DHS) Undersecretary of Science and Technology is troubling to say the least. As former CEO and Director of UPMC’s Center for Biosecurity, critics charge that O’Toole’s appointment will be nothing short of a disaster.

No ordinary policy wonk with an impressive résumé and years as a government insider, O’Toole is a key player advocating for the expansion of dual-use biological weapons programs rebranded as biodefense.

Subverting the Biological Weapons Convention

The resuscitation of American bioweapons programs are facilitated by their secretive and highly-classified nature. Under cover of academic freedom or intellectual property rights, the U.S. Bioweapons-Industrial-Complex has largely been outsourced by the state to private companies and contractors at top American corporations and universities.

Efforts to strengthen the Biological Weapons Convention (BWC) by the inclusion of verification language into the treaty and regular inspection of suspect facilities by international experts have been shot-down since 2001 by the Bush and now, the Obama administrations. Why?

Primarily because the United States view onsite measures as a threat to the commercial proprietary information of multinational pharmaceutical and biotechnology companies as well as to America’s reputedly “defensive” biological programs; initiatives that continue to work with nature’s most dangerous and deadly pathogens.

In fact, the problem of the dual-use nature of such research is a conundrum facing critics who challenge the break-neck expansion of concealed weapons programs. Simply put, military activities can be disguised as commercial research to develop medical countermeasures without anyone, least of all the American people, being any the wiser.

Highly-trained microbiologists deployed across a spectrum of low-key companies, trained for academic, public health, or commercial employment are part of the dual-use problem. Who’s to say whether scientists who genetically-manipulate pathogens or create Frankenstein-like chimera disease organisms (say, synthesized Marburg or Ebola virus as has already been done with poliovirus in a U.S. lab) are engaged in treaty-busting weapons research or the development of life-saving measures.

And what about the accidental, or more sinisterly, the deliberate release of some horrific new plague by a scientist who’s “gone rogue”? As researcher Edward Hammond pointed out:

British researchers pled guilty in 2001 to charges that they improperly handled a genetically engineered hybrid of the viruses causing hepatitis C and dengue fever. British authorities characterized the virus as “more lethal than HIV”. ‘Dengatitis’ was deliberately created by researchers who wanted to use fewer laboratory animals in a search for a vaccine for Hepatitis C. Under unsafe laboratory conditions, the researchers created and nearly accidentally released a new hybrid human disease whose effects, fortunately, remain unknown; but which may have displayed different symptoms than its parents and thus been difficult to diagnose, and have required a new, unknown treatment regime. (Emerging Technologies: Genetic Engineering and Biological Weapons, The Sunshine Project, Background Paper No. 12, November 2003)

A new report by the Center for Arms Control and Nonproliferation has charged that despite restrictions under the BWC prohibiting the development, production, stockpiling and use of weaponized disease agents such as anthrax, smallpox or plague, as well as equipment and delivery systems intended for offensive use, the rapid growth of “biodefense and research programs over the last decade” has placed “new pressure” on efforts to curb the development of banned weapons listed in the treaty.

In an interview with Global Security Newswire Gerald Epstein, a senior fellow with the hawkish Center for Security and International Studies (CSIS) told the publication, “When one is doing bioresearch and biodefense, one has to be careful to not overstep the treaty itself.”

He cited the U.S biodefense effort Project Bacchus–an investigation by the Defense Threat Reduction Agency to determine whether it was possible to build a bioweapons production facility using readily available equipment–as an instance where questions were raised if the treaty had been violated.

The type of biodefense activity that is most likely to raise questions regarding treaty compliance is “threat assessment,” the process of determining what type of biological attacks are most likely to occur, he told Global Security Newswire. A dangerous biological agent could inadvertently be developed during such research, Epstein said. (Martin Matishak, “Biodefense Research Could Violate Weapons Convention, Report Warns,” Global Security Newswire, August 20, 2009)

But Pentagon bioweaponeers did more than build “a bioweapons productions facility using readily available equipment.” They built banned weapons. According to Jeanne Guillemin, author of Biological Weapons: From the Invention of State-Sponsored Programs to Contemporary Bioterrorism, the Pentagon and CIA made and tested a model of a Soviet anthrax bomb and created an antibiotic-resistant strain of anthrax.

After consulting with scientists who strongly suggested that the CIA anthrax bomb project would violate the BWC, “CIA lawyers decided the project was within the allowed realm of defensive research,” Guillemin revealed. Project Clear Vision, a joint investigation by the CIA and the Battelle Memorial Institute, under contract to the Agency, reconstructed and tested a Soviet-era anthrax bomblet in order to test its dissemination characteristics. The Agency “decided the same” for the small, fully functional bioweapons facility built under the rubric of Project Bacchus.

The third initiative, Project Jefferson, led to the development of an antibiotic-resistant strain of anthrax based on a Soviet model. After the outgoing Clinton administration hesitated to give the CIA the go-ahead for the project, the Bush regime’s National Security Council gave the Pentagon permission. “They believed” Guillemin wrote, “the Pentagon had the right to investigate genetically altered pathogens in the name of biodefense, ‘to save American lives’.”

Shortly thereafter, the Pentagon authorized the Defense Intelligence Agency (DIA), one of the most secretive and heavily-outsourced Defense Department branches, to re-create the deadly anthrax strain.

What the scope of these programs are today is currently unknown. We do know however, that based on available evidence the Department of Homeland Security, the Defense Department and the oxymoronic Intelligence Community, using the Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) as a cover, continue to investigate the feasibility of transforming nature’s most deadly pathogens into weapons.

In close coordination, the United States government and their outsourced corporate partners are spending billions of dollars on research and simulation exercises, dubbed “disaster drills” by a compliant media, to facilitate this grisly trade.

Secrecy and Deceit

That the official bioterror narrative is a preposterous fiction and swindle as even the FBI was forced to admit during its much-maligned Amerithrax investigation, is hardly worth a second glance by corporate media beholden to the pharmaceutical industry for advertising revenue; call it business as usual here in the heimat.

As we now know, the finely-milled anthrax powder which killed five people and shut down representative government didn’t come from the Afghan-Arab database of disposable Western intelligence assets known as al Qaeda, but rather from deep within America’s own Bioweapons-Industrial-Complex, to wit, from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Ft. Detrick in Maryland. But such troublesome and inconvenient truths are barely worth a mention by “respectable” media, e.g. the corporate stenographers who sold two imperialist military adventures to the American people.

Indeed, a credible case can be made that without the anthrax attacks, the fear levels gripping the country in the wake of the 9/11 terrorist events–and the subsequent clamp-down that followed, from the USA Patriot Act to the indefinite detention and torture of “terrorism” suspects, and from warrantless wiretapping to the demonization of dissent–may very well have been impossible.

It is difficult not to conclude that from the beginning of the affair, there was a clear intent on the part of the anthrax terrorist(s) to draw a straight line between 9/11 and the anthrax mailings. From there, it was but a short step to stitching-up a case for “regime change” in Iraq. The media’s role in this criminal enterprise was indispensable for what Salon’s Glenn Greenwald has called“the single greatest, unresolved media scandal of this decade.” As Greenwald points out,

During the last week of October, 2001, ABC News, led by Brian Ross, continuously trumpeted the claim as their top news story that government tests conducted on the anthrax–tests conducted at Ft. Detrick–revealed that the anthrax sent to [former Senator Tom] Daschle contained the chemical additive known as bentonite. ABC News, including Peter Jennings, repeatedly claimed that the presence of bentonite in the anthrax was compelling evidence that Iraq was responsible for the attacks, since–as ABC variously claimed–bentonite “is a trademark of Iraqi leader Saddam Hussein’s biological weapons program” and “only one country, Iraq, has used bentonite to produce biological weapons.” (Glenn Greenwald, “Vital unresolved anthrax questions and ABC News,” Salon, August 1, 2008)

Despite ABC News’ claims that their information came from “four well-placed and separate sources,” they were fed information that was patently false; as Greenwald avers, “No tests ever found or even suggested the presence of bentonite. The claim was just concocted from the start. It just never happened.”

And as we will shortly explore below, the dubious “Dark Winter” and “Atlantic Storm” bioterror exercises designed by Dr. Tara O’Toole freely drew from the neocon’s sinister playbook, right down to the weaponized smallpox supplied to al Qaeda by Saddam.

Whether or not one buys the current permutation of the “lone nut” theory, this one alleges that Dr. Bruce Ivins, a vaccine specialist employed by USAMRIID, was the anthrax mailer; the fact is, when all is said and done the attacks, to use a much over-hyped phrase, were an inside job.

And like other “lone nuts” who have entered the parapolitical frame at their own peril, Ivins isn’t around to refute the charges.

The Alliance for Biosecurity: Insiders with a Mission and (Very) Deep Pockets

Before being pegged by the Obama administration to head DHS’s Science and Technology division where she will oversee the department’s billion dollar budget, with some 45 percent of it going towards chemical and bioweapons defense, O’Toole, as previously mentioned, was the CEO and Director of UPMC’s Center for Biosecurity, a satrapy which describes itself as “an independent organization dedicated to improving the country’s resilience to major biological threats.”

How “independent”? You make the call!

According to their web site The Alliance for Biosecurity is “a collaboration among the Center for Biosecurity and 13 pharmaceutical and biotechnology companies whose mission is to work in the public interest to improve prevention and treatment of severe infectious diseases–particularly those diseases that present global security challenges.”

Alliance partners include the usual suspects: Bavarian Nordic; Center for Biosecurity of UPMC; Cangene Corporation; DOR BioPharma, Inc.; DynPort Vaccine Company LLC, a CSC company; Elusys Therapeutics, Inc.; Emergent BioSolutions; Hematech, Inc., a subsidiary of Kyowa Kirin; Human Genome Sciences, Inc.; NanoViricides, Inc.; Pfizer Inc.; PharmAthene; Siga Technologies, Inc.; Unither Virology LLC, a subsidiary of United Therapeutics Corporation. Rounding out this rogues gallery are associate members, the spooky Battelle Medical Research and Evaluation Facility and the Lovelace Respiratory Research Institute.

Among the chief activities of the Alliance is lobbying Congress for increased funding for the development of new drugs deemed “countermeasures” under the Project BioShield Act of 2004, previously described by Antifascist Calling as a particularly grotesque piece of Bushist legislative flotsam.

The Alliance avers that “the United States faces unprecedented risks to national security … by the clear and growing danger of bioterrorism or a destabilizing infectious disease pandemic,” and that “our nation’s vulnerability to biothreats is so severe” due to the fact that “most of the vaccines and medicines that will be needed to protect our citizens do not now exist.” Therefore, countermeasures needed to mitigate nebulous biothreats never spelled out once in the group’s literature “will likely require several years and several hundred million dollars each to successfully develop and produce.” (emphasis added)

An Alliance report, The State of Biosecurity in 2008 and Proposals for a Public/Private Pathway Forward, charts a course for “improving and accelerating” efforts to “develop medical countermeasures (MCMs) for the nation’s Strategic National Stockpile (SNS).”

Under the Project Bioshield Act of 2004, Congress authorized $5.6 billion over ten years “to purchase MCMs for the SNS.” Funds were allocated for the procurement of the anthrax vaccine as well as for “therapeutic antibodies for inhalational anthrax, a botulism heptavalent antitoxin, a smallpox vaccine, and several products for radiological and nuclear threats, obligating a total of about $1.9 billion of the $5.6 billion BioShield fund.”

In 2006 as I noted previously, Congress created the Biomedical Advanced Research and Development Authority (BARDA) within the Department of Health and Human Services (HHS). BARDA was authorized to spend some $1.07 billion over three years for MCMs, “only $201 million has been provided by Congress through FY 2008″ noted the Alliance, “approximately one-fifth of the authorized level.”

According to an “independent economic analysis” carried out by (who else!) the Alliance’s academic partner, the Center for Biosecurity, “it would require $3.4 billion in FY 2009 to support one year of advanced development.”

“Similarly” according to the organization, “the original appropriation of $5.6 billion for Project BioShield is equally insufficient to ensure that once MCMs are developed there will be funds available to procure them and maintain the stockpile.” Indeed, “this level of funding would need to be sustained for many years.” You can bet however, that Alliance lobbyists are busy as proverbial bees in pressuring Congress to fork over the dough!

The report state’s that Alliance goals necessarily entail instilling “a sense of urgency … with Congress” by hyping the “bioterror threat.” But there’s much more here than a simple cynical exercise at preparing the “public diplomacy” ground through academic and industry “message force multipliers” that will enable Congress to shower Big Pharma with a veritable tsunami of cash. A “risk-tolerant culture” should be promoted within BARDA, one that “understands the realities, risks, timelines, and costs of drug development.”

The “risks” to whom and for what purpose are not enumerated, but one can be certain that a “risk-tolerant culture” crafted by industry insiders will come at the expense of the health and safety of the American people, one that pushes potential legal liability should things head south onto the taxpaying public.

The stealth nature of Alliance recommendations are clearly spelled out when they aver that “stakeholders” should “focus more on the potential biothreats and the corresponding countermeasures, rather than the price tag” and that BARDA, ostensibly a public agency, should be packed with insiders “who have drug development and manufacturing experience.” This will lead to the development of “a culture that is focused on partnering with industry and academia.”

But the bottom line as always, is the corporatist bottom line for Alliance shareholders! How else can one interpret their statement that emerging “biothreats” are all the more dire today now that “interest of the public and private capital markets in biodefense has declined over the last 2-3 years.” What better way then, to beef-up those sagging capital markets than to install an industry-friendly individual at DHS with a documented track record of overplaying the “bioterror threat.”

Dark Winter

O’Toole was the principal designer of two “tabletop” bioterror preparedness drills, the 2001 Dark Winter exercise and the 2005 Atlantic Storm run-through; both were criticized by scientific experts as fabrications of an alleged threat of a smallpox attack mounted by al Qaeda.

Reviewing Milton Leitenberg’s 2005 report, Assessing the Biological Weapons and Bioterrorism Threat, published the U.S. Army War College’s Strategic Studies Institute, protein chemist Dr. Eric Smith wrote the following:

Of note is Leitenberg’s dissection of the process of assessment as practiced through bioterrorism threat scenarios conducted by the US government and private think tanks. Exercises like Dark Winter, which modeled an “aerosolized” smallpox attack, Top Off 2 and 3, both on pneumonic plague strikes, and Atlantic Storm, an exercise that purported to show an al Qaida group manufacturing a dry powder smallpox weapon, were rigged. In the cases of Dark Winter and the Top Offs, transmission rates of disease were sexed up beyond historical averages so that “a disastrous outcome was assured” no matter any steps taken to contain outbreaks. Eight pages are reserved to pointedly condemn the Atlantic Storm exercise on a host of sins which can generally be described as a bundle of frank lies and misinformation coupled with a claimed terrorist facility for making smallpox into a weapon that even state run biological warfare operations did not possess. And once again, juiced transmission rates of disease were employed to grease theoretical calamity. The reader comes to recognize the deus ex machina–a concoction or intervention added to dictate an outcome, in these cases very bad ones–as a regular feature of the exercises. However, the results of the same assessments–the alleged lessons learned–have never been reported with much, if any, skepticism in the media. (Eric Smith, “A Vaccine for the Hype: Milton Leitenberg’s new ‘Assessing the Biological Weapons and Bioterrorism Threat,” Global Security, National Security Notes, March 31, 2006)

In criticizing “the fancy that such attacks are easy and one of the most catastrophic threats faced by the American people,” Smith denounces the alarmist scenarios of Dark Winter and Atlantic Storm’s designers–people like Dr. Tara O’Toole and the coterie of industry insiders and other well-paid “experts”–as guilty of perpetrating a massive “fraud … and a substantial one” on the American people.

While one of Atlantic Storm’s architects proclaimed “this is not science fiction” and that “the age of Bioterror is now…” Leitenberg and Smith denounce O’Toole’s spurious claims as “not the least bit plausible.”

Leitenberg wrote that “well before October-November 2001, the spectre of ‘bioterrorism’ benefitted from an extremely successful sales campaign.” Indeed, hyped-up scenarios such as Dark Winter and Atlantic Storm that place “weapons of mass destruction” in the hands of shadowy, intelligence-linked terror outfits like al Qaeda provided “inflated predictions that … were certainly not realistic. Much worse, in addition to being wrong, inflated predictions were counterproductive. They induced interest in BW in the wrong audiences.”

But the implausible nature of the scenarios deployed in national exercises hardly prohibited the Bioweapons-Industrial-Complex from concocting scarecrow-like straw men designed to sow terror amongst the American people while extracting regular infusions of cash from Congress.

Among the eight exercises analyzed by Leitenberg between 1998-2005, he found that each and every one were fraudulently designed and the threat of bioterrorism had been framed as a rationalization for “political action, the expenditure of public funds for bioterrorism prevention and response programs,” that could “not occur without it.” This is “not benign,” Leitenberg concludes.

A second consequence of sexed-up “bioterror” drills have even more ominous implications for the immediate future. Because of national security state perceptions that mitigation of catastrophic bioterrorism is of supreme importance for national survival–perceptions reinforced by academic, corporate and militarist peddlers of crisis–”the US biodefense research program appears to be drifting into violation” of the Biological Weapons Convention. This is a menacing development and has happened, I would argue precisely because the evaluation process which justifies research into biological weapons threat capabilities and scenarios, are repackaged to conceal the offensive thrust of this research as wholly defensive in nature, which it certainly is not.

How else would one explain ongoing research funded by the National Institutes of Health to study botulism toxin, “with the added qualification” Smith points out, that because the protein toxin is “unstable, therefore there will be collaboration with other researchers to stabilize it.” The NIH grant “means preparing a much more effective botulinum toxin than had been available before.”

Smith goes on to cite “another problematical breakout” offered by two scientists to study the “aerobiological” characteristics of the lethal Marburg and Ebola viruses. How this is “defensive” in nature, in keeping with research restrictions under the Biological Weapons Convention, is another instance of a backdoor move to kick-start illicit bioweapons development.

According to Smith, the study “looks to define how the organisms can be aerosolized, an instance of research into examining vulnerability in the complete absence of a verified threat.” But I would argue that showering taxpayers dollars into such dark and troubling research tributaries deploy hyped-up threats as cover for the development of illegal weapons.

When her nomination was announced in May, Rutgers University and homeland security critic Richard Ebright told Wired,

“This is a disastrous nomination. O’Toole supported every flawed decision and counterproductive policy on biodefense, biosafety, and biosecurity during the Bush Administration. O’Toole is as out of touch with reality, and as paranoiac, as former Vice President Cheney. It would be hard to think of a person less well suited for the position.”

“She was the single most extreme person, either in or out of government, advocating for a massive biodefense expansion and relaxation of provisions for safety and security,” he adds. “She makes Dr. Strangelove look sane.” (Noah Shachtman, “DHS’ New Geek Chief is a Bioterror ‘Disaster,’ Critics Charge,” Wired, May 6, 2009)

And Dr. Smith told Wired that exercises designed by O’Toole and her colleagues show her to be “the top academic/salesperson for the coming of apocalyptic bioterrorism which has never quite arrived.”

As noted above, “[She’s] most prominent for always lobbying for more money for biodefense, conducting tabletop exercises on bioterrorism for easily overawed public officials, exercises tweaked to be horrifying,” Smith told Wired.

But Smith goes even further and denounces O’Toole as an industry shill who “has never obviously appeared to examine what current terrorist capabilities have been… in favor of extrapolating how easy it would be to launch bioterror attacks if one had potentially unlimited resources and scientific know-how.” It’s a “superb appointment if you’re in the biodefense industry and interested in further opportunity and growth.”

“Alternatively” Smith avers, O’Toole’s appointment is “a disaster if threat assessment and prevention” has “some basis in reality.”

Not that any of this matters in Washington. The Senate Homeland Security and Governmental Affairs Committee led by “independent Democrat” and arch neocon Sen. Joseph Lieberman, voted to send her nomination to the full Senate July 29.

Never mind that the deadly weaponized pathogen employed in the attacks didn’t originate in some desolate Afghan cave or secret underground bunker controlled by Saddam.

And never mind that the principal cheerleaders for expanding state-funded programs are Pentagon bioweaponeers, private corporations and a shadowy nexus of biosecurity apparatchiks who stand to make a bundle under current and future federal initiatives.

Leading the charge for increased funding is the Alliance for Biosecurity, a collaborative venture between the Center for Biosecurity of the University of Pittsburgh Medical Center (UPMC) and Big Pharma.

Tom Burghardt is a researcher and activist based in the San Francisco Bay Area. His articles are published in many venues. He is the editor of Police State America: U.S. Military “Civil Disturbance” Planning

Bioweapon manufacturing and trading is ‘biodefense’. Guess who does the bioterrorism that sells the ‘biodefense’.
Deleted article ARCHIVED HERE

 Soviet scientists reportedly used newly developed genetic engineering techniques to create vaccine-subverting and antibiotic-resistant strains of anthrax, plague, tularemia, and smallpox for attacks against military forces and civilian populations (Bozheyeva et al. 1999Alibek and Handelman 2000)

More info: BBC / GRUNGE / THE GUARDIAN
Sure
Is that US bill ‘military’ for the same reason the Defence Force is involved in this act?
SOURCE
TRUMP: WE’RE MOBILIZING THE MILITARY TO DELIVER THE CORONAVIRUS VACCINE END OF 2020
Dr Sharad S. Chauhan is a decorated Indian Police Service (IPS) officer awarded the Prime Minister’s baton and the Home Minister’s Revolver. He is also a Gold Medallist MBBS Doctor from Delhi University with a PhD in Bioterrorism. He also authored the book Biological Weapons.
SOURCE

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Alexeter Technologies LLC, Alnylam Pharmaceuticals Inc., Altimmune Inc., ANP Technologies Inc., Bavarian Nordic AS, Cleveland BioLabs Inc., Elusys Therapeutics Inc., Emergent BioSolutions Inc., General Dynamics Corp., and GlaxoSmithKline Plc are some of the major market participants. Although the rising prevalence of infectious disease and rapid increase in government funding in R&D will offer immense growth opportunities, to leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments.

TECHNAVIO BIODEFENSSE MARKET REPORT

GERMAN & UK DEFENSE WORK ON MASSIVE “HUMAN AUGUMENTATION” PROJECT FOR CIVILIAN POPULATION

In an exclusive interview, Dr. Boyle touches upon GreatGameIndia‘s exclusive report Coronavirus Bioweapon – where we reported in detail how Chinese Biowarfare agents working at the Canadian lab in Winnipeg were involved in the smuggling of Coronavirus to Wuhan’s lab from where it is believed to have been leaked.

In this bombshell interview (full transcript below), Boyle talks about:

  • The bioweapons origins of the coronavirus
  • How the Deep State deployed anthrax on US soil to whip up publicity about biological weapons and increase funding for bioweapons labs
  • Why the WHO and CDC are both criminal organizations which are complicit in the covert development of biological weapons
  • The “death science” industry and why the US government has spent over $100 billion developing self-replicating weapons
  • Details about the Pirbright Institute and its ties to bioweapons, depopulation, vaccines and coronavirus patents. (It’s partially funded by Bill & Melinda Gates)
  • Why all BSL-3 and BSL-4 labs in the world should be banned and shut down.

Full transcript


Geopolitics and Empire: Geopolitics & Empire is joined by Dr. Francis Boyle, who is international law professor at the University of Illinois. We’ll be discussing the Wuhan coronavirus and biological warfare. He’s served as counsel to numerous governments such as Bosnia and Herzegovina and the Palestinian authority. He’s represented numerous national international bodies in the areas of human rights, war crimes and genocide, nuclear policy, and biowarfare. He’s written numerous books, one of my favorites being “Destroying Libya and World Order”, which I assigned as mandatory reading material for my own students when I taught at the Monterrey Institute of Technology.

But most important for this interview, he’s written a book called “Biowarfare and Terrorism”, and drafted the US domestic implementing legislation for the biological weapons convention, known as the Biological Weapons Anti-Terrorism Act of 1989 that was approved unanimously by both houses of the US Congress and signed into law by President Bush. Thanks for joining us, Dr. Boyle.

Dr. Francis Boyle: Wow. Thank you so much for having me on and thanks for that kind introduction.

Geopolitics and Empire:  Now let’s get to what’s been on the news recently. This coronavirus in Wuhan. There have been some reports recently, there’s a really interesting website called GreatGameIndia that has been reporting on this. They’ve been talking about China, which they say has been complying with biological weapons convention in recent years.

But then there are some people in the US and experts that have been saying that in reality, China isn’t complying with the weapons convention. And I think neither, perhaps the US as well. I’m wondering if China is developing its own biosafety level four lab in Wuhan and elsewhere, as you know, as a type of deterrence. Is it a type of a biological arms race that we have going on?

You told me in an email that you suspect China was developing the coronavirus as a dual use of biowarfare weapons agent. Also, what do you make of reports that Chinese scientists have been stealing research and viruses, including the coronavirus from a Canadian bio lab this past December?

And as well, Chinese nationals have been charged with smuggling vials of biological research to China from the US with the aid of Charles Lieber who was the chair of Harvard’s chemistry department. And he also happens to be in 2011 a strategic scientist at Wuhan University. So, can you tell us what’s going on with this recent outbreak in Wuhan?

Dr. Francis Boyle: Well, that’s a lot of questions. I guess we can take them one at a time, but if you just do a very simple Google search on “Does China have a BSL-4 laboratory?”, Wuhan comes up right away. It’s at the top of the list. That’s all with the moment this type of thing happened I began to do that. So a BSL-4 is the most serious type. And basically BSL-4 labs, we have many of them here in the United States, are used to develop offensive biological warfare weapons with DNA genetic engineering.

So it does seem to me that the Wuhan BSL-4 is the source of the coronavirus. My guess is that they were researching SARS, and they weaponize it further by giving it a gain of function properties, which means it could be more lethal.

Indeed, the latest report now is it’s a 15% fatality rate, which is more than SARS at 83% infection rate. A typical gain of function travels in the air so it could reach out maybe six feet or more from someone emitting a sneeze or a cough. Likewise, this is a specially designated WHO research lab. The WHO was in on it and they knew full well what was going on there.

Yes. It’s also been reported that Chinese scientists stole coronavirus materials from the Canadian lab at Winnipeg. Winnipeg is Canada’s formal center for research, developing, testing, biological warfare weapons. It’s along the lines of Fort Detrick here in the United States of America. I have three degrees from Harvard. It would not surprise me if something was being stolen out of Harvard to turn over to China. I read that report. I don’t know what was in those vials one way or the other.

But the bottom line is I drafted the US domestic implementing legislation for the Biological Weapons Convention that was approved unanimously by both Houses in the United States Congress signed into law by President Bush Sr. that it appears the coronavirus that we’re dealing with here is an offensive biological warfare weapon that leaped out of Wuhan BSL-4. I’m not saying it was done deliberately. But there had been previous reports of problems with that lab and things leaking out of it. I’m afraid that is what we are dealing with today.

Geopolitics and Empire: We’ll be talking about the Wuhan and the coronavirus and China, but can you give us kind of like a bigger context. I know you’ve, previously, in interviews said that since 9/11, you think that the US has spent $100 billion on biological warfare research. We know the Soviet Union, if I’m not mistaken, developed anthrax as a bioweapon. And you’ve also mentioned that UK, France, Israel and China are all involved in biological warfare weapons research.

And something interesting, I believe one or two years ago a Bulgarian journalist and the Russian government shared their concern of the discovery of a US bioweapons lab in the country of Georgia. You’ve commented how in Africa, US has set up bioweapons labs to work on Ebola, which I think is illegal under international law. But they were allowed somehow to put those in Africa. Can you give us like a bigger picture? What’s going on with these different countries and what’s the purpose of this research?

Dr. Francis Boyle: All these BSL-4 labs are by United States, Europe, Russia, China, Israel are all there to research, develop, test biological warfare agents. There’s really no legitimate scientific reason to have BSL-4 labs. That figure I gave $100 billion, that was about 2015 I believe. I had crunched the numbers and came up with that figure the United States since 9/11.

To give you an idea that’s as much in constant dollars as the US spent to develop the Manhattan Project and the atom bomb. So it’s clearly all weapons related. We have well over 13,000 alleged life science scientists involved in research developed testing biological weapons here in the United States. Actually this goes back it even precedes 9/11 2001.

I have another book, The Future of International Law and American Foreign Policy, tracing that all the way back to the Reagan administration under the influence of the neocons and they got very heavily involved in research development testing of biological weapons with DNA genetic engineers. It was because of that I issued my plea in 1985 in a Congressional briefing sponsored by the Council for Responsible Genetics, I’m a lawyer for them. They’re headquartered in Cambridge, Mass. All the MIT, Harvard people are involved in that, the principal ones. And then they asked me to draft the implementing legislation.

The implementing legislation that I drafted was originally designed to stop this type of work. “Death science work”, I call it, “by the United States government”. After 9/11, 2001, it just completely accelerated. My current figure, that last figure a 100 billion. I haven’t had a chance to re-crunch the numbers because I just started classes. But you have to add in about another 5 billion per year.

Basically, this is offensive biological weapons raised by the United States government and with its assistance in Canada and Britain. And so other States, the world have responded accordingly including Russia and China. They were going to set up a whole series of BSL-4 facilities as well. And you know Wuhan was the first. It backfired on them.

Geopolitics and Empire: Would you basically consider what happened and Wuhan and just boil it down to ineptitude or incompetence on the Chinese part?

Dr. Francis Boyle: Well, it’s criminality. It does appear they stole something there from Winnipeg. This activity that they engaged in clearly violates the Biological Weapons Convention. Research development of biological weapons these days is an international crime, the use of it would be. That was criminal.

I’m not saying they deliberately inflicted this on their own people, but it leaked out of there and all these BSL-4 facilities leak. Everyone knows that who studies this. So this was a catastrophe waiting to happen. Unfortunately, it happened. The Chinese government under Xi and his comrades there have been covering this up from the get-go. The first reported case was December 1, so they’d been sitting on this until they couldn’t anymore. And everything they’re telling you is a lie. It’s propaganda.

The WHO still refuses to declare a global health emergency. It said Tedros was over there shaking hands with Xi and smiling and yanking it up. The WHO was in on it. They’ve approved many of these BSL-4 labs., they know exactly what’s going on and that is a WHO research-approved laboratory. They know what’s going on too. You can’t really believe anything the WHO is telling you about this, either they’re up to their eyeballs in it, in my opinion.

Geopolitics and Empire: I’d probably agree with you that this outbreak in Wuhan was an accidental leak from the laboratory. But just your thoughts, it’s happening at quite an opportune time because namely we’re smack in the middle of a US-China new Cold War, which is currently characterized by economic warfare such as the trade war among other forms of hybrid and technological warfare. And it seems the Wuhan outbreak will likely hit the Chinese economy hard. The Chinese are flat out dismissing any idea that the US is involved in. Like I said, it’s probably they made the mistakes in the Wuhan lab. What are your thoughts of any seemingly, this would benefit the US…

Dr. Francis Boyle: When the outbreak occurred, of course I considered that alternative too. When you have an outbreak, you’re never quite sure who or what is behind it. It certainly isn’t bats, that’s ridiculous. They made the same argument on Ebola in West Africa. I demolished that online. You can check it out. So I kept competing theories about this.

But right now, when you originally contacted me, I said I wasn’t prepared to comment because I was weighing the evidence. I’m a law professor and a lawyer,  I try to do the best I can to weigh the evidence. But right now, the Wuhan BSL-4 in my opinion is the most likely source, apply Occam’s razor, the simplest explanation. I’m not ruling out some type of sabotage. But right now, I believe that is the source here.

Geopolitics and Empire: And you mentioned WHO. I’d like to just get your thoughts on the WHO and the Big Pharma. There’s also some analysts who are downplaying this news media hype of the coronavirus. You’ve just said that it seems to be lethal, but if we go back a decade to the 2009 swine flu, which I believe didn’t have too many casualties, but I think profited greatly the pharmaceutical companies. If I recall that back in 2009, many countries purchased great stocks of the vaccines and they ended up not using anywhere from 50 to 80% of the vaccines that they purchased.

You’ve previously stated in an interview that the World Health Organization is a front for Big Pharma if I’m not mistaken. Robert F. Kennedy Jr. also agrees and he says, you know, 50% of WHO funding comes from pharmaceutical companies. And that the CDC itself is also severely compromised. What are your thoughts on the WHO? The CDC?

Dr. Francis Boyle: Can’t trust anything the WHO says because they’re all bought and paid for by Big Pharma and when they work in cahoots with the CDC, which is the United States government, they work in cahoots with Fort Detrick, so you can’t trust any of it.

However, the swine flu and yes, I agree pharma made a lot of money, but that swine flu which I looked at it, it did seem to me to be a genetically modified biological warfare weapon. It was a chimera of three different types of genetic strains that someone put it together in a cocktail. Fortunately, it was not as lethal as all of us fear. So fine. But as I said, this figure I just gave to you was Saturday from Lancet, which is a medical publication, saying it’s a 15% fatality rate and an 83% infection rate. So it’s quite serious, I think, far more serious than the swine flu.

As for big pharma, sure they’re all trying to profit off this today as we speak. There was a big article yesterday in the Wall Street Journal, all big pharma trying to peddle whatever they can over there in China even if it’s worthless and won’t help. We do know, if you read the mainstream news media they say there isn’t a vaccine.

Well, there is, it’s by the Pirbright Institute in Britain that’s tied into their biological warfare program over there. They were behind the hoof and mouth disease outbreak over there that wiped out their cattle herd and it leaked out of there. So it’s clear they’re working on a hoof and mouth biological warfare weapon, but the vaccine is there. I have the patent for it here, I haven’t had a chance to read the patent it’s about 25 pages long and my classes just resume. So eventually, I get some free time and I’ll read the patent.

You can’t patent a vaccine with the United States patent office unless the science is there. So there is a vaccine. Everyone’s lying about that, no one’s pointing this out – there’s a vaccine but instead big pharma wants to make money and the researchers say, well, it’ll take three months and we’re racing forward, you know. Everyone’s gonna make a buck off of this, that’s for sure. But there is a vaccine, I have the patent here. It’s been patented by the United States government.

So obviously, I don’t know exactly how workable it is, but it’s a vaccine. I don’t know why it isn’t out there now? Why isn’t someone saying there is a vaccine? Perhaps political leaders have already been vaccinated for all I know, I really don’t know.  But there is a vaccine, Pirbright is well known there in Britain and it’s tied into Fort Detrick and CDC is tied into Fort Detrick too. So they all know there’s a patented vaccine.

Geopolitics and Empire:  And just to get your comment on, I mean, something to related to this, which was my next question. So I think, I’m not sure if it’s that same Institute that you just mentioned that has the patent.  I read somewhere that the Bill & Melinda Gates foundation maybe funds or has some connection to that Institute that has the patent.

Dr. Francis Boyle:  I think they do. The Bill & Melinda Gates information, they fund this type of DNA genetically engineered biological warfare work. That’s correct. So you can’t trust anything they’re telling you that somehow they’re out there trying to make the world a better place.  I mean, we have Bill Gates publicly admitting that the world be a better place if there were a lot less people. So the Bill & Melinda Gates foundation, they are wolves in sheep’s clothing and they are funding this type of stuff. Sure.

Geopolitics and Empire: And just your comment, there was also the report that I guess it was a consortium of companies which included the Gates foundation that back in just two or three months ago in October of 2019 they held a pandemic exercise simulating an outbreak. I mean, what are the chances specifically of a coronavirus and it was called events 201. People can find this online online and they gave a list of seven recommendations for governments and international organizations to take. I also find that kind of interesting how they had this simulation.

Dr. Francis Boyle:  That’s correct. It raises that question,  the origins of what happened here.  But right now, I’m just looking at the evidence I have and applying Occam’s razor and we know that Wuhan BSL-4 was research developing, testing, SARS as a biological warfare agent. So it could have been, they gave it this DNA genetic engineering enhanced properties gain of function which we do here in the West, in the United States all the time. We have  all sorts of research that is clearly a bio warfare research that has been  approved by the National Institutes of Health, it’s a joke. They know full well they are proving all kinds of biological warfare research and it gets funded by the United States government.

Geopolitics and Empire:  And you’ve also mentioned in the email to me that what happened in the biosafety lab level 4 in Wuhan calls into question the safety of all of these level 3and 4four labs around the world.

Dr. Francis Boyle:  They’re complete unsafe. BSL-3 and BSL-4 lab are only designed for research development testing of offense of biological warfare agents.  In my opinion, they serve no legitimate purpose at all. They should all be shut down, every one of them. Even assuming, they’re simply too dangerous. If you want, there’s an excellent  documentary called Anthrax Wars by Nadler and Coen and I’m in there.  Repeatedly at the end, I say with respect to these labs, three and four, this is a catastrophe waiting to happen. Well, I’m afraid the catastrophe is now happened. So there it is.

Geopolitics and Empire:  Yeah, I was just watching that documentary before we connected and I recommend the listeners go check that out. Do you see, in the future, any countries,  if we come to a conflict between US, EU, Israel, Saudi Arabia, Iran, China, Russia,  I mean you name it. Do you see any of these countries actually utilizing these biological weapons?  I mean, it’s illegal under international law but we know like in the past that international law isn’t followed. Do you think that there’s a real danger of this escalating?

Dr. Francis Boyle: For sure. That’s the only reason they develop these biological weapons to eventually be used, sure.  I mean, it’s like the Manhattan project, we put all that money into developing an atom bomb and even though it was not needed to end world war II they still knew Hiroshima and Nagasaki. So, yes,  I think that’s correct.  And also these can be used covertly. Anytime you see an unexplained  sudden outbreak of a disease like this anywhere in the world, both for human beings and or animals, I always suspect the bio warfare agent is at work.  I monitor the situation like I did at Wuhan until I can reach a conclusion. Yes, they can be used as the eyes for the United States government, today they are fully prepared, armed, equipped, supplied to wage a biological warfare with anthrax.

These other more exotic things I don’t know, but they have the weapons, there are stockpiles. We have to understand if you read Seymour Martin Hersh’s book published about 1968, he won the Pulitzer prize, he had the whole offensive US biological warfare industry in there back before it was illegal and criminal. Basically after 9/11, 2001, that entire industry – offensive biological warfare industry has been reconstituted here in the United States with all these BSL-4 BSL-3 labs, well over 13,000, alleged scientists sort of like Dr. Mengele working on these things. Other countries have responded in kind like Russia, like China, France is involved, Britain’s involved. Sure.

Geopolitics and Empire: I just wanted to get your thoughts on, in the last few years there was the Russian double agent spy Sergei Skripal who had been allegedly poisoned with Novichok out in Britain and  I thought it was funny. It just so happened where he was allegedly poisoned, he was right in Porton down the British bio weapons lab, I guess the world’s first bio weapons lab that was created in 1916. I mean,  I don’t know if you have thoughts on that whole incident.

Dr. Francis Boyle: Yeah, I was right down the street from Porton Down, so applying Occam’s razor who you think might’ve been behind this and it was not a nerve agent. A nerve agent would have killed him immediately. This is Novichok. It was something else like DX or something like that. So fine. But, I would just say that I don’t think that was a coincidence, but, you know, there you go. There’s the, obviously there’s a lot of speculation on that.

Geopolitics and Empire: Something else that’s kind of interesting. You’ve written in bio warfare and terrorism in your book and there’s also Graeme Macqueen, I think your colleague who wrote the anthrax deception the case for domestic conspiracy…

Dr. Francis Boyle:  Everything you said in there. That’s correct.

Geopolitics and Empire:  I’m wondering also if this new war for biotechnological dominance, whatever you want to call it, if it can also be used kind of as a pretext for the centralization of political power and the initiation of wars like I guess it did in the 2003 Iraq war. I mean, is this another danger that we get these events like now this coronavirus and then governments will call for a centralization of greater power and taking away some of our civil liberties?

Dr. Francis Boyle:  Sure. If you look at the October, 2001 anthrax attacks here in the United States, that was clearly by elements of the United States government that was behind that. That was a super weapons grade anthrax with a trillion spores per gram and it floated in the air solely a very sophisticated biological weapons lab like Fort Detrick could produce that. And they use that anthrax attack including on Congress to brand through the USA Patriot act which basically turned the United States to a police state which is what we have now. You have to understand the Pentagon, Fort Dietrich made the dugway proving ground still has a stockpile of that super weapons grade anthrax that we saw in October of 2001 that they can use the next time they want to do something like that to further develop the American police thing. Right.

Geopolitics and Empire:  Is there anything else you feel important to mention regarding this Wuhan Coronavirus outbreak or biological warfare or any other thoughts you’d like to leave us with?

Dr. Francis Boyle:  Well, you just can’t believe anything the Chinese government, the WHO,  the CDC are telling. They’re all lies because they know what’s going on here  and so you’re going to have to figure it out as fast as you can. But in my opinion, as of this time and I’m fully prepared to consider further evidence on this, it does seem to me that this was  a DNA genetically engineered biological warfare agent leaking out of Wuhan that has gain-of-function properties which can make it more lethal.  I think they are probably doing something with SARS to make it a lot more lethal and more infectious. And so for that reason,  you have to take extreme precautions and they’re now finally admitted anyone within six feet can be infected, whereas with SARS that was about two feet. Well, that’s gaining a function right there and that should be a tip off.

So, I guess you’re gonna have to protect yourself.  Laurie Garrett had a pretty good essay in a foreign policy yesterday and she was over there covering the SARS and she has very good advice in there except that she took the SARS figure out two to three feet and said  well, you gotta stay to two to three. I think you’ve got to stay at least six feet away because this is gained function. It can flow through the air and infect and it can get you in the eyes. Any orifice, the mouth, maybe the ears, we’re not sure at this point.

Geopolitics and Empire: I’m here on the border of China in Kazakhstan and I was just reading yesterday – today that they’re no longer allowing Chinese citizens into Kazakhstan without a medical paper, a medical check to get their visas to enter Kazakhstan

Dr. Francis Boyle:  Those medical checks are worthless because this is just public relations by all the governments involved because there is a 14 day incubation period where people can still be infected. So someone could walk right through a medical inspection and passing a gate into your country and then they come down with the coronavirus.  So that’s all public relations in my opinion by governments and they know it and they’re just sending people out there with temperatures and things like that. It’s not like SARS, this is more dangerous than SARS.  As I said, I think that Wuhan lab, we know they had SARS in there that they were dealing with and I think they enhanced it at and  I’m afraid that’s what we’re dealing with. But you know, I’m keeping an open mind as to what other sources that might have and I wasn’t prepared to say anything until that Wuhan lab is right there and it’s dealing with coronavirus. So again, apply Occam’s razor. It seems to me that’s the simplest explanation here.

Geopolitics and Empire: I guess my, one of my final question would be in the months ahead, apart of what you say staying six feet away from people.  I’ve read taking high doses of vitamin C and other things like this can help you. But, if they come out as the situation develops and if it gets worse and they come out with a coronavirus vaccine,  should people take it or not? What are your thoughts?

Dr. Francis Boyle:  Well, what I would say is this. Right now, if you look at the article at the Wall Street Journal, big pharma is trying to sell all sorts of – they’re taking all their drugs off the shelf and say well let’s see if it works. Which is preposterous. Okay. The scientists are saying, well, we can get you a vaccine maybe two to three months but they’re not tested.  So what we do know, however, is that Pirbright vaccine has been patented. So all I can assume is that that might work. But I don’t think I’d be taking any of these other vaccines. No, you have no idea what’s in there. You’ll be the Guinea pig for big pharma and everyone figures they’re gonna make a lot of money here. So I’ll keep my eye open on this  and how it develop but I wouldn’t trust anything they’re trying to sell right now. They’re just pulling these things off the shelf.

If they do come up with something in two to three months, even that’s not going to be tested in accordance with normal scientific protocol. So it’s going to be a crap shoot. If it’s going to help you, indeed it might not help you because they’ll be using for this vaccines (these DNA genetic engineered vaccines) they’ll be using live coronavirus probably and sticking it in there and giving you some live coronavirus on the theory you’ll develop an immunityThat’s the way a lot of these vaccines worked out, that’s what happened with the Ebola vaccine that created the Ebola pandemic there in West Africa. They were testing out a vaccine on poor black Africans, as usual, and  this vaccine had live Ebola in it so it gave them Ebola. So again, I’d be very careful even if they do come up with these vaccines two to three months from now, very careful. Why would you want to inject the live coronavirus in you?

Geopolitics and Empire: All right. I don’t believe you have a strong online presence. How can people best follow your work? I suppose to search for interviews as well as get your books.

Dr. Francis Boyle: Well, basically I’m blackballed and blacklisted off all the mainstream news media here on purpose. As far as I can figure out, the US government gave an order that I should not be interviewed by anyone, so I’m not.  I guess you could just put my name in there under Google, Google alert, and some interviews might come up. What happened was, right after the anthrax attacks of 9/11 2001, I was giving a lecture out at Harvard m Alma Mater.  I was running a panel on biological warfare for the council for responsible genetics and it was at Harvard Divinity School and as I was going in, there was a Fox camera crew there from Boston and I said it looks to me like this has come out of the US government lab. We know they do research and testing on anthrax. Then I said the same thing there at Harvard then I gave an interview to a radio station in Washington, D C then I gave an interview on that to the BBC. So the whole world saw it and at that point I was completely cut off and I’ve been cut off  ever since. So you  probably not going to hear too many  interviews from me here. As for my book. Biowarfare & Terrorism, you can just get it at amazon.com. That picks up the story pretty much from 9/11 2001 and until it went to press and then there are interviews I’d given to an investigative reporter, Sherwood Ross and a big one I just sent you and you might want to put that on your web page. That was pretty comprehensive.

Geopolitics and Empire: Yeah,  I read that as well and I’ll include the link in the description of this interview so people can go check that out. You’re not the only academic I know and have heard of others that similar things have happened and that’s just I guess the price we pay for telling the truth. Again, for listeners, if people wanted to have a broader context and deeper understanding of what’s happening today especially with biological warfare as well as us foreign policy and international affairs, I urge you to get Dr. Francis Boyle’s books and listen to his interviews as well as his colleagues book. Graeme Macqueen, The Anthrax Deception, The Case For Domestic Conspiracy. Thank you for being with us, Dr. Boyle.

Dr. Francis Boyle: Well, thank you and again, please understand these are my current opinions.  I could change my opinion here based on more evidence. So  I’m just looking at the evidence out there as I see it and you have to understand there is so much disinformation, lies and propaganda that it’s kind of very difficult to distinguish truth from fact.  I’m doing the best job I can here.

— end interview —


Originally published (greatgameindia.com)


A message from a former US Army psyops officer
VINCE JAMES DOES A GREAT JOB EXPLORING THE COMPLEX FROM THE CIA ANGLE AND ARRIVING TO THE SAME BIG PICTRE AND ALL THE GOOD CONCLUSIONS, MUST WATCH ENTIRELY!

UPDATE SEPTEMBER 23, 2022:

The Pentagon has ordered a sweeping audit of how it conducts clandestine information warfare after major social media companies identified and took offline fake accounts suspected of being run by the U.S. military in violation of the platforms’ rules.

Colin Kahl, the undersecretary of defense for policy, last weekinstructed the military commands that engage in psychological operations online to provide a full accounting of their activities by next month after the White House and somefederal agencies expressed mounting concerns over the Defense Department’s attempted manipulation of audiences overseas, according to several defense and administration officials familiar with the matter.

The takedowns in recent years by Twitter and Facebook of more than 150 bogus personas and media sites created in the United States was disclosed last month by internet researchers Graphika and the Stanford Internet Observatory. While the researchers did not attribute the sham accounts to the U.S. military, two officials familiar with the matter said that U.S. Central Command is among those whose activities are facing scrutiny. Like others interviewed for this report, they spoke on the condition of anonymity to discuss sensitive military operations.

The researchers did not specify when the takedowns occurred, but those familiar with the matter said they were within the pasttwo or three years. Some were recent, they said, and involved posts from the summer that advanced anti-Russia narratives citing the Kremlin’s “imperialist” war in Ukraine and warning of the conflict’s direct impact on Central Asian countries. Significantly, they found that the pretend personas — employing tactics used by countries such as Russia and China — did not gain much traction, and that overt accounts actually attracted more followers.

Centcom, headquartered in Tampa, has purview over military operations across 21 countries in the Middle East, North Africa and Central and South Asia. A spokesman declined to comment.

Air Force Brig. Gen. Patrick Ryder, the Pentagon press secretary, said in a statement that the military’s information operations “support our national security priorities” and must be conducted in compliance with relevant laws and policies. “We are committed to enforcing those safeguards,” he said.

Spokespersons for Facebook and Twitter declined to comment.

According to the researchers’ report, the accounts taken down included a made-up Persian-language media site that shared content reposted from the U.S.-funded Voice of America Farsi and Radio Free Europe. Another, it said, was linked to a Twitter handle that in the past had claimed to operate on behalf of Centcom.

One fake account posted an inflammatory tweet claiming that relatives of deceased Afghan refugees had reported bodies being returned from Iran with missing organs, according to the report. The tweet linked to a video that was part of an article posted on a U.S.-military affiliated website.

Centcom has not commented on whether these accounts were created by its personnel or contractors. If the organ-harvesting tweet is shown to be Centcom’s, one defense official said, it would “absolutely be a violation of doctrine and training practices.”

Independent of the report, The Washington Post has learned that in 2020 Facebook disabled fictitious personas created by Centcom to counter disinformation spread by China suggesting the coronavirus responsible for covid-19 was created at a U.S. Army lab in Fort Detrick, Md., according to officials familiar with the matter. The pseudo profiles — active in Facebook groups that conversed in Arabic, Farsi and Urdu, the officials said — were used to amplify truthful information from the U.S. Centers for Disease Control and Prevention about the virus’s origination in China.

The U.S. government’suse of ersatz social mediaaccounts, though authorized by law and policy, has stirred controversy inside the Biden administration, with the White House pressing the Pentagon to clarify and justify its policies. The White House, agencies such as the State Department and even some officials within the Defense Department have been concerned that the policies are too broad, allowing leeway for tactics that even if used to spread truthful information, risk eroding U.S. credibility, several U.S. officials said.

“Our adversaries are absolutely operating in the information domain,” said a second senior defense official. “There are some who think we shouldn’t do anything clandestine in that space. Ceding an entire domain to an adversary would be unwise. But we need stronger policy guardrails.”

A spokeswoman for the National Security Council, which is part of the White House, declined to comment.

Kahl disclosed his review at a virtual meeting convened by the National Security Council on Tuesday, saying he wants to know what types of operations have been carried out, who they’re targeting, what tools are being used and why military commanders have chosen those tactics, and how effective they have been, several officials said.

The message was essentially, “You have to justify to me why you’re doing these types of things,” the first defense official said.

Pentagon policy and doctrine discourage the military from peddling falsehoods, but there are no specific rules mandating the use of truthful information for psychological operations. For instance, the military sometimes employs fiction and satire for persuasion purposes, but generally the messages are supposed to stick to facts, officials said.

In 2020, officers at Facebook and Twitter contacted the Pentagon to raise concerns about the phony accounts they were having to remove, suspicious they were associated with the military. That summer, David Agranovich, Facebook’s director for global threat disruption, spoke to Christopher C. Miller, then assistant director for Special Operations/Low Intensity Conflict, which oversees influence operations policy, warning him that if Facebook could sniff them out, so could U.S. adversaries, several people familiar with the conversation said.

“His point‚” one person said, “was ‘Guys, you got caught. That’s a problem.’ ”

Before Miller could take action, he was tapped to head a different agency — the National Counterterrorism Center. Then the November election happened and time ran out for the Trump administration to address the matter, although Miller did spend the last few weeks of Donald Trump’s presidency serving as acting defense secretary.

With the rise of Russia and China as strategic competitors, military commanders have wanted to fight back, including online. And Congress supported that. Frustrated with perceived legal obstacles to the Defense Department’s ability to conduct clandestine activities in cyberspace, Congress in late 2019 passed a law affirming that the military could conduct operations in the “information environment” to defend the United States and to push back against foreign disinformation aimed at undermining its interests. The measure, known as Section 1631, allows the military to carry out clandestine psychologic operations without crossing what the CIA has claimed as its covert authority, alleviating some of the friction that had hindered such operations previously.

“Combatant commanders got really excited,” recalled the first defense official. “They were very eager to utilize these new authorities. The defense contractors were equally eager to land lucrative classified contracts to enable clandestine influence operations.”

At the same time, the official said, military leaders were not trained to oversee “technically complex operations conducted by contractors” or coordinate such activities with other stakeholders elsewhere in the U.S. government.

President Biden, right, Defense Secretary Lloyd Austin, left, and Chairman of the Joint Chiefs of Staff Gen. Mark A. Milley attend a Pentagon ceremony to remember the victims of 9/11. (Leigh Vogel/Bloomberg)

Last year, with a new administration in place, Facebook’s Agranovich tried again. This time he took his complaint to President Biden’s deputy national security adviser for cyber, Anne Neuberger. Agranovich, who had worked at the NSC under Trump, told Neuberger that Facebook was taking down fake accounts because they violated the company’s terms of service, according to people familiar with the exchange.

The accounts were easily detected by Facebook, which since Russia’s campaign to interfere in the 2016 presidential election has enhanced its ability to identify mock personas and sites. In some cases, the company had removed profiles, which appeared to be associated with the military, that promoted information deemed by fact-checkers to be false, said a person familiar with the matter.

Agranovich alsospoke to officials at the Pentagon. His messagewas: “We know what DOD is doing. It violates our policies. We will enforce our policies” and so “DOD should knock it off,” said aU.S. official briefed on the matter.

In response to White House concerns, Kahl ordered a review of Military Information Support Operations, or MISO, the Pentagon’s moniker for psychological operations. A draft concluded that policies, training and oversight all needed tightening, and that coordination with other agencies, such as the State Department and the CIA, needed strengthening, according to officials.

The review also found that while there were cases in which fictitious information was pushed by the military, they were the result of inadequate oversight of contractors and personnel training — not systemic problems, officials said.

Pentagon leadership did little with the review, two officials said, before Graphika and Stanford published their report on Aug. 24, which elicited a flurry of news coverage and questions for the military.

Army psyop graduates receive pins at the end of a field exercise reading “Persuade, Change, Influence.” (Cynthia McIntyre/Fort Hunter Liggett Public Affairs)

The State Department and CIA have been perturbed by the military’s use of clandestine tactics. Officers at State have admonished the Defense Department, “Hey don’t amplify our policies using fake personas, because we don’t want to be seen as creating false grass roots efforts,” the first defense official said.

One diplomat put it this way: “Generally speaking, we shouldn’t be employing the same kind of tactics that our adversaries are using because the bottom line is we have the moral high ground. We are a society that is built on a certain set of values. We promote those values around the world and when we use tactics like those, it just undermines our argument about who we are.”

Psychological operations to promote U.S. narratives overseas is nothing new in the military, but the popularity of western social media across the globehas led to an expansion of tactics, including the use of artificial personas and images — sometimes called “deep fakes.” The logic is that views expressed by what appears to be, say, an Afghan woman or an Iranian student might be more persuasive than if they were openly pushed by the U.S. government.

The majority of the military’s influence operations are overt, promoting U.S. policies in the Middle East, Asia and elsewhere under its own name, officials said. And there are valid reasons to use clandestine tactics, such as trying to infiltrate a closed terrorist chat group, they said.

A key issue for senior policymakers now is determining whether the military’s execution of clandestine influence operations is delivering results. “Is the juice worth the squeeze? Does our approach really have the potential for the return on investment we hoped or is it just causing more challenges?” one person familiar with the debate said.

The report by Graphika and Stanford suggests that the clandestine activity did not have much impact. It noted that the “vast majority of posts and tweets” reviewed received “no more than a handful of likes or retweets,” and only 19 percent of the concocted accounts had more than 1,000 followers. “Tellingly,” the report stated, “the two most-followed assets in the data provided by Twitter were overt accounts that publicly declared a connection to the U.S. military.”

Clandestine influence operations have a role in support of military operations, but it should be a narrow one with “intrusive oversight” by military and civilian leadership, said Michael Lumpkin, a former senior Pentagon official handling information operations policy and a former head of the State Department’s Global Engagement Center. “Otherwise, we risk making more enemies than friends.”

Excerpt from the article sourced above:

A LONG PATTERN OF INFILTRATION

45 years ago, legendary journalist Carl Bernstein released an investigation documenting how the CIA had managed to infiltrate U.S. and global media. The CIA had placed hundreds of agents into newsrooms and had convinced hundreds more reporters to collaborate with them. These included individuals at some of the most influential outlets, including The New York Times. The CIA needed to do this clandestinely because any attempt to do so openly would harm the effectiveness of the operation and provoke stiff public resistance. But by 2015, there was barely a murmur of disapproval when Reuters announced that it was hiring 33-year veteran CIA manager and director Dawn Scalici as a global director, even when the company announced that her primary responsibility was to “advanc[e] Thomson Reuters’ ability to meet the disparate needs of the U.S. government.”

Facebook, however, is vastly more influential than the New York Times or Reuters, reaching billions of people daily. In that sense, it stands to reason that it would be a prime target of any intelligence organization. It has become so big and ubiquitous that many consider it a de facto public commons and believe it should no longer be treated as a private company. Considering who is making many of the decisions on the platform, that distinction between public and private entities is even more blurry than many presume.

BONUS:

I’ve just brought to light insider information that confirms a very similar model has been pursued in USSR / Russia. I wonder if the two are eventually merging at the top, like Coca-Cola and Pepsi, seeing that Putin is a former Klaus Schwab disciple and a Davos regular.

Bottom line…

‘It’s warfare, not science’ – Dr. Nancy T. Banks – the legendary 2012 interview on vaccines & pharma

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

ORDER

! Articles can always be subject of later editing as a way of perfecting them

THERE’S NO BETTER PREVENTION THAN SHARING THE KNOWLEDGE FASTER THAN THEY SHARE THEIR PROPAGANDA!

The original title of this article was URGENT! DEBUNKING THE NEXT ENGINEERED PANDEMIC: NIPAH VIRUS. I expanded the scope because in the meantime I learned they are ramping up propaganda for all three. These viruses have more things in common, as you will find out below.

You should actually begin with this earlier report:

‘OBSCENE’ PANDEMIC BONDS ISSUED IN 2017 BY WORLD BANK FOR CORONAVIRUSES, MARBURG, EBOLA. DESIGNED TO FAIL

UPDATE 7, JAN 10 2022: Dr. Robert Malone Warns Of ‘Ebola-Like Hemorrhagic Fever’ Super Virus In China Caused By Mutations Due To Mass Vaccination

UPDATE 6: NOVEMBER 9, 2021:

To further develop the ChAd3 Ebola and Marburg vaccines, Sabin has entered into a Research Collaboration Agreement with the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases.
The Sabin Vaccine Institute, a non-profit organization founded in 1993, is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Sabin received more than $110 million for vaccine R&D programs from public and philanthropic funding sources, including the Bill & Melinda Gates Foundation, European Commission, Dutch Ministry of Foreign Affairs, Global Health Innovative Technology Fund and the Michelson Medical Research Foundation.

SABIN VACCINE INSTITUTE, August 6, 2019

Washington DC, Oct. 21, 2021 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute (Sabin) announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has exercised the third contract option, valued at $34.5 million, under the 2019 contract to advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials.  

In September 2019, BARDA awarded Sabin a development contract, valued up to $128 million, and has already provided funding of $40.5 million. This third contract option will enable continued nonclinical efficacy and safety studies, Phase 2 clinical trials in Africa, and vaccine manufacturing processes to ensure quality and safety.

In August, a case of Marburg disease was confirmed in the West African country of Guinea where the Ministry of Health officially declared an outbreak of Marburg.1 This recent case, as well as Marburg’s history of outbreaks and their potential for future devastating outbreaks, demonstrates that preventative measures are overdue to protect civilian populations, military personnel, first responders, health care workers and laboratory workers, both in the United States and abroad, against these emerging infectious diseases.

Ebola Sudan and Marburg viruses are closely related to Ebola Zaire virus, which has caused more than 2,200 deaths since 2018, leading the World Health Organization (WHO) to declare it a Public Health Emergency of International Concern. Like Ebola Zaire, Ebola Sudan and Marburg are among the world’s deadliest viruses, causing hemorrhagic fever with subsequent death in an average of 50 percent of cases.2,3

“Even as the world struggles with the COVID-19 pandemic, disease caused by Ebola Sudan and Marburg viruses continue to be a serious threat, as we have seen with the recent outbreak of Marburg in Guinea. We are grateful for BARDA’s continued support of Sabin’s efforts to advance vaccines against these deadly viruses,” said Sabin Chief Executive Officer Amy Finan. “We also thank our partners at the Vaccine Research Center of the NIH National Institute of Allergy and Infectious Diseases for their continued collaboration, and GSK for their earlier work on the candidates.” 

The two candidate vaccines, based on GSK’s proprietary ChAd3 platform, were exclusively licensed to the Sabin Vaccine Institute from GSK in 2019.

This project has been funded in whole or in part with federal funds from the U.S. Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number 75A50119C00055.

Learn more about Sabin’s Ebola Sudan and Marburg program.

This above is the official Sabin Inst. press release, this below isn’t:

November 4, 2021 – The U.S. CDC published a Level Three Travel Advisory for the recent Ebola outbreak in the Beni Health Zone of the Democratic Republic of the Congo.

November 3, 2021 – The U.S. CDC vaccine advisory committee reviewed previous recommendation preexposure vaccination with Ervebo for adults aged ≥18 years in the U.S. population who are at highest risk for potential occupational exposure to Ebola virus species Zaire ebolavirus because they are: responding to an outbreak of Ebola Virus Disease (EVD), or work as health care personnel at federally designated Ebola treatment centers in the U.S., or work as laboratorians or other staff at biosafety level 4 facilities in the U.S.

November 2, 2021 – The WHO reported additional cases and deaths confirmed in the Ebola virus disease outbreak in the Democratic Republic of the Congo with two new health areas affected. A total of 394 people (67 primary care providers including nine high-risk contacts, nine contacts of contacts, and 49 probable contacts) have been vaccinated including 182 contacts of contacts, 125 probable contacts, and 87 high-risk contacts.

October 29, 2021 – A Research Article – Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomized, placebo-controlled Phase II clinical trial in Africa – was published by the journal PLOS Medicine. Conclusion – The Ad26.ZEBOV and MVA-BN-Filo combo vaccination were well tolerated and immunogenic in healthy and HIV-infected African adults. Increasing the interval between vaccinations from 28 to 56 days improved the magnitude of humoral immune responses. Antibody levels persisted to at least 1 year, and an Ad26.ZEBOV booster vaccination demonstrated the presence of vaccination-induced immune memory. These data supported the approval by the European Union for prophylaxis against EBOV disease in adults and children ≥1 year of age.

October 27, 2021 – IAVI announced an award of up to US$126 million from the Biomedical Advanced Research and Development Authority to develop two recombinant vesicular stomatitis virus (rVSV)-vectored filovirus vaccine candidates. This award supports preclinical activities and includes options for clinical development up to and inclusive of a Phase II clinical trial of IAVI’s rVSV Sudan ebolavirus vaccine candidate (rVSVΔG-SUDV-GP). Optional work that would continue the development of IAVI’s Marburg virus vaccine candidate (rVSVΔG-MARV-GP) that is currently supported by the Defense Threat Reduction Agency of the U.S. Department of Defense could be funded at a later date.

“Vectored” means, most likely, mRNA or some other genetic / nanotech targeting technology.

October 20, 2021 – The WHO African Region reported 5 Ebola cases, and over 27,000 travelers have been screened in the DRC. Furthermore, over 116 people have been vaccinated.

October 17, 2021 – Africa News reported Ebola vaccinations started in Beni, DRC, after at least two people died due to the virus in October 2021. The WHO African Region Tweeted DRC Situation Report (17/10/21) 5 confirmed cases, three deaths, 369 contacts identified, and 308 contacts monitored.

October 13, 2021 – Democratic Republic of the Congo (DRC) health officials confirmed an Ebola vaccination campaign had launched in the North Kivu province where one confirmed Ebola case, plus three related suspected deaths, were recently reported. About 1,000 doses of the rVSV-ZEBOV Ebola vaccine and other medical supplies were delivered from the capital Kinshasa to Goma city in North Kivu. The DRC has more than 12,000 vaccine doses in Kinshasa that can be deployed if necessary.

October 10, 2021 – The WHO reported additional Ebola cases related to the recent DRC case of a 3-year-old boy. A cluster of three deaths (two children and their father) who were neighbors of the case. These three patients died on 14, 19, and 29 September 2021 after developing symptoms consistent with Ebola. However, none were tested for the virus. As of October 9th, a total of 148 contacts have been identified and are under follow-up by the local response team.

October 8, 2021 – A case of Ebola has been confirmed in the eastern Democratic Republic of the Congo, five months after the end of the most recent Ebola outbreak there. The child died on October 6th. It was not immediately known if the Ebola case was related to the 2018-20 outbreak that killed more than 2,200 people in eastern Congo or the flare-up that killed six people in 2021.

September 13, 2021 – A new study based in Sierra Leone concluded the Ebola vaccine regimen from Janssen – J&J. It was found well tolerated with no safety concerns in children aged 1–17 years and induced robust humoral immune responses, suggesting the suitability of this regimen for Ebola virus disease prevention in children.

August 31, 2021 – The government of Cote d’Ivoire has informed the WHO that a second laboratory has tested samples from a patient suspected of having Ebola and has found no evidence of the virus. Around a dozen WHO experts were mobilized to support the country’s efforts, and 5,000 Ebola vaccine doses which WHO had helped Guinea procure were sent from Guinea to Cote d’Ivoire.

August 23, 2021 – The WHO African region reported Ebola booster dose vaccinations in Sierra Leone following administration of the prime dose of the Johnson & Johnson Ebola vaccine in May 2021. Frontline health workers, practitioners of traditional medicines or traditional healers, and commercial motorbike riders who received the first dose are now given their second jab to maximize their protection against the disease. 

August 17, 2021 – The WHO confirmed Cote d’Ivoire deployed 2,000 vaccine doses from Merck and around 3,000 vaccine doses manufactured by Johnson & Johnson – Janssen.

August 14, 2021 – The WHO Africa reported the Ministry of Health of Cote d’Ivoire today confirmed the country’s first case of Ebola since 1994. This came after the Institut Pasteur in Cote d’Ivoire confirmed the Ebola Virus Disease in samples collected from a patient hospitalized in Abidjan’s commercial capital after arriving from Guinea.

August 9, 2021 – The WHO confirmed ‘Marburg virus disease (MVD) is a highly virulent, epidemic-prone disease associated with high case fatality rates (CFR 24-90%). In the early course of the disease, the clinical diagnosis of MVD is difficult to distinguish from other tropical febrile illnesses because of the similarities in the clinical symptoms. Differential diagnoses to be excluded include Ebola virus disease, as well as malaria, typhoid fever, leptospirosis, rickettsial infection, and plague.’

June 15, 2021 – The Southwest National Primate Research Center at Texas Biomedical Research Institute (Texas Biomed) has been awarded more than $37 million from the U.S. National Institutes of Health to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe.

June 4, 2021 – Johnson & Johnson welcomed a new recommendation by the Strategic Advisory Group of Experts on Immunization for the WHO that supports the use of the Johnson & Johnson Ebola vaccine regimen both during outbreaks for individuals at some risk of Ebola exposure and preventively, in the absence of an outbreak, for national and international first responders in neighboring areas or countries where an outbreak might spread.

June 4, 2021 – J&J confirmed about 235,000 people had received at least the first dose of the Janssen two-dose Ebola vaccine regimen.

April 10, 2021 – The government of Sierra Leone and the WHO announced Johnson & Johnson had donated about 4,500 Zabdeno and Mvabea Ebola vaccines to Sierra Leone to help prevent any Ebola outbreak. The last Ebola outbreak in Sierra Leone was in 2016.

March 25, 2021 – Ohio Gov. Mike DeWine revealed health officials are monitoring 44 people who have returned from areas of Africa with active outbreaks of Ebola.

March 25, 2021 – Oregon public health officials announced they are monitoring four people who recently visited the West African countries of Guinea and the Democratic Republic of the Congo. Regions in each of these countries are currently experiencing outbreaks of Ebola virus disease. The Oregon Health Authority and local public health departments have been in contact with these individuals, considered “persons under monitoring” since they arrived in the state earlier in March 2021.

March 23, 2021 – The WHO African Region Tweeted Guinea Ebola outbreak Situation Report (22/03/21) 18 cases, nine deaths, 78 contacts, 82% monitored. And 3,905 people have been vaccinated.

March 13, 2021 – After a request from the Guinean authorities, Russia is considering supplying a domestic vaccine against the Ebola virus to the African country, reported TASS.

May 13, 2020 – BARDA Provides the Sabin Vaccine Institute with an Additional $20 Million for Further Development of Ebola Sudan and Marburg Vaccines

The Sabin Vaccine Institute (Sabin) and its partner ReiThera Srl today announced that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, has exercised the first two options, valued at $20 million, under the 2019 contract to advance the development of vaccines against Ebola Sudan and Marburg viruses through Phase 2 clinical trials. In September 2019, BARDA awarded Sabin a development contract, valued at $128 million, and provided the initial funding award of $20.5 million. This second $20 million award will enable the manufacture and release of clinical vaccine material developed by ReiThera, a specialist in the development and cGMP manufacture of adenoviral vector vaccines. The funding will also support non-clinical studies to evaluate efficacy and immune response.

UPDATE 5: NOVEMBER 7, 2021: MARBURG GOES VIRAL ON INTERNET ONLY, YET. I’m happy awareness increases, it’s crucial. I’ve addressed this virus below, but not many had the patience to go through all text, and I kind of understand them, but there’s no easier way than reading.
Here’s another angle to keep in sight when computing all this info:

UPDATE 4: OCTOBER 19 2021: THE FEARPORN CAMPAIGN TAKES SPEED AS IF THEY ARE TO RELEASE THIS SOON. IF YOU FALL FOR THEIR BRAINWASH, THEY HAVE NO REASON TO STOP.

And they’re still not running out of stupid ideas we can see through:

UPDATE 3: OCTOBER 17 2021:

TOLD YA!

Guess who has a vaccine in works for it

Oh, look who pushes the fear! Exactly who I would’ve expected:

Later update: In the meantime I’ve learned that Marburg (an Ebola relative) and Xinjiang fever, a Chinese relative of the Yellow Fever virus, are also top candidates, and that goes in line with the Fauci e-mails I highlighted below. I will be back with more details shortly. Almost certainly it will be some form of hemorrhagic fever, most likely to cover for injections side-effects on the blood stream.

UPDATE 2:

One month later, they’re starting to catch up and it’s still not too late to un-play it if this goes BOOM NOW!



By the end of last century, The Military has abandoned you and has joined Pharmafia and the super-rich elites in a plan to govern you with bioweapons and psy-ops. As I’ve said many times, Big Pharma and Big Tech are long gone, The Military BioTech Complex has been running the show for quite a while.
This is just a chapter from that book, more to come if we get some love.

WHAT YOU NEED TO KNOW:

INDIA BLACKLISTED US CDC FOR SECRETLY FUNDING BIOWEAPONS RESEARCH IN MANIPAL – Silview.media

Government pulls up U.S. agency for work on Nipah virus – The Hindu

NIPAH IS ONE OF THREE VIRUSES MODIFIED BY WUHAN LAB AT NIAD’S REQUEST, FAUCI E-MAIL REVEAL – Silview.media

SOURCE

Canadian lab’s shipment of Ebola, Henipah viruses to China raises questions

  • Henipah and Nipah are interchangeable

Scientists at the National Microbiology Lab sent live Ebola and Henipah viruses to Beijing on an Air Canada flight March 31, and while the Public Health Agency of Canada says all federal policies were followed, there are questions about whether that shipment is part of an ongoing RCMP investigation.

Ebola and Henipah are Level 4 pathogens, meaning they’re some of the deadliest viruses in the world. They must be contained in a lab with the highest level of biosafety control, such as the one in Winnipeg. 

Two months after that shipment, on May 24, the Public Health Agency of Canada (PHAC) referred an “administrative matter” to RCMP that resulted in the removal of two Chinese research scientists — Xiangguo Qiu and Keding Cheng — and several international students on July 5. 

Both agencies have said repeatedly that public safety has not been at risk. 

PHAC will not confirm if the March 31 shipment is part of the RCMP investigation.

Strict protocols

Several sources, who have asked to remain anonymous because they fear for their jobs, say the pathogens may have been shipped to the Chinese Academy of Sciences in a way that circumvented the lab’s operating procedures, and without a document protecting Canada’s intellectual property rights.

Researchers working at the National Microbiology Lab on cutting-edge, high-containment research are not allowed to send anything to other countries or labs without the intellectual property office negotiating and having a material transfer agreement in place, in case the material sent leads to a notable discovery.

A PHAC spokesperson did not confirm if this shipment included such an agreement.

However, Eric Morrissette said it’s “routine” for the lab to share samples of pathogens and toxins with partners in other countries to advance scientific work worldwide.

The transfers follow strict protocols, including requirements under the Human Pathogens and Toxins Act(HPTA), the Transportation of Dangerous Goods Act, theCanadian Biosafety Standard and the lab’s standard operating procedures, Morrisette added.

“All transfers of Risk Group 4 samples follow strict transportation requirements and are authorized by senior officials at the lab and the NML tracks and keeps electronic records of all shipments of samples in accordance with the HPTA. Agreements for the transfer of materials are determined on a case-by-case basis,” Morrisette wrote in an email statement.

“On the specific shipments to China earlier this year, we can confirm that we have all records pertaining to the shipment, and that all protocols were followed as directed by the above Acts and Standards.”

Sources say Xiangguo Qiu and her husband, Keding Cheng, were escorted from the National Microbiology Lab in Winnipeg on July 5. (Governor General’s Innovation Awards)

Xiangguo Qiu is head of the National Microbiology Lab’s Vaccine Development and Antiviral Therapies section in the Special Pathogens Program. She is responsible for the lab that works with Ebola. Her husband, Keding Cheng, is also a PHAC biologist. 

After their security clearance was revoked and they were escorted from the lab, the University of Manitoba also cut ties with them and re-assigned Qiu’s graduate students, pending the RCMP investigation. No charges have been laid.

Neither scientist has responded to requests for comment, although some of their former colleagues say Qiu is not just a world-renowned scientist who helped develop a treatment for Ebola, but also a researcher with ethics and integrity.

Case raises questions 

One question raised by this case is that of intellectual property protection, says Leah West, who practises, studies and publishes in the field of national security law and lectures at the Norman Paterson School of International Affairs.

“If China was leveraging these scientists in Canada to gain access to a potentially valuable pathogen or to elements of a virus without having to license the patent  … it makes sense with the idea of China trying to gain access to valuable IP without paying for it,” she said.

Leah West says she hopes the lab and Health Canada are doing an investigation in addition to the one the RCMP is conducting. (Submitted by Leah West)

West accepts PHAC’s assertion that public safety is not an issue, even though the viruses were transported on a commercial Air Canada flight.

However, she says the fact the RCMP is involved means there’s a legitimate concern.

“You don’t send a policy breach, a bureaucratic policy breach, to the RCMP to investigate unless you believe that that policy breach has resulted in a criminal offence or could have resulted in a criminal offence. So what is the criminal offence potentially here?” West said.

She said she hopes the lab and Health Canada are also doing an internal investigation.

“I think there will need to be an inquiry into the scientists to potentially see whether or not they were compromised or any elements of their work were compromised and that China gained illegal or improper access to Canadian intellectual property … to see what China may have gained access to without knowledge, prior to this incident,” West says.

Don’t ‘jump into any conclusions too quickly’

However, the deputy director of the University of Alberta’s China Institute is urging caution when it comes to making assumptions. 

Jia Wang doesn’t dispute China has been involved in the past in espionage and intellectual property theft, but she says that country is making big investments in developing STEM (science, technology, engineering and mathematics) scholars and then putting that into innovation.

China has its own reasons to protect intellectual property because many new ideas are coming from there, Wang says.

She’s waiting to see what comes of the RCMP investigation of the lab in Winnipeg.

“As China observers, we’d like to perhaps gently remind people not to jump into any conclusions too quickly,” she said.

“It will be good to get to the bottom of this and see what might have gone wrong and what was the oversight and how can the procedures be improved or people involved can be reminded of how to adhere to the policies better.”

Jia Wang, deputy director of the University of Alberta’s China Institute, is advising caution about making assumptions concerning the case. (Submitted by Jia Wang)

The shipment of the viruses took place at a time when relations between Canada and China have been strained over the arrest of a Huawei executive, at the request of the United States. 

In retaliation, China has detained two Canadians and is boycotting Canadian canola and pork.

Because of the strained relationship between the two countries, and this case at the lab, Chinese-Canadian researchers and academics are starting to worry they may be singled out and targeted, Wang said.

“Certain assumptions are made or their loyalty to Canada is questioned in any way. And as multicultural as we are in Canada, we don’t want to see that.”  – CBC, 2019

SOURCE

On December 19, 2019, the U.S. Food and Drug Administration announced the approval of Ervebo to prevent EVD caused by Zaire ebolavirus in individuals 18 years of age and older. This report, published by the U.S. CDC on January 8, 2021, summarizes the Advisory Committee on Immunization Practices (ACIP) recommendations for using the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the USA.

On July 1, 2020, the European Medicines Agency granted Johnson & Johnson Janssen’s Zabdeno and Mvabea Ebola vaccine therapy, a prime-boost vaccination approach for preventing infectious diseases. Janssen’s Ebola vaccine regimen is specifically designed to induce long-term immunity against the Ebola virus in adults and children aged one year and above.

CanSino Biologics’s Ad5-EBOV Ebola vaccine received approval in China in October 2017. Ad5-EBOV is an adenovirus type 5 vector-based Ebola virus disease vaccine that protects against Ebola by relying on the recombinant replication-defective human adenovirus type-5 vector immune response. In addition, Ad5-EBOV is manufactured as a lyophilized powder, highly stable, and does not require storage at ultra-low temperatures. This feature renders it viable for use in resource-limited tropical areas.

The WHO published the revised Ebola Vaccine FAQ on January 11, 2020.

In 2019, World’s deadliest viruses were ‘shipped to Wuhan ‘leak lab’ from Canada by rogue scientists linked to Chinese military’ – The Sun

Experts Say Nipah Virus Has Potential To Be Another Pandemic — With A Higher Death Toll – Yahoo

What is Henipavirus?

Henipaviruses belong to the family of paramyxoviruses. Two species have been identified to be zoonotic, causing disease in animals. These are the Hendra virus (HeV) and the Nipah virus (NiV). They produce severe and often fatal illness in humans and horses.

News-Medical.net

THAT IS TO SAY ‘NIPAH’, ‘HENIPAH’ AND ‘HENIPAVIRUS’ ARE INTERCHANGEABLE HERE

Samples from early Wuhan COVID-19 patients show the presence of genetically modified Henipah virus, an American scientist has found.

Henipah was one of the two types of viruses sent to China by Chinese-born scientists from a Canadian laboratory at the centre of a controversy over the firing of the scientists and collaboration with Chinese military researchers. It is not clear whether the virus found in the Chinese samples is related to the samples sent by the Canadian lab, which were shipped in late March 2019.

The finding was confirmed for The Epoch Times by another qualified scientist.

The evidence was first found by Dr. Steven Quay, a Seattle-based physician-scientist and former faculty member at the Stanford University School of Medicine, who looked at early COVID-19 samples uploaded by scientists at the Wuhan Institute of Virology (WIV) shortly after China informed the World Health Organization about the SARS-CoV-2 outbreak.

Epoch Times Photo
Chinese virologist Shi Zhengli is seen inside the P4 laboratory in Wuhan, China, on Feb. 23, 2017. (Johannes Eisele/AFP via Getty Images)

The samples from the patients, who reportedly were found to have the “unknown pneumonia” in December 2019, were uploaded to the genetic sequence database, GenBank, on the website of the U.S. National Institute of Health (NIH).

Quay says that while other scientists around the world were mostly interested in examining the genome of SARS-CoV-2 in the samples uploaded by the WIV scientists, he wanted to see what else was in the samples collected from the patients.

So he collaborated with a few other scientists to analyze sequences from the samples.

“We started fishing inside for weird things,” Quay told The Epoch Times.

What they found, he says, are the results of what could likely be contamination from different experiments in the lab making their way into the samples, as well as evidence of Henipah virus.

“We found genetic manipulation of the Nipah virus, which is more lethal than Ebola.” Nipah is a type of Henipah virus.

The Epoch Times asked Joe Wang, PhD, who formerly spearheaded a vaccine development program for SARS in Canada with one of the world’s leading pharmaceutical companies, to verify the finding. Wang is currently the president of NTD Television Canada, the sister company of The Epoch Times in Canada.

After examining the evidence, Wang said he was able to replicate Quay’s findings on the Henipah virus. He explains that the genetic manipulation of the virus was likely for the purposes of vaccine development.

Winnipeg Lab

The firing of Chinese-born scientist Xiangguo Qiu and her husband, Keding Cheng, from the National Microbiology laboratory (NML) in Winnipeg has been the subject of much controversy in Canada, with opposition parties pressing the government for more details on the case, and the government refusing to release information citing national security and privacy concerns.

Qiu and Cheng along with several Chinese students were escorted out of NML, Canada’s only Level 4 lab, in July 2019, amid a police investigation. The two scientists were formally fired in January 2021.

The Public Health Agency of Canada (PHAC), which is in charge of NML, said the termination was the result of an “administrative matter” and “possible breaches of security protocols,” but has declined to provide further details, citing security and privacy concerns.

Epoch Times Photo
House Speaker Anthony Rota admonishes Public Health Agency of Canada President Iain Stewart in the House of Commons on June 21, 2021, for failing to provide documents related to the firing of two scientists from the National Microbiology Laboratory in Winnipeg. (The Canadian Press/Sean Kilpatrick)

During her time at NML, Qiu travelled several times in an official capacity to WIV, helping train personnel on Level 4 safety. The Globe and Mail later reported that scientists at NML have been collaborating with Chinese military researchers on deadly pathogens, and that one of the Chinese military researchers worked at the high-security Winnipeg lab for a period of time.

Documents and emails released by PHAC show that the shipment of Henipah and Ebola samples was done with the permission of NML authorities.

In one of the emails sent in September 2018, David Safronetz, chief of special pathogens at PHAC, informs then-head of NML Matthew Gilmour and other lab administrators about the request from WIV for the shipment of the samples, saying “I trust the lab.”

In response, Gilmour asks about the nature of the work that will be done at the Wuhan lab, and why the lab doesn’t get the material from “other, more local labs.” He also tells Safronetz that it’s “good to know that you trust this group,” asking how NML was connected with them.

In his reply, Safronetz doesn’t specifically say what the samples will be used for in China, but notes they will only be sent once all paperwork and certification is completed. He also says the WIV is requesting the material from NML “due to collaboration” with Qiu.

He adds, “Historically, it’s also been easier to obtain material from us as opposed to US labs. I don’t think other, closer labs have the ability to ship these materials.”

Gilmour resigned from his position at NML in May 2020 and joined a UK-based bioresearch company.

MPs have asked NML management why shipment of the samples was allowed and whether they knew if China performs any Gain of Function (GoF) research at WIV. GoF research involves increasing the lethal level (virulence) or transmissibility of pathogens.

NML’s acting scientific director general Guillaume Poliquin told MPs during a parliamentary committee meeting on March 22 that the lab only sent the samples to WIV after receiving assurance that no GoF research would take place.

Conservative MP John Williamson pressed for more answers, saying the word of the state-run Chinese lab can’t be trusted as the Chinese regime “has a history of theft and lies.”

The issue of GoF research at WIV has been a point of contention in the United States between lawmakers and Dr. Anthony Fauci, NIH’s head of the National Institute of Allergy and Infectious Diseases, whose organization has funded research (through EcoHealth Alliance) on coronaviruses at the Wuhan lab. U.S. Sen. Rand Paul says published work from WIV on coronaviruses shows the lab is conducting GoF research, a charge Fauci denies.

Epoch Times Photo
The P4 laboratory on the campus of the Wuhan Institute of Virology in Wuhan, China, on May 13, 2020. (Hector Retamal/AFP via Getty Images)

The Epoch Times sought comment from PHAC, including as to how the agency addressed issues of intellectual property and the development of any products such as vaccines with WIV, but didn’t hear back by time of publication.

Despite repeated requests by opposition parties for more details related to the firing of the two NML scientists, the Liberal government has refused to provide records, saying there are national security and privacy concerns.

After the House of Commons issued an order for the government to disclose the information, the government took the Speaker of the House to court to obtain confirmation from a judge that it can withhold the documents. The government later dropped its court case once Prime Minister Justin Trudeau called an election and Parliament was dissolved. – Epoch Times

LATER UPDATE: JUST LEARNED NIPAH WAS THE INSPIRATION FOR ANOTHER DRILL VERY SIMILAR TO EVENT201 – CLADE-X

NOTEWORTHY: Germany is the epicenter of this psyop, in their scenario

‘For the next pandemic, we’ll have gigantic mRNA factories in India’ – Bill Gates

The next pandemic: Nipah virus? – Bill Gates’ GAVI

SOURCE

Oh, look, a Dutch NGO on Taiwan TV pushing Nipah fearporn to WHO as early as February 2021:

SOURCE

India fighting to contain Nipah, a virus deadlier than COVID-19 – NY Post

Experimental drug by Gilead completely effective against Nipah virus infection in monkeys – NIH

ALSO IN 2019, INDIA CONDUCTS NIPAH OUTBREAK DRILLS. OFFICIALS SAY THEY HOPE FOR FULL PREPAREDNESS BY 2022:

ECO-HEALTH ALLIANCE INVOLVED AGAIN!

Remember the host?

THERE ARE SEVERAL PATENTS FOR NIPAH DRUGS AND SOME ARE mRNA GENE THERAPIES REGISTERED AS VACCINES

SOURCE
SOURCE
SOURCE

UPDATE 3: I FOUND CREDIBLE SOURCES FOR MOST OF DR. ARYANA LOVE’S EXPLOSIVE CLAIMS BELOW:

I didn’t have an in depth look at all her sources, I can’t have a final 100% verdict, but I did more than a glance and no lies detected. You can review her blog post yourself HERE.
This might be the closure to this report and the start for another.

OBAMA: EBOLA RESPONSE A TRIAL RUN FOR A POTENTIAL AIRBORNE VIRUS THAT MIGHT HIT SOON (2014)

BONUS

This is from 2014, but the story goes a way long back. And forward. Let’s not forget Putin is a Davos regular since before he became such a literal czar.

‘Contagion’ Reality Check: CDC Experts Explore Some of the Film’s Scenarios – PBS

WE ARE BEING PRIMED FOR THE DARKEST WINTER

To be continued?
Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them